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This thesis describes development of enantioselective additions of fluorocarbon 
nucleophiles using bifunctional organic catalysts. 
A brief historic overview of asymmetric organocatalysis was provided in Chapter 
1, in particular, chiral Brønsted acid organocatalysis was discussed. A selection of 
examples showing recent advancements in this field of catalysis was described in 
detail. 
In Chapter 2, α-fluorinated β-ketoesters were employed as nucleophiles, and their 
conjugate addition to nitroolefin could be effectively catalyzed by cinchona alkaloid-
based bifunctional thiourea organocatalysts. The products containing adjacent 
quaternary fluorinated and tertiary chiral centers were obtained in high yield and with 
up to 19:1 diastereomeric ratio and excellent enantioselectivity, and synthetic useful 
chiral structural scaffolds with three contiguous stereogenic centers were also derived. 
In Chapter 3, we introduced a novel tryptophan-based bifunctional thiourea 
catalyst that was remarkable effective in promoting the asymmetric Mannich reaction 
of α-fluorinated β-ketoesters. The resulting compounds with fluorinated quaternary 
and tertiary stereocenters were converted readily into α-fluoro-β-lactams. We have 
also shown that tertiary amine-thiourea bifunctional catalysts can be easily derived 
from natural amino acids, this strategy may lead to the discovery of various novel 
multifunctional organic catalysts. 
In Chapter 4, an enantioselective, organocatalytic asymmetric route was chosen 
for the preparation of α-fluoro-α-hydrazino β-ketoesters, potential precursors for α-
fluoro-α-amino acids. Towards this end, novel bifunctional chiral guanidine catalysts 
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Chapter 1 Introduction 
 
1.1 Asymmetric Organocatalysis 
Molecular chirality is a very important element in nature.1 A wide range of 
biological and physical functions are generated through precise molecular 
recognition that requires matching of chirality. A compound that contains a chiral 
center is called chiral compound. The demand for chiral compounds (often as single 
enantiomers) has increased sharply in recent years, driven by pharmaceutical 
industry and other applications such as agriculture chemicals, flavors and materials. 
Two-thirds of drugs are chiral and half of new chiral drugs are single enantiomers. 
Although most of the applications for chiral compounds are bio-related, materials 
science also relies on the properties imparted by chirality, notably in chiral polymers 
and liquid crystals. This widespread demand for chiral compounds has stimulated 
research to develop improved methods for synthesizing such compounds.  
Historically, chiral compounds were generated either by using chemical 
transformation of chiral precursors, or by resolving a racemic mixture of the two 
enantiomers. Each of these two approaches suffers from its own drawbacks: the 
former requires suitable precursors whereas the latter can only yield 50% of the 
desired enantiomer in theory. 
2 
 
Compared with these two old methods, asymmetric catalysis has significant 
advantages because it can generate many chiral products by continually regenerating 
each chiral catalyst. When chemists synthesize chiral compounds such as drugs, 
sugars, amino acids or nucleic acids—they usually use asymmetric catalysis, because 
a chiral catalyst can selectively accelerate the reaction that leads to one enantiomer. 
The field of efficient asymmetric catalysis can broadly be classified into three parts: 
enzymes catalysis, synthetic metal complexes catalysis and pure organic catalysts 
catalysis.2  
 Most biological molecules are synthesized by enzymes. Chemists also use 
enzymes to produce chiral compounds because perfect enantioselectivities often 
observed. This kind of biological catalysis is widely used on industrial scale and 
particularly favored for hydrolytic reactions.  In addition, high enantioselectivity can 
also be achieved using synthetic metal complexes as catalysts. This kind of catalysts 
provided a flexible ground for almost all types of reactions, and thus received much 
emphasis. Great progresses have been made from 1980 till now, which makes this 
area more and more attractive.3-25 However,  transition metal catalysis has its serious 
limitations such as high cost and toxicity of the metals, waste treatment resulted 
from uses of transition metals and tedious product contamination.26 
3 
 
In contrast, organocatalysts are purely “organic” molecules which are mainly 
composed of carbon, hydrogen, oxygen, sulfur, and phosphorus. The catalytic 
activity of organocatalysts resides in the low molecular weight organic molecule 
itself, and no transition metals are required. The advantages of organocatalysts are 
notable: robust, inexpensive, readily available, and non-toxic.  
 ‘Organic catalyst’ was first introduced by Otswald in 1900, with the purpose of 
distinguishing organic compounds as catalysts from that of enzymes and inorganic 
compounds.27 A few years later, Bredig reported the first example of an asymmetric 
reaction using organic catalysts.28 The hydrocyanation of benzaldehyde was 
catalyzed by the Cinchona alkaloids quinine 1 and quinidine 2. The products 3a and 
3b obtained had opposite chirality, although the enantioselectivity of these reactions 
were very poor (≤ 10%) (Scheme 1.11). The restudy of Bredig’s asymmetric 
hydrocyanation  reaction by Prelog in the 1950s undoubtedly promoted the concept 
of asymmetric catalysis, and led the way to more efficient reactions.29 In the late 
1950s, Pracejus reported that the use of O-acetyl-quinine 4 as the catalyst in the 
addition of methanol to methyl phenyl ketene could give 5 in 74% ee (Scheme 1.11).  
However, before the turn of the century, only a few examples of organocatalytic 
reactions were reported,30-34 such as the proline-catalyzed asymmetric Robinson 
annulation30-31 and phase-transfer catalyzed asymmetric alkylation reactions.32-34 
4 
 
Triggered by the groundbreaking study of Jacobsen,35-37 List,38-43 Maruoka,44-46 
MacMillan,47-51 and other researchers in the late 1990s and 2000s, there has been an 
enormous development in this field over the last few years.52-57  





































Scheme 1.11 Examples of asymmetric reactions using organic catalysts in the early 
age 
Organocatalysts can be broadly classified into four catagories: Lewis acids, 
Lewis bases, Brønsted acids, and Brønsted bases.58 The corresponding catalytic 
cycles are shown below (Scheme 1.12). Accordingly, Lewis acid catalysts (A) 
5 
 
initiates the catalytic cycle via electrophilic addition to the substrate (S:). The 
resulting intermediate undergoes a reaction and then releases the product (P) and the 
catalyst for further cycle. Lewis base catalysts (B:) initiate the catalytic cycle via 
nucleophilic addition to the substrates (S) in a similar manner. Brønsted acid and 
base catalytic cycles are initiated through a (partial) protonation or deprotonation, 
respectively.  Brønsted acid organocatalysis will be the main focus of this 
introduction. 
 






1.2 Chiral Brønsted Acids Organocatalysis 
1.2.1 Introduction 
 Nucleophilic addition to C=O and C=N bond is generally catalyzed by Lewis 
acid catalysts. A number of metal-centered Lewis acid catalysts have been developed 
and a wide range of center metals such as Ti, Zr, Cu, Al, Zn and others have been 
studied so far.59 The proton is the smallest element of the Lewis acid, that is 
Brønsted acid. While Lewis acids have been widely employed as catalysts for 
carbon-carbon bond formations, Brønsted acids have been used as catalysts mainly 
focus on the hydrolysis and formation of esters, acetals, etc. The synthetic utility of 
Brønsted acids as catalysts for carbon-carbon bond-forming reactions has been quite 
limited until recently. Chiral Brønsted acids as a new class of organocatalysts for 
enantioselective reactions has gained great development quite recently.
60-63 
 
There are three modes of electrophilic activation of carbonyl compounds: single 
hydrogen bonding, double hydrogen bonding and Brønsted acids as catalysis which 
can form oxonium/iminium ion species in the transition state (Figure 1.11). 
 
Figure 1.11 Three modes of electrophilic activation of carbonyl compounds 
7 
 
In this chapter, the recent development in chiral Brønsted acid catalysis will be 
discuessed, and the following four parts will be mainly focused: (1) hydroxyl-
containing catalysts, (2) thiourea catalysts, (3) guanidium salts, (4) chiral phosphoric 
acids. The first three catalysts are neutral or weak Brønsted acids and they are also 
called hydrogen-bonding catalysts. In contrast, phosphoric acids are much stronger 
acids which are called Brønsted acid in a narrow sense (Figure 1.12). 
 
Figure 1.12 Brønsted acid family 
 
1.2.2 Hydroxyl-containing  Organocatalysts 
 It has been acknowledged that significant rates acceleration of Diels-Alder 
reactions is found when the reactions performed in aqueous media.
64-66 
Kelly 
reported that electron deficient biphenylenediols 6 accelerated Diels-Alder reactions 
of cyclopentadiene and acrolein in 1990, and proposed that the aldehyde moiety was 
activated by two hydrogen bonds.67 This activation model is consistent with the 
Jørgensen’s model, which is based on the computational calculations on the rate 
acceleration of Claisen rearrangements and Diels-Alder reactions68,69 (Figure 1.13). 
8 
 
From these initial studies, two new types of hydrogen-bond donor organocatalysts 
emerged: TADDOL 8 and derivatives of BINOL 9, 10 (Figure 1.14). 
 
Figure 1.13 Kelly and Jørgensen’s activation models 
 
Figure 1.14 Structures of orgnaocatalysts TADDOL 8 and derivatives of BINOL 9, 
10  
TADDOL 8 was initially introduced by Rawal in 2003 in the hetero-Diels-Alder 
reaction of benzaldehyde and aminosiloxydiene to give a single diastereomer of 
cycloadduct 11, which was treated with AcCl to deliver hetero-Diels-Alder products 
with good yield and excellent enantioselectivity (Scheme 1.13).
70 
 
Scheme 1.13 TADDOL catalyzed hetero-Diels-Alder reaction 
9 
 
In 2006 Rawal et al. reported a highly diastereoselective, enantioselective, 
organocatalytic Mukaiyama aldol reactions of O-silyl-N, O-ketene acetals and 
aldehydes mediated by activation through hydrogen bonding. After the catalysts 
screening, a TADDOL derivative 13 gave the best result (Scheme 1.14).71 
 
Scheme 1.14 TADDOL catalyzed Mukaiyama aldol reaction 
This type of hydrogen bonding catalyst also turned out to be effective for the 
enantioselective nitroso aldol reactions. In 2005, Yamamoto et al. reported the 
nitroso aldol reaction between nitrosobenzene and enamines catalyzed by TADDOL 
8 to give N-nitroso aldol product in 77-91% ee. O-nitroso aldol products could also 





Scheme 1.15 TADDOL catalyzed nitroso aldol reaction of enamine 
The enantioselective Morita-Baylis-Hillman reaction catalyzed by BINOL 




Sasai and co-workers 
developed a series of bifunctional BINOL-derived catalysts such as 21, and reported 
an aza-Morita-Baylis-Hillman reaction (Scheme 1.17).74 Their results suggested that 
the 2-hydroxyl group worked as Brønsted acid and involved in the activation of 
imine, while the pyridine moiety functioned as a Lewis base and played an important 
role in attaining excellent enantioselectivity. 




Scheme 1.17 BINOL derivative catalyzed aza-Morita-Baylis-Hillman reaction 
Nitroso Diels-Alder-type reaction of nitrosobenzene and diene using binaphthol 
derivative 23 was reported by Yamamoto in 2007 (Scheme 1.18).75 With the 
hydrogen bonding of two hydroxyl groups in the bulky catalyst 23, high 
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1.2.3 Thiourea-based Catalyst 
1.2.3.1 Monofunctional Thiourea-based Catalyst 
The concept that ureas and thioureas can act as catalysts to activate electrophiles 
through double hydrogen-bonding has been investigated by many research groups. 
In 1990, Etter found hydrogen-bonded cocrystals of diaryl ureas bearing electron-
withdrawing groups with a variety of proton acceptors such as carbonyl compound 
(Figure 1.15).76-78 
 
Figure 1.15 Double hydrogen bonding monofunctional urea and thiourea catalysts  
In 1994, Curran found that catalytic diaryl urea 27 improved the reaction rate 
and diastereoselectivity in the allylation of cyclic α-sulfinyl radicals E and 
allyltributylstannane (Scheme 1.19).79 The stereochemistry and the rate acceleration 
are attributed to the double activation of the radical intermediate. In the following 




Scheme 1.19 Catalytic diaryl urea catalyzed radical addition reaction and Claisen 
rearrangement 
 Figure 1.16 Jacobsen’s monofunctional thiourea catalysts 
In 1998, a library of Schiff base derived thiourea catalysts were synthesized and 
reported by Jacobsen (Figure 1.16).81 These catalysts were initially designed as 
potential ligands for Lewis acidic metals. However, high enantioselectivity was 
observed in the absence of the metal ion when tested in the Strecker reaction of 




Scheme 1.20 Strecker reaction of hydrogen cyanide with N-allylaldimine 
Based on the structure modification and computational study, they proposed a 
double hydrogen bonding activation between the imine lone pair and the acidic N-H 
proton.82 This catalytic system is applicable to a wide range of reactions such as 
Mannich-type reaction of N-Boc-aldimine with ketene silyl acetals,83 
hydrophosphonylation of imines84 and the aza-Baylis-Hillman reaction (Scheme 
1.21).85 
Scheme 1.21 Reactions catalyzed by Jacobsen’s monofunctional thiourea catalysts 
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 In 2004, Nagasawa reported the use of chiral bis-thiourea 35 to promote the 
DMAP mediated asymmetric Baylis-Hillman addition of cyclohexenone and 
aldehydes to give the products with high enantioselectivity (Scheme 1.22).86 This 
high selectivity is proposed to come from bis-thiourea moiety being bound to the 
substrate during the transition state. This type of organocatalyst has been modified 
and applied to Friedel-Crafts addition of N-methyl indole and nitroolefins (Scheme 
1.23).87 
 



























Scheme 1.23 Friedel-Crafts addition catalyzed by bis-thiourea 
 
1.2.3.2 Bifunctional Thiourea-based Catalyst 
The first example of bifunctional catalyst bearing tertiary amine was reported by 
Takemoto in 2003, which gave excellent enantioselectivity in the Michael reaction 




The activation model 
proposed by Takemoto shows that the nitroolefin interacts with the thiourea moiety 
via double hydrogen-bonding, while the tertiary amine holds the malonate via a 
hydrogen-bond in the activated enol form (Figure 1.17). 
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Scheme 1.24 Enantioselective Michael Addition Reaction catalyzed by a tertiary 
amine thiourea 
 
Figure 1.17 Takemoto’s activation model of the Michael reaction between malonate 
esters and nitro alkenes  
In 2006, an alternative mode of this reaction was postulated based on density 
functional theory calculations by Pápai et al.
90 
In this case, the nitroolefin is 
activated by the protonated tertiary amine and the enolate is activated by the double 
hydrogen bonding of thiourea group (Figure 1.18). Both activation models predict 
the same (R)-configuration and the tightly organized transition state yield the 




Figure 1.18 Pápai’s activation model for the Michael reaction  
Other reactions have also been explored using this bifunctional thiourea catalyst, 






 Scheme 1.25 Enantioselective 1,4-additions and aza-Henry reactions catalyzed by 




Jacobsen et al. also synthesized bifunctional thiourea catalysts (Figure 1.19). 
These catalysts have been used in many reactions such as Nitro-Mannich reaction,95 
acyl-Picter-Spengler reaction, 96 hydrocyanation (Scheme 1.26).97 
 
Figure 1.19 Jacobsen’s bifunctional thiourea catalysts 
 
Scheme 1.26 Reactions catalyzed by Jacobsen’s bifunctional thiourea catalysts 
Wang et al. developed a novel bifunctional thiourea catalyst 51 with binaphthyl 
moiety for enantioselective Baylis–Hillman reactions. Catalyst 51 was found to 
promote the addition of cyclohexenone with a range of aldehydes in good yields and 
selectivities.98 Catalyst 51 has also been used to catalyze the enantioselective 




Scheme 1.27 Enantioselective Baylis–Hillman reaction and Michael addition 
reaction catalyzed by Wang’s novel bifunctional thiourea catalyst 
 
In 2005, Ricci et al. reported the Friedel-Crafts alkylation of indoles and 
nitroalkenes for the first time using a novel thiourea catalyst (Scheme 1.28).100 The 
transition state showed that the thiourea interacted with the nitro group and the free 
alcohol activated the indole proton via a weak hydrogen bond (Figure 1.20). 
 




Figure 1.20 Proposed transition state model of the thiourea-catalyzed addition of 
indole to nitroalkene 
 
Recently, a series of bifunctional thiourea catalysts, bearing cinchona alkaloid 
backbone have been synthesized (Figure 1.21).101 In 2005, Soόs et al. found the 
highly enantioselective 1,4-addition of nitromethane to α,β-unsaturated ketones 
catalyzed by 57a.102 Wang et al. reported 1, 4-addition of malonate esters to α,β-
unsaturated ketones using the same catalyst in the following year (Scheme 1.29).103 
 




Scheme 1.29 1,4-Addition to α,β-unsaturated ketones catalyzed by cinchona alkaloid 
derived thiourea catalyst 
 
1,4-Addition of malonate esters to nitroolefin catalyzed by cinchona alkaloid 
was reported by two research groups respectively. Dixon et al.104 employed 58 and 
Connon et al.105 utilized 57a (Scheme 1.30). In 2006, Deng et al. reported addition of 
malonate esters and indoles to N-Boc-imines and N-Ts-imines (Scheme 1.31).106,107  
 
Scheme 1.30 1,4-Addition of malonate esters to nitro olefin catalyzed by cinchona 
alkaloid derived thiourea catalyst 
 
 
Scheme 1.31 Addition of malonate esters and indoles to imines 
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Cinchona alkaloid thiourea catalyst 57b is also effective for the cascade 
Michael-aldol reaction between 2-mercaptobenzaldehyde and α,β-unsaturated 
oxazolidinones.108 Three chiral centers were controlled and excellent 
enantioselectivity was obtained (Scheme 1.32). 
 
Scheme 1.32 Cascade Michael-aldol reaction catalyzed by cinchona alkaloid catalyst 
 
1.2.4 Guanidium Salts 
In 1996, Lipton et al. reported the Strecker synthesis of amino acids employing 
a cyclic dipeptide with guanidine motif as catalyst, permitting the conversion of 
substituted imines to (S)-amino nitriles in high yield and enantioselectivity (Scheme 
1.33).109,110 
 
Scheme 1.33 Strecker synthesis of amino acids employing a cyclic dipeptide with 
guanidine motif as catalyst 
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Enantioselective Strecker synthesis of chiral α-amino nitriles from N-
Benzhydryl Imines catalyzed by C2-symmetric guanidine 68 was reported by Corey 
et al. in 1999.111 HCN hydrogen bonds to the catalyst, generating a guanidinium 
cyanide salt which serves as a hydrogen bond donor to activate the aldimine 
(Scheme 1.34). 
 
Scheme 1.34 Strecker synthesis of chiral α-amino nitriles catalyzed by C2-symmetric 
guanidine 
 
Terada et al. developed axially chiral guanidine 71 as an effective 
organocatalyst that promoted the highly enantioselective Michael reaction of 1,3-
dicarbonyl compounds with nitroalkenes in 2006.112 In the same year, a modified 
axially chiral seven-membered guanidine 72 has been synthesized and used in the 
electrophilic amination reaction of ketoesters and azodicarboxylate with very high 




Scheme 1.35 Axially chiral guanidinium catalysts for1,3-dicarbonyl addition 
reactions and α-hydrazination of β-ketoesters 
 
Tan et al. did modification to Corey’s guanidine catalyst and found that 
modified bicyclic guanidine 75 worked particularly well with conjugate addition 
type reactions (Figure 1.22).114  
 
Figure 1.22 Tan’s bicyclic guanidine 
 
1.2.5 Chiral Phosphoric Acid   
 In 2004, enantioselective Mannich reactions catalyzed by chiral phosphoric 
acid
 




 independently (Figure 1.23). The 
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results showed that 3,3’-positions, with different aryl groups of these catalysts 
played critical roles in the enantioselectivity (Scheme 1.36). 
 
Figure 1.23 Chiral phosphoric acids 
 
Scheme 1.36 Mannich reactions catalyzed by chiral phosphoric acids 
Akiyama et al. later reported the hydrophosphonylation of imines catalyzed by 
76d to give the product in good yield and high enantioselectivity (Scheme 1.37).117 
In this case, N-hydroxyphenyl-substituted imines were employed and proved to be 
important for excellent enantioselectivity because of nine-membered cyclic 
transition state, where the catalyst acts both as a Brønsted acid towards the imine 




Scheme 1.37 Hydrophosphonylation of imines catalyzed by chiral phosphoric acid 
 
Figure 1.24 Transition state model of the Hydrophosphonylation reaction 
Terada et al. later reported the new asymmetric aza-Friedel-Crafts reaction of 
Furan with N-Boc aldimines catalyzed by the chiral phosphoric acid 76h (Scheme 
1.38).118 This reaction provided an atom-economical route to synthesize furan-2-
ylamine derivatives in highly enantioselectivity.  
 
Scheme 1.38 Aza-Friedel-Crafts reaction of Furan with N-Boc aldimines catalyzed 
by the chiral phosphoric acid 
 
Phosphoric acid catalysts for the reductive amination reactions in the presence 
of Hantzsch ester as a nicotinamide adenine dinucleotide plus hydrogen (NADH) 
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independently (Scheme 1.39). 
 
Scheme 1.39 Phosphoric acid catalysts for the reductive amination reactions 
1.3 Project Objectives 
Chiral Brønsted acid catalysis is a rapidly growing area of organocatalysis. In 
this context, bifunctional organic molecules are remarkable useful organocatalysts in 
a wide range of organic reactions. They represent a powerful new mode of 
asymmetric catalysis. The main purpose of our study was to design, synthesize novel 
bifunctional organocatalysts, employ these catalysts in enantioselective 
organocatalytic additions of fluorocarbon nucleophiles, apply the new methodology 
to synthetic molecules, and explore the kinetic study of the catalyst with the 
substrates to gain more insight into their reaction mechanism. 
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Chapter 2 Asymmetric Generation of Fluorine-containing 
Quaternary Carbons Adjacent to Tertiary Stereocenters: 
Uses of Fluorinated Methines as Nucleophiles 
 
2.1 Chiral Fluorinated Molecules 
The electronegativity of fluorine is the largest among all the elements. The C-F 
bond length is shorter than the C-H bond but is much stronger in energy. The 
adjacent C–C single bonds are strengthened, whereas allylic C=C double bonds are 
weakened by F substitution.122 The carbon of a C-F bond is slightly polarized to δ+ in 
contrast to a carbon of a C-H bond. Thus, Substitution of hydrogen in biologically 
active molecules by fluorine often causes the size and stereoelectronic influences 
with big change. Accordingly, the organofluorine compounds demonstrate a variety 
of unique biological activities and physical properties.123 
 Organofluorine compounds are absent as natural products, until 1957, 5-
fluorouracil, an antineoplastic agent was firstly synthesized. It shows high anticancer 
activity by inhibiting the enzyme thymidylate to prevent the cellular synthesis of 
thymidine.124 Since then, synthetic fluorinated compounds are commonly used in 
medicinal chemistry to improve the metabolic stability, bioavailability, and protein-
ligand interactions. So far, more than 150 fluorinated drugs have come to market and 
make up 20~25% of all pharmaceuticals. Top-selling fluorinated pharmaceuticals 
include the antidepressant fluoxetine (Prozac), the cholesterol-lowering drug 
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atorvastatin (Lipitor) and the antibacterial ciprofloxacin (Ciprobay) (Figure 2.11). 
Although fluorine is very often found on aromatic rings, the enatioselective 
induction of the C-F bond at a stereogenic center has emerged as a clear goal in the 
synthesis of fluorinated compounds. To date, both nucleophilic fluorination125 and 
electrophilic fluorination126 have been developed.    
 
Figure 2.11 Top-selling fluorinated pharmaceuticals 
Quaternary stereocenters are very useful and can be found in a wide range of 
important pharmaceuticals and natural products. There is a growing need for 
efficient methodologies for asymmetric synthesis of  quaternary stereocenters in 
organic synthesis, and impressive progress has been made in the past twenty 
years.127 Catalytic synthesis of chiral fluorinated quaternary carbon centers is even 
more challenging and a number of approaches based on metal catalysis have been 
reported recently.128 In contrast to the transition metal-based fluorination methods, 
organocatalytic approaches for the preparation of fluorinated quaternary carbon 
centers are rather limited. In 2002, the first example of organocatalytic 
enantioselective fluorination with moderate enantioselectivity using the phase 
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transfer catalyst was reported by Kim and Park.129 In 2006, Jøgensen et al. reported 
the asymmetric α-fluorination of α-branched aldehydes to access fluorinated 
quaternary carbon centers with up to 90% ee.130 Recently, Shibata and co-workers 
disclosed a bis-Cinchona alkaloid catalyzed enantioselective fluorination of allyl 
silanes, silyl enol ethers and oxindoles.131 
Quaternary stereogenic centers adjacent to tertiary stereocenters are very 
common structural motifs in natural products, stereoselective synthesis of adjacent 
quaternary and tertiary stereocenters is one of the most challenging tasks in organic 
synthesis, and highly enantioselective methods to access these structural motifs are 
scarce.132 We became interested in developing an organocatalytic approach to 
construct chiral fluorinated quaternary stereogenic centers adjacent to tertiary 
stereocenters. To the best of our knowledge, highly enantioselective construction of 
fluorinated quaternary carbons adjacent to tertiary stereocenters has not yet been 
reported in the literature. Herein, we wish to report a Cinchona alkaloid-catalyzed 
asymmetric generation of fluorine-containing quaternary carbons adjacent to tertiary 
stereocenters using fluorinated methines as nucleophiles. 
Pure α-substituted α-fluorinated β-ketoesters are important molecules, and the 
presence of ketone moieties and ester groups allows for easily synthetic 
manipulations. There are two approaches for the construction of chiral α-fluorinated 
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α-substituted β-ketoesters adjacent to a tertiary stereocenter (Figure 2.12). One 
approach is asymmetric fluorination on the α-substituted β-ketoester, presumably 
due to the enol formation and the subsequent competing non-stereoselective 
fluorination reaction, an efficient highly enantioselective asymmetric organocatalytic 
fluorination of α-substituted β-ketoester has not yet been discovered. Another 
approach is to perform asymmetric carbon-carbon bond formation on the α-
fluorinated β-ketoesters, we envisioned that this method could be an easy solution, 
because the carbon–carbon bond-forming reactions of this type of substrate are well 
established in the literature.133 
Figure 2.12 Construction of adjacent fluorinated quaternary tertiary stereocenters 
 
2.2 Results and Discussion 
2.2.1 Preliminary Studies 
In our initial studies, a number of α-unsubstituted and α-substituted β-ketoesters 
were selected as nucleophiles, and their Michael additions to nitroolefins catalyzed 




Table 2.11 Screening of different ketoesters for the asymmetric Michael addition to   
nitroolefina 
 
Entry Product Catalyst drb eec (%) 
1 2-3a QD-1b 1 : 1 82/92 
2 2-3b QD-1b 1 : 1 85/85 
3 2-3c QD-1b 2 : 3 88/88 
4 2-3d QD-1b 2 : 3 93/94 
5 2-3e QD-1b 3 : 2 91/90 
6 2-3f QD-1b 5 : 1 94 
a The reactions were performed with ketoester (0.05 mmol), nitroolefin (0.05 
mmol) and catalyst (0.005 mmol) in solvent (0.1 ml) at room temperature, 
unless otherwise specified. Yields were estimated by 1H NMR analysis of 
the crude product. For entries 1-4, the reactions were run for 12h. b 
Determined by 1H NMR analysis of the crude product. c The ee value of both 





The α-unsubstituted β-ketoesters led to the formation of the products with high 
enantioselectivity, but no diastereoselectivity was observed (entries 1–3). Methyl 
substitution at the α-position did not improve the diastereoselectivity (entry 4). But 
the β-ketoesters with α-fluorine atoms gave promising results. The methyl ketone 
with α-fluorine atom led to the formation of product with low diastereoselectivity 
(entry 5), while the phenyl ketone with α-fluorine atom yielded the desired products 
with moderate diastereoselectivity and excellent enantioselectivity (entry 6) which 
meant that the ketone moieties in the nucleophiles were important in stereochemical 
control.  
 
2.2.2 Catalyst and Solvent Screening 
Based on the initial results, different Cinchona alkaloid-derived catalysts have 
been tested and showed similar catalytic activities (Table 2.12). Trifluoromethyl-
substituted thioureas worked slightly better than the non-fluorinated counterparts 
(entries 1–5). After solvents screening, toluene was found to be the best solvent for 
this reaction, and by lowering the reaction temperature to -20oC, we were able to 





Table 2.12 Screening of organocatalysts for the asymmetric Michael addition to 
nitroolefina 
 
Entry Product Catalyst Solvent drb eec (%) 
1 2-3f CD-1a toluene 4 : 1 -90 
2 2-3f CD-1b toluene 5 : 1 -94 
3 2-3f Q-1a toluene 4 : 1 -93 
4 2-3f Q-1b toluene 5 : 1 -94 
5 2-3f QD-1a toluene 4 : 1 91 
6 2-3f QD-1b CHCl3 5 : 1 91 
7 2-3f QD-1b THF 2 : 1 92 
8 2-3f QD-1b CH3CN 4 : 1 92 
9 2-3f QD-1b acetone 2: 1 88 
10d 2-3f QD-1b toluene 6 : 1 97 
a The reactions were performed with ketoester (0.05 mmol), nitroolefin (0.05 mmol) and 
catalyst (0.005 mmol) in solvent (0.1 ml) at room temperature， unless otherwise specified. 
Yields were estimated by 1H NMR analysis of the crude product. b Determined by 1H NMR 
analysis of the crude product. c The ee value of both diastereomers or the major 
diastereomers, determined by chiral HPLC analysis. d The reaction was carried out at -20oC. 
 
2.2.3 Substrate Scope 
2.2.3.1 Michael Acceptors 
In order to expand the reaction scope, a variety of ortho-, meta- and para-
substituted aryl and alkyl nitroolefins were synthesized and treated with 2-1f and 
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catalyst QD-1b in toluene
 
at –20 °C. The results of the nitroolefin screening are 
summarized in Table 2.13. 
Table 2.13 Diastereoselective and enantioselective Michael addition of α-fluorinated 
β-ketoester 2-1f to various nitroolefinsa 
 
Entry R Yieldb (%) drc eed (%) 
1 p-FC6H4 99 5 : 1 98 
2 m-BrC6H4 98 5 : 1 99 
3 p-BrC6H4 97 5 : 1 97 
4 o-ClC6H4 98 4 : 1 99 
5 p-MeC6H4 96 5 : 1 96 
6 p-MeOC6H4 96 5 : 1 97 
7 o-CF3C6H4 97 3 : 1 99 
8 p-CNC6H4 99 5 : 1 99 
9 o-MeC6H4 98 8 : 1 98 
10 2-Thiophene 97 6 : 1 96 
11e n-Butyl 95 6 : 1 97 
12e Isobutyl 96 6 : 1 96 
13f Cyclohexyl - - - 
a The reactions were performed with ketoester (0.05 mmol), nitroolefin (0.05 mmol) and 
catalyst (0.005 mmol) in solvent (0.1 ml) at -20oC. b Isolated yield. c Determined by 1H 
NMR analysis of the crude product. d The ee value of the major diastereomer, determined 




From the above table we can see that a wide range of aryl and alkyl nitroolefins 
could be used as Michael acceptors. In all the examples studied, almost quantitative 
yields and perfect enantioselectivities were achieved (entry 1-12). Cyclohexylvinyl 
benzene proved to be ineffective, presumably due to the steric hindrance induced by 
the substituent (entry 13). 
 
2.2.3.2 α-Fluorinated β-Ketoesters Screening 
We then investigated the effects of various ketone components in the 
asymmetric induction (Table 2.14). Different aryl ketonesters were employed, 
generating the desired products with moderate diastereoselectivity and excellent 
enantioselectivity (entries 1–8). When tert-butyl ketone was utilized, very high 
diastereoselectivity was obtained, and the enantioselectivity of the Michael addition 
product remained near perfect, although the reaction time doubled compared with 
other substrates (entries 9 and 10). However, tert-butyl ester turned out to be less 
effective, much longer reaction time was required to achieve moderate chemical 
yield, and there was no improvement in diastereoselectivity (entry 11). 




Entry R/Ar/R’ Yieldb (%) drc eed (%) 
1 p-OMeC6H4/Ph/Et 97 4 : 1 97 
2 m-ClC6H4/Ph/Et 98 4 : 1 96 
3 m-ClC6H4/p-FC6H4/Et 97 4 : 1 96 
4 p-NO2C6H4/Ph/Et 98 4 : 1 97 
5 p-NO2C6H4/p-MeC6H4/Et 96 3 : 1 96 
6 p-NO2C6H4/m-BrC6H4/Et 98 4 : 1 97 
7 p-CF3C6H4/Ph/Et 97 3 : 1 95 
8 p-CF3C6H4/o-ClC6H4/Et 96 3 : 1 95 
9e t-Bu/p-BrC6H4/Et 90 19 : 1 97 
10e t-Bu/p-MeC6H4/Et 90 19 : 1 98 
11f Ph/o-ClC6H4/t-Bu 65 2.5 : 1 98 
a The reactions were performed with ketoester (0.05 mmol), nitroolefin (0.05 
mmol) and catalyst (0.005 mmol) in solvent (0.1 ml) at -20oC. b Isolated yield. c 
Determined by 1H NMR analysis of the crude product. d The ee value of the major 
diastereomer, determined by chiral HPLC analysis. e Reactions were carried out at 
room temperature for 24h. f The reaction was run at room temperature for 48h. 
 
2.2.4 Chiral Pyrrolidine and Lactam Synthesis 
The Michael addition adducts containing fluorinated quaternary carbons and 
tertiary stereogenic centers could be easily converted into useful chiral structural 
scaffolds (Scheme 2.11). Reduction of the nitro group to amino functionality, 
followed by reductive amination yielded highly substituted chiral pyrrolidine 2-10. 
Alternatively, selective reduction of ketone, subsequent nitro reduction and 




Scheme 2.11 Conversion of fluorinated Michael adduct to a chiral pyrrolidine and 
lactam. 
 
2.2.5 Postulated catalyst mode of action 
On the basis of the observed reactivity and experimental results of the described 
reactions, we propose that this Michael addition reaction proceeds via a dual 
activation model. As shown in Figure 2.13, the ketoester and nitroolefin may get 
activated simultaneously through their interactions with cinchona alkaloid-derived 

























In summary, we have disclosed a highly enantioselective organocatalytic 
generation of fluorinated quaternary carbons adjacent to tertiary stereocenters using 
fluorinated methines as nucleophiles. We believe that our approach could 
complement the existing asymmetric fluorination method to access a wide range of 
chiral fluorinated molecules. Our results represent the first example in the literature 
that α-fluorinated β-ketoesters were used as nucleophiles, and highly functional, 
congested fluorinated quaternary and chiral tertiary centers could be constructed. 
Investigations to understand the origin of the observed high enantioselectivity and 
the full extension of the scope of different type of fluorinated nucleophiles are in 
progress. 
 
2.4 Experimental Section 
2.4.1 General Information 
Chemicals and solvents were purchased from commercial suppliers and used as 
received. 1H and 13C NMR spectra were recorded on a Bruker ACF300 or DPX300 
(300 MHz) or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in 
parts per million (ppm), and the residual solvent peak was used as an internal 
reference: proton (chloroform 7.26), carbon (chloroform 77.0). Multiplicity was 
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indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd 
(doublet of doublet), br s (broad singlet). Coupling constants were reported in Hertz 
(Hz). Low resolution mass spectra were obtained on a Finnigan/MAT LCQ 
spectrometer in ESI mode, and a Finnigan/MAT 95XL-T mass spectrometer in FAB 
mode. All high resolution mass spectra were obtained on a Finnigan/MAT 95XL-T 
spectrometer. For thin-layer chromatography (TLC), Merck pre-coated TLC plates 
(Merck 60 F254) were used, and compounds were visualized with a UV light at 254 
nm. Further visualization was achieved by staining with iodine, or ceric ammonium 
molybdate followed by heating on a hot plate. Flash chromatography separations 
were performed on Merck 60 (0.040 - 0.063 mm) mesh silica gel. The enantiomeric 
excesses of products were determined by chiral-phase HPLC analysis. 
Substrates 2-1f, 2-6a~f were prepared according to the literature procedures.135 
 
2.4.2 Representative Procedure 
 
Ethyl 2-fluoro-3-oxo-3-phenylpropanoate 2-1f (10.5 mg, 0.05 mmol) was added 
to a mixture of catalyst QD-1b (3 mg, 0.005 mmol) and nitrooelfin 2-2 (7.45 mg, 
0.05 mmol) in toluene (0.1 mL) in a sample vial. The vial was then capped and the 
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reaction mixture was stirred at -20 oC for 12 h and quenched with the addition of 
aqueous HCl (1 N). The organic layer was extracted with ethyl acetate three times (3 
x 5 mL). The combined organic extracts were dried over anhydrous Na2SO4, filtered, 
and concentrated in vacuo. Purification by flash column chromatography (ethyl 
acetate/hexanes = 1:15 to 1:5) afforded the desired product 2-3f as a white solid 
(17.1 mg, 95%). The enantiometric excess of product was determined by chiral 
HPLC analysis. 
 
2.4.3 Determination of Absolute Configurations of the Michael Products 
Determination of absolute configuration of 2-3f 
Michael adduct 2-3f was reduced to the corresponding alcohol by Ph3SiH/AlCl3. 
It was well documented in the literature136 that the reduction of α-fluoro-β-ketoesters 
by Ph3SiH/AlCl3 led to the formation of anti-isomer, and the formation of which can 
be explained by the chelation model shown below. Therefore, the configurations at 
the fluorine chiral center and the hydroxyl chiral center can be either both S or R. 
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Scheme 2.12 Selective reduction of Michael adduct 2-3f 
The absolute configuration at the hydroxyl chiral center was determined to be S, 
by using Mosher’s method.137 Thus, the configuration at the fluorine chiral center 
was assigned to be S (alcohol 2-8 in the Scheme 2.12). 
Lactam 2-9 derived from alcohol 2-8 was used to determine the chiral center at 
C1 in the Michael adduct. 2D-NOESY experiment showed correlation between Ha 
and Hb in lactam 2-9, thus absolute configuration of 2-9 could be determined 
(Scheme 2.13). The absolute configuration of Michael adduct 2-3f was deduced 
accordingly. Configurations of other Michael adducts were assigned by analogy. 
 
Scheme 2.13 2D-NOESY effect between Ha and Hb in lactam 2-9 
The below Scheme 2.14 describes the reaction employed in the assignment of 




Scheme 2.14 Reaction employed in the assignment of absolute configuration of 




To a stirring solution of 2-3f (230 mg, 0.64 mmol) in dichloromethane (3 mL) 
were added Ph3SiH (252 mg, 0.97 mmol) and AlCl3 (130 mg, 0.97 mmol) at -30 oC. 
The reaction mixture was kept at this temperature for 3.5 h. The mixture was then 
diluted with ether (5 mL), and saturated NaHCO3 was added. Aqueous layer was 
extracted with ether (3 x 10 mL), and the combined organic layers were washed with 
water and brine, and dried over Na2SO4. Purification by flash column 
chromatography (hexane: ethyl acetate = 5:1) afforded 2-8 as a white powder (201 
mg, 87%). 
1H NMR (300 MHz, CDCl3) δ 0.89-0.92 (t, 3H), 2.49-2.51 (m, 1H), 2.36 (s, 1H), 
3.85-3.96 (m, 2H), 4.34-4.45 (m, 1H), 5.02-5.27 (m, 3H), 7.28-7.35 (m, 10H); 13C 
NMR (125 MHz, CDCl3) δ 13.5, 47.6 (d, J = 25.5 Hz), 62.0, 74.8 (d, J = 19.1 Hz), 
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75.7 (d, J = 7.3 Hz), 98.6 (d, J = 203.1 Hz), 127.9, 128.0, 128.4, 128.6, 128.8, 129.1, 
133.7, 136.8, 168.3 (d, J = 22.7 Hz).  
 
Preparation of (R)-MTPA (2-methoxy-2-trifluoromethyl-2-phenylacetic acid) 
Ester A 
The compound 2-8 (18 mg, 0.05 mmol) was dissolved in CH2Cl2 (2 mL) and (R) 
– MTPA (23mg, 0.01 mmol), DCC (26mg, 0.125 mmol), DMAP (1.0 mg, 0.01 
mmol) was added at 0 oC. After stirring for 5 min at 0 oC and 0.5 h at room 
temperature, the reaction was quenched with water (1 mL) and ether (5 mL). The 
solution was washed with brine and dried over NaSO4. The solvent was removed in 
vacuo, and the residue was purified by column chromatography on silica gel (hexane: 
ethyl acetate = 10:1) to afford desired product A as colorless oil (23 mg, 80%). 
1H NMR (500 MHz, CDCl3) δ 0.88-0.99 (t, 3H), 3.47 (s, 3H), 3.88-3.96 (m, 2H), 
4.04-4.10 (m, 1H), 4.81-4.85 (dd, 1H), 5.07-5.12 (dd, 1H), 6.26-6.30 (d, J = 22.7 Hz), 
7.05-7.07 (m, 2H), 7.27-7.36 (m, 13H); 13C NMR (125 MHz, CDCl3) δ 13.5, 29.7, 
46.8, 55.7, 62.5, 75.2, 85.5, 97.5, 124.1, 127.2, 128.3, 128.6, 128.8, 128.9, 129.0, 
129.2, 129.9, 131.7, 132.0, 132.6, 166.4, 167.3; HRMS (IT-TOF) m/z calcd for 






1H NMR (500 MHz, CDCl3) δ 0.96-0.99 (t, 3H), 3.56 (s, 3H), 3.98-4.11 (m, 2H), 
4.12-4.17 (m, 1H), 4.76-4.80 (dd, J = 13.3 Hz, 3.75 Hz, 1H), 5.03-5.09 (dd, J = 13.2 
Hz, 11.3 Hz, 1H), 6.18- 6.23 (d, J = 20.8 Hz), 7.06-7.08 (m, 2H), 7.27-7.36 (m, 13H); 
13C NMR (125 MHz, CDCl3) δ 13.5, 29.7, 46.8, 55.7, 62.5, 75.2, 85.5, 97.5, 124.1, 
127.2, 128.3, 128.6, 128.8, 128.9, 129.0, 129.2, 129.9, 131.7, 132.0, 132.6, 166.4, 
167.3. 
The absolute configuration at the hydroxyl chiral center was assigned to be S, 
based on the differences in the chemical shifts observed in both diastereomers, 
according to the model developed by Mosher and Dale.138  
 
(3S, 4R)-3-Fluoro-3-((S)-hydroxy (phenyl) methyl)-4-phenylpyrrolidin-2-one 2-9 
To a suspension of 2- 8 (36 mg, 0.1 mmol) and NiCl2 (25.6 mg, 0.2 mmol) in 
MeOH (1.0 mL) at 0 oC under argon was added NaBH4 (38 mg, 1.0 mmol). After the 
mixture was stirred at room temperature for 8 hours, the reaction mixture was 
quenched by the addition of saturated aqueous NH4Cl, and then diluted with CHCl3. 
The organic layer was separated, and dried over MgSO4. The solvent was removed 
in vacuo, and the residue was purified by column chromatography (hexane: ethyl 
acetate = 5:1) to afford the desired product as a white solid (26 mg, 91%). 
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1H NMR (500 MHz, CDCl3) δ 3.53-3.66 (m, 3H), 3.81 (br, 1H), 5.21-5.25 (d, J = 2.2 
Hz, 1H), 6.45 (s, 1H, -OH), 6.97-6.99 (m, 2H), 7.17-7.19 (m. 3H), 7.26-7.28 (m, 3H), 
7.41-7.43 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 44.0 (d, J = 18.2 Hz), 46.9, 73.2 
(d, J = 28.2 Hz), 95.5 (d, J = 190.4 Hz), 127.1, 127.3, 128.1, 128.2, 128.3, 129.3, 
129.4, 135.0, 135.1, 137.7, 172.5; HRMS (IT-TOF) m/z calcd for C17H18FNO 
[M+H]+ = 272.1451, found = 272.1238. 
 
2.4.4 Conversion of Michael Adduct to Chiral Lactam and Pyrrolidine 
2.4.4.1 Conversion of Michael Adduct to Chiral Lactam  
The procedure for the preparation of lactam 2-9 is described above. 
2.4.4.2 Conversion of Michael Adduct to Pyrrolidine   
 
(2R, 3S, 4R)-Ethyl 3-fluoro-2,4-diphenylpyrrolidine-3-carboxylate 2-10 
To a solution of 2-3f (18 mg, 0.05 mmol) in ethanol (0.5 mL), Fe (56 mg, 0.25 
mmol) and acetic acid (0.1 mL) were added. After the reaction mixture was stirred at 
50 oC for 12 h, the mixture was cooled to room temperature, and NaBH3CN (6.3 mg, 
0.10 mmol) was added. The mixture was stirred at room temperature for another 
hour. The reaction was quenched by adding saturated NH4Cl aqueous solution and 
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extracted with CHCl3. The organic layer was separated and dried over MgSO4. The 
solvent was removed in vacuo, and the residue was purified by column 
chromatography (hexane: ethyl acetate = 5:1) to afford pyrrolidine 2-10 as a 
colorless oil (14 mg, 90%). 
1H NMR (500 MHz, CDCl3) δ 0.68-0.71 (t, 3H), 3.59-3.63 (m, 2H), 3.74-3.84 (m, 
2H), 4.10-4.15 (m, 1H), 4.77-4.81 (d, J = 14.5 Hz, 1H), 7.23-7.32 (m, 8H), 7.41-7.45 
(d, 2H); 13C NMR (125 MHz, CDCl3) δ 13.49, 48.42 (d, J = 9.11 Hz), 54.53 (d, J = 
20.03 Hz), 60.84, 69.55 (d, J = 23.68 Hz),.105.2 (d, J = 190.4 Hz), 126.09, 127.43, 
127.78, 127.80, 128.28, 128.38, 136.28, 136.87, 167.49 (d, d, J = 28.23 Hz); HRMS 
(IT-TOF) m/z calcd for C19H20FNO2 [M+H]+ = 314.1556, found = 314.1208. 
 
2.4.5 Analytical Data of Substrates and Michael Adducts 
Substrates 
Ethyl 2-fluoro-3-oxo-3-phenylpropanoate 2-1f 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.25-1.32 (t, 3H), 4.26-4.34 (m, 2H), 
5.78-5.94 (d, J = 48.81 Hz, 1H), 7.48-7.53 (m, 2H), 7.61-7.68 (m, 1H), 8.03-8.05 (d, 
2H). 
 
Ethyl 2-fluoro-3-(4-methoxyphenyl)-3-oxopropanoate 2-6a 
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A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.25-1.27 (t, 3H), 3.88 (s, 3H), 4.26-
4.33 (m, 2H), 5.76-5.86 (d, J = 49.15 Hz, 1H), 6.95-6.97 (m, 2H), 8.03-8.05 (d, 2H). 
 
Ethyl 3-(3-chlorophenyl)-2-fluoro-3-oxopropanoate 2-6b 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.25-1.30 (t, 3H), 4.27-4.35 (m, 2H), 
5.73-5.89 (d, J = 48.66 Hz, 1H), 7.42-7.48 (t, 1H), 7.59-7.60 (m, 1H), 7.91-7.94 (m, 
1H), 8.01 (s, 1H). 
 
Ethyl 2-fluoro-3-(4-nitrophenyl)-3-oxopropanoate 2-6c 
A yellow oil; 1H NMR (300 MHz, CDCl3) δ 1.26-1.30 (t, 3H), 4.31-4.34 (m, 2H), 
5.75-5.91 (d, J = 48.66 Hz, 1H), 8.20-8.24 (dd, 2H), 8.33-8.36 (d, 2H). 
 
Ethyl 2-fluoro-3-oxo-3-(4-(trifluoromethyl)phenyl)propanoate 2-6d 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.25-1.30 (t, 3H), 4.28-4.35 (m, 2H), 
5.75-5.91 (d, J = 48.81 Hz, 1H), 7.76-7.78 (d, 2H), 8.14-8.17 (d, 2H). 
 
Ethyl 2-fluoro-4,4-dimethyl-3-oxopentanoate 2-6e 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.24-1.25 (d, J = 1.14 Hz, 9H), 1.28-






A white solid; 1H NMR (300 MHz, CDCl3) δ 0.97-1.02 (t, 1.6H), 1.25-1.30 (t, 1.4H), 
2.05 (s, 1.3H), 2.29 (s, 1.7H), 3.92-4.03 (m, 1.5H), 4.09-4.27 (m, 2.5H), 4.74-4.76 (d, 
J = 6.06 Hz, 1.2H), 4.81-4.84 (dd, 0.8H), 7.18-7.31 (m, 5H); HPLC [Chiralcel AD-H, 
λ = 220 nm, 15% iPrOH/hexane, flow rate = 0.75 mL/min, tR (major) = 9.1 min, 12.1 
min, tR (minor) = 13.0 min, 21.5 min].           
              
Benzyl-2-acetyl-4-nitro-3-phenylbutanoate 2-3b 
 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 2.00 (s, 1.3H), 2.25 (s, 1.7H), 4.03-
4.06 (d, J = 9.54 Hz, 0.5), 4.15-4.28 (m, 1.5H), 4.73-4.80 (m, 2H), 4.93 (s, 1.1H), 
5.19 (s, 0.9H), 7.07-7.28 (m, 10H); 13C NMR (75 MHz, CDCl3) δ 30.07, 30.17, 
42.23, 42.50, 61.16, 61.83, 67.64, 67.82, 77.74, 127.78, 127.83, 128.24, 128.32, 
128.46, 128.53, 128.69, 128.75, 128.96, 129.10, 134.45, 134.59, 136.21, 166.68, 
167.33, 199.92, 200.86; HPLC [Chiralcel AD-H, λ = 220 nm, 15% iPrOH/hexane, 
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flow rate = 0.75 mL/min, tR (major ) = 12.8 min, 20.4 min, tR (minor) = 16.9 min, 
26.4 min]. 
       
Ethyl-2-benzoyl-4-nitro-3-phenylbutanoate 2-3c 
 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 0.87-0.92 (t, 1.7H), 1.15-1.19 (t, 
1.3H), 3.83-3.91 (m, 1.1H), 4.15-4.39 (m, 0.9H), 4.41-4.53 (m, 1H), 4.73-4.85 (m, 
1.1H), 4.89-4.96 (m, 1.9H), 7.17-7.33 (m, 5H), 7.39-7.65 (m, 3H), 7.82-7.89 (m, 
0.9H), 8.05-8.09 (m, 1.1H); 13C NMR (75 MHz, CDCl3) δ 13.50, 13.81, 42.99, 43.03, 
56.30, 56.94, 61.87, 62.14,  77.89, 127.89, 128.04, 128.20, 128.26, 128.48, 128.66, 
128.82, 128.84, 128.87, 133.74, 134.15, 135.76, 135.95, 136.17, 136.68, 166.88, 
167.62, 192.61, 192.67; HPLC [Chiralcel AD-H, λ = 220 nm, 15% iPrOH/hexane, 
flow rate = 0.75 mL/min, tR (major) = 21.5 min, 38.6 min; tR (minor) =16.6 min, 19.4 
min]. 
          
Ethyl-2-acetyl-2-methyl-4-nitro-3-phenylbutanoate 2-3d 
 
A white solid; 1H NMR (300 MHz, CDCl3) δ 1.18-1.21 (t, 1.8H), 1.29-1.32 (t, 1.2H), 
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1.45 (s, 3H), 2.11 (s, 1.8H), 2.17 (s, 1.2H), 4.01-4.10 (m, 0.6H), 4.11-4.15 (m, 1H), 
4.21-4.30 (m, 1.4H), 4.87-4.98 (m, 2H), 7.11-7.12 (t, 0.8H), 7.13 (d, J = 1.53 Hz, 
1.2H),  7.20-7.27 (m, 3H); HPLC [Chiralcel 0D-H, λ = 210 nm, 10% iPrOH/hexane, 
flow rate = 0.50 mL/min, tR (major) = 20.7min, 30.6 min; tR (minor) =19.1 min, 39.4 
min]. Which were consistent with literature values.138 
 








A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.31-1.37 (t, 3.0H), 1.86-1.88 (d, J = 
5.61 Hz, 3H), 4.29-4.37 (m, 2H), 4.49-65 (m, 1H), 4.81-4.90 (m, 2H), 7.26-7.39 (m, 
5H); 13C NMR (75 MHz, CDCl3) δ 13.90, 26.37, 47.17 (d, J = 18.00Hz), 63.61, 
77.21 (d, J = 31.63 Hz), 100.52 (d, J = 206.19 Hz), 128.94, 129.03, 129.49, 129.51, 
132.43,  164.45 (d, J = 25.64 Hz), 201.20 (d, J = 28.91 Hz); HRMS (IT-TOF) m/z 
calcd for C14H16FNO5 [M+Na]+ = 320.0910, found = 320.0551; HPLC [Chiralcel 
OD-H, λ = 220 nm, 10% iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) = 24.7 
min, 46.3 min]. 
                




A white solid; 1H NMR (300 MHz, CDCl3) δ 1.25-1.30 (t, 3.0H), 4.27-4.38 (m, 2H), 
4.73-4.94 (m, 3H), 7.22-7.36 (m, 7H), 7.48-7.51 (m, 1H), 7.69-7.75 (d, 1H); 13C 
NMR (75 MHz, CDCl3) δ 13.77, 47.84 (d, J = 19.09Hz), 63.85, 75.70 (d, J = 4.91 
Hz), 100.73 (d, J = 206.73 Hz), 128.42, 128.70, 128.91, 129.18, 129.64, 133.19, 
133.69, 134.07, 165.49 (d, J = 26.18 Hz), 191.70 (d, J = 25.64 Hz); HRMS (IT-TOF) 
m/z calcd for C19H18FNO5 [M+Na]+ = 382.1067, found = 382.0630; HPLC 
[Chiralcel IA, λ = 254 nm, 5% iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) = 
22.2 min, 31.6 min; tR (minor ) 21.1 min, 45.9 min].     
 
 (2S, 3R)-Ethyl 2-benzoyl-2-fluoro-3-(4-fluorophenyl)-4-nitrobutanoate 2-5a 
 
A white solid; 1H NMR (300 MHz, CDCl3) δ 0.97-1.02 (t, 3.0H), 4.29-4.39 (m, 2H), 
4.73-4.80 (m, 0.6H), 4.85-4.87 (m, 2.4H), 6.91-6.97 (t, 2H), 7.28-7.39 (m, 4H), 7.51-
7.56 (t, 1H), 7.69-7.79 (d, 2H); 13C NMR (75 MHz, CDCl3) δ 13.86, 47.19 (d, J = 
19.09Hz), 63.83, 75.75 (d, J = 4.91 Hz), 100.74 (d, J = 207.29 Hz), 115.76 (d, J = 
21.27 Hz), 128.50, 128.98, 129.03, 129.20, 129.29, 131.49, 131.52, 131.63, 133.97, 
161.03, 164.32, 165.42 (d, J = 25.64 Hz), 191.55 (d, J = 25.64 Hz); HRMS (IT-TOF) 
m/z calcd for C19H17F2NO5 [M+Na]+ = 400.0927, found = 400.0873; HPLC 
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[Chiralcel IA, λ = 254 nm, 5% iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) = 
22.4 min, 34.6 min]. 
         
 (2S, 3R)-Ethyl 2-benzoyl-3-(3-bromophenyl)-2-fluoro-4-nitrobutanoate 2-5b 
 
A yellow oil; 1H NMR (300 MHz, CDCl3) δ 1.25-1.30(t, 3.0H), 4.28-4.38 (m, 2H), 
4.69-4.93 (m, 3H), 7.19-7.05 (t, 1H), 7.28-7.57 (m, 6H), 7.73-7.74 (d, 2H); 13C NMR 
(125 MHz, CDCl3) δ 13.84, 47.43 (d, J = 19.13Hz), 63.83, 75.52 (d, J = 4.55 Hz), 
100.48 (d, J = 207.69 Hz), 122.73, 128.46, 129.35, 130.23, 131.83, 132.74, 133.80, 
134.07, 135.71, 165.33 (d, J = 25.50 Hz), 191.17 (d, J = 25.51 Hz); HRMS (IT-TOF) 
m/z calcd for C19H17BrFNO5 [M+H]+ = 437.0274, found = 437.1107; HPLC 
[Chiralcel OD-H, λ = 254 nm, 5% iPrOH/hexane, flow rate = 0.50 mL/min, tR 
(major) = 31.3 min, 58.1 min, tR (minor) = 44.7 min, 69.1 min]. 
 




A yellow oil; 1H NMR (300 MHz, CDCl3) δ 0.97-1.02 (t, 0.5H), 1.25-1.30 (t, 2.5H), 
3.94-3.98 (m, 0.3H), 4.28-4.39 (m, 1.7H), 4.71-4.89 (m, 3H), 7.19-7.26 (m, 2H), 
7.35-7.39 (m,3.5H), 7.48-7.56 (m, 1.5H), 7.72-7.75 (d, 1.7H), 8.06-8.09 (d, 0.3H); 
13C NMR (125 MHz, CDCl3) 13.85, 47.34 (d, J = 19.11 Hz), 63.89, 75.57 (d, J = 
5.47 Hz), 100.57 (d, J = 206.77 Hz), 122.93, 128.57, 129.32, 129.37, 131.43, 131.94, 
132.44, 132.88, 133.85, 134.09, 165.38 (d, J = 25.51 Hz), 191.20 (d, J = 25.51 Hz); 
HRMS (IT-TOF) m/z calcd for C19H17BrFNO5 [M]+ = 437.0274, found = 437.1520; 
HPLC [Chiralcel OD-H, λ = 254 nm, 5% iPrOH/hexane, flow rate = 0.50 mL/min, tR 
(major) = 32.4 min, 85.5 min, tR (minor) = 59.2 min, 68.9 min]. 
     
(2S, 3R)-Ethyl 2-benzoyl-3-(2-chlorophenyl)-2-fluoro-4-nitrobutanoate 2-5d 
 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 0.96-0.99 (t, 0.5H), 1.25-1.28 (t, 
2.5H), 3.94-4.03 (m, 0.3H), 4.28-4.39 (m, 1.7H), 4.75-4.80 (m, 1H), 4.85-4.89 (m, 
0.3H), 5.01-5.05 (m, 1H), 5.43-5.51 (m, 1H), 7.11-7.47 (m, 9H); 13C NMR (125 
MHz, CDCl3) δ 13.77, 43.11 (d, J = 20.05 Hz), 63.80, 75.32 (d, J = 6.37 Hz), 100.33 
(d, J = 206.78 Hz), 127.25, 128.52, 129.31, 130.37, 132.53, 133.98, 134.68, 135.73, 
165.51 (d, J = 25.50 Hz), 191.88 (d, J = 25.51 Hz); HRMS (ESI) m/z calcd for 
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C19H17ClFNO5 [M+Na]+ = 421.1092, found = 421.1; HPLC [Chiralcel OD-H, λ = 
254 nm, 5% iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) = 33.1 min, 45.3 
min, tR (minor) = 37.9 min, 69.1 min]. 
        
(2S, 3R)-Ethyl 2-benzoyl-2-fluoro-4-nitro-3-p-tolylbutanoate 2-5e 
 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.26-1.29 (t, 3H), 2.25 (s, 3H), 4.27-
4.37 (m, 2H), 4.72-4.81 (m, 1H), 4.87-4.89 (m, 2H), 7.03-7.05 (d, 2H), 7.18-7.19 (d, 
2H), 7.33-7.36 (m, 2H), 7.49-7.52 (m, 1H), 7.70-7.72 (d, 2H); 13C NMR (125 MHz, 
CDCl3) δ 13.85, 21.04, 47.60 (d, J = 19.13 Hz), 63.67, 75.90 (d, J = 4.56 Hz), 
100.82 (d, J = 205.86 Hz), 128.61, 129.25, 129.37, 129.55, 130.15, 133.74, 134.20, 
138.36, 165.67 (d, J = 26.43 Hz), 191.69 (d, J = 25.50 Hz); HRMS (IT-TOF) m/z 
calcd for C20H20FNO5 [M+Na]+ = 396.1223, found = 396.0783; HPLC [Chiralcel IC, 
λ = 210 nm, 5% iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) = 23.0 min, 28.0 
min, tR (minor) = 21.7 min, 32.7 min]. 
       




A yellow solid; 1H NMR (300 MHz, CDCl3) δ 0.97-1.02 (t, 0.4H), 1.26-1.30 (t, 
2.6H), 3.69 (s, 3H), 3.95-3.97 (m, 0.3H), 4.27-4.37 (m, 1.7H), 4.68-4.87 (m, 3H), 
6.74-6.77 (t, 1.7H), 6.85-6.88 (d, 0.3H), 7.21-7.40 (m, 4H), 7.45-7.49 (m, 1H), 7.50-
7.54 (m, 1.7H), 8.05-8.09 (d, 0.3H); 13C NMR (75 MHz, CDCl3) δ 13.79, 47.21 (d, J 
= 19.08 Hz), 55.08, 63.59, 75.85 (d, J = 4.9 Hz), 100.82 (d, J = 206.19 Hz), 114.10 
(d, J = 9.82 Hz), 124.87, 128.53, 129.20, 130.45, 133.67, 134.12, 159.51, 165.55 (d, 
J = 25.63 Hz), 191.73 (d, J = 25.64 Hz); HRMS (IT-TOF) m/z calcd for C20H20FNO6 
[M+Na]+ = 412.1172, found = 412.0791; HPLC [Chiralcel IC, λ = 254 nm, 7.5% 
iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) = 29.6 min, 32.7 min, tR (minor) 
= 26.1 min, 34.7 min]. 
   
 (2S, 3R)-Ethyl 2-benzoyl-2-fluoro-4-nitro-3-(2-(trifluoromethyl)phenyl)butanoate 2-
5g 
 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 0.81-0.86 (t, 0.75H), 1.25-1.30 (t, 
2.1H), 3.78-3.98 (m, 0.5H), 4.24-4.41 (m, 1.5H), 4.57-4.70 (m, 0.9H), 4.85-4.89 (m, 
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0.3H), 5.07-5.30 (m, 1.5H), 5.45-5.59 (m, 0.3H), 7.38-7.75 (m, 6H), 7.71-7.78 (m, 
2.5H), 8.05-8.09 (d, 0.5H); 13C NMR (75 MHz, CDCl3) δ 13.59, 42.72 (d, J = 17.46 
Hz), 63.87,  75.97 (d, J = 7.64 Hz), 99.73 (d, J = 207.83 Hz), 122.09, 125.72, 127.19, 
128.50, 129.40, 130.03, 132.35, 134.41, 165.47 (d, J = 26.18 Hz), 190.48 (d, J = 
25.10 Hz); HRMS (IT-TOF) m/z calcd for C20H17F4NO6 [M+Na]+ = 450.0941, found 
= 450.0424; HPLC [Chiralcel OD-H, λ = 254 nm, 7.5% iPrOH/hexane, flow rate = 
0.50 mL/min, tR (major) = 21.8 min, 25.3 min, tR (minor) = 29.0 min, 46.0 min]. 
     
(2S, 3R)-Ethyl 2-benzoyl-3-(4-cyanophenyl)-2-fluoro-4-nitrobutanoate 2-5h 
 
A yellow oil; 1H NMR (300 MHz, CDCl3) δ 0.96-1.00 (t, 0.5H), 1.26-1.31 (t, 2.5H), 
3.93-4.00 (m, 0.4H), 4.30-4,43 (m, 1.6H), 4.80-4.98 (m, 3H), 7.36-7.41 (m, 1.5H), 
7.46-7.69 (m, 5.5H), 7.71-7.79 (m, 1.7H), 8.05-8.11 (d, 0.3H); 13C NMR (75 MHz, 
CDCl3) δ 13.79, 42.54 (d, J = 19.08 Hz), 63.03,  75.20 (d, J = 4.9 Hz), 100.38 (d, J = 
207.83 Hz), 112.66, 118.02, 128.60, 129.30, 130.57, 132.42, 133.39, 134.32, 138.83, 
165.03 (d, J = 25.64 Hz), 190.64 (d, J = 25.08 Hz); HRMS (IT-TOF) m/z calcd for 
C20H17FN2O5 [M+2Na]+ = 430.0917, found = 430.8738; HPLC [Chiralcel OD-H, λ 
= 254 nm, 20% iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) = 29.8 min, 69.7 
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min, tR (minor) = 35.0 min, 104.5 min]. 
    
 (2S, 3R)-Ethyl 2-benzoyl-2-fluoro-3-(2-methoxyphenyl)-4-nitrobutanoate 2-5i 
 
A yellow oil; 1H NMR (300 MHz, CDCl3) δ 0.91-0.96 (t, 0.4H), 1.22-1.27 (t, 2.6H), 
3.76 (s, 2.6H), 3.83 (s, 0.4H), 4.27-4.34 (m, 2H), 4.81-4.88 (m, 1H), 5.00-5.06 (m, 
1H), 5.24-5.28 (m, 1H), 6.79-6.86 (m, 2H), 7.18-7.39 (m, 4H), 7.50-7.55 (m, 1H), 
7.76-7.79 (d, 1.7H), 8.05-8.10 (d, 0.3H); 13C NMR (75 MHz, CDCl3) δ 13.71, 40.97 
(d, J = 20.18 Hz), 55.58, 63.34, 75.34 (d, J = 6.0 Hz), 100.10 (d, J = 205.67 Hz), 
111.14, 120.75, 122.56, 128.31, 129.20, 129.28, 129.34, 129.40, 129.63, 133.61, 
133.96, 134.01, 157.41, 165.86 (d, J = 25.09 Hz), 191.33 (d, J = 24.55 Hz); HRMS 
(IT-TOF) m/z calcd for C20H20FNO6 [M+Na]+ = 412.1172, found = 412.0705; HPLC 
[Chiralcel OD-H, λ = 254 nm, 5% iPrOH/hexane, flow rate = 0.50 mL/min, tR 
(major) = 29.5 min, 35.5 min, tR (minor) = 33.8 min, 39.9 min]. 
           
 




A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.25-1.28 (t, 3H), 4.26-4.37 (m, 2H), 
4.80-4.87 (m, 2H), 5.11-5.20 (m, 1H), 6.87-6.88 (m, 1H), 6.97-6.99 (m, 1H), 7.11-
7.12 (m, 1H), 7.38-7.45 (m, 2H), 7.55-7.59 (m, 1H), 7.71-7.89 (d, 1H); 13C NMR 
(125 MHz, CDCl3) δ 13.82, 43.88 (d, J = 20.05 Hz), 63.81, 76.51 (d, J = 3.6 Hz), 
100.25 (d, J = 206.77 Hz), 126.70, 126.88, 128.52, 129.09, 129.36, 129.41, 134.00, 
134.47, 165.27 (d, J = 25.51 Hz), 191.18 (d, J = 24.6 Hz); HRMS (IT-TOF) m/z 
calcd for C17H16FNO5S [M]+ = 365.0733, found = 365.1551; HPLC [Chiralcel OD-H, 
λ = 254 nm, 5% iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) = 26.3 min, 51.9 
min, tR (minor) = 42.5 min, 56.5 min]. 
 
(2S, 3R)-ethyl 2-benzoyl-2-fluoro-3-(nitromethyl)heptanoate 2-5k 
 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 0.86-0.89 (t, 3.0H), 1.21-1.24 (t, 3H), 
1.27-1.47 (m, 5H), 1.56-1.61 (m, 1H), 3.51-3.62 (m, 1H), 4.23-4.39 (m, 2H), 4.41-
4.43 (m, 1H), 4.66-4.70 (m, 1H), 7.45-7.49 (t, 2H), 7.59-7.60 (t, 1H), 8.00-8.02 (m, 
2H); 13C NMR (125 MHz, CDCl3) δ 13.73, 22.44, 28.23, 28.26, 29.18, 41.90, 42.07, 
63.38, 74.81 (d, J = 2.74 Hz), 100.96 (d, J = 203.14 Hz), 128.70, 129.68, 129.74, 
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133.94, 133.97, 134.19, 166.02 (d, J = 25.51 Hz), 191.66 (d, J = 24.6 Hz); HRMS 
(ESI) m/z calcd for C17H22FNO5 [M+Na]+ = 339.1482, found =339.1495; The ee 
value was 96%, tR (major) = 14.8 min, tR (minor) = 11.8 min (Chiralcel OD-H, λ = 
254 nm, 5% iPrOH/hexanes, flow rate = 0.5 mL/min) 
   
(2S, 3R)-ethyl 2-benzoyl-2-fluoro-5-methyl-3-(nitromethyl)hexanoate 2-5l 
 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 0.94-0.96 (d, 2.6H), 0.97-0.99 (d, 
0.8H), 1.01-1.02 (d, 2.6H), 1.24-1.26 (t, 3H), 1.32-1.46 (m, 2H), 1.63-1.70 (m, 1H), 
3.62-3.72 (m, 1H), 4.23-4.38 (m, 2H), 4.31-4.41 (m, 1H), 4.67-4.77 (m, 1H), 7.43-
7.49 (t, 2H), 7.55-7.65 (m, 1H), 7.94-8.05(d, 2H); 13C NMR (125 MHz, CDCl3) δ 
13.71, 21.17, 23.46, 25.64, 37.49, 37.51, 40.19, 40.37, 63.37, 74.96, 74.98, 100.96 (d, 
J = 202.22 Hz), 128.69, 129.67, 129.73, 133.98, 134.01, 134.17, 166.01 (d, J = 26.41 
Hz), 191.61 (d, J = 25.5 Hz); HRMS (ESI) m/z calcd for C17H22FNO5 [M+Na]+ = 
339.1482, found =339.1498; The ee value was 96%, tR (major) = 15.2 min, tR (minor) 
= 16.5 min (Chiralcel IC, λ = 254 nm, 3% iPrOH/hexanes, flow rate = 0.5 mL/min) 
 




A colorless oil; 1H NMR (300 MHz, CDCl3) δ 0.94-0.98 (t, 0.6H), 1.23-1.29 (t, 
2.4H), 3.82 (s, 2.4H), 3.87 (s, 0.6H), 3.89-3.96 (m, 0.4H), 4.25-4.36 (m, 1.5H), 4.73-
4.92 (m, 3H), 6.80-6.83 (d, 1.5H), 6.92-6.95 (d, 0.5H), 7.22-7.40 (m, 5H), 7.72-
7.79(d, 1.5H), 8.08-8.15 (d, 0.5H); 13C NMR (75 MHz, CDCl3) δ 13.52, 13.75, 46.85 
(d, J = 18.00 Hz ), 47.86 (d, J = 19.09 Hz), 55.39, 55.51, 62.86, 63.45, 75.86 (d, J = 
5.46 Hz), 100.76 (d, J = 206.73 Hz), 113.66, 114.00, 126.73, 126.77, 128.37, 128.58, 
128.73. 128.79, 129.42, 129.45, 129.61, 129.64, 131.90, 132.00, 132.76, 134.49, 
165.82 (d, J = 25.71 Hz), 187.80 (d, J = 25.08 Hz), 189.25 (d, J = 24.54 Hz); HRMS 
(IT-TOF) m/z calcd for C20H20FNO6 [M+H]+ = 390.1353, found = 390.0976; HPLC 
[Chiralcel AD-H, λ = 254 nm, 10% iPrOH/hexane, flow rate = 0.50 mL/min, tR 
(major) = 25.7 min, 46.3 min, tR (minor) = 29.3 min,31.6 min]. 
    








A colorless oil; 1H NMR (500 MHz, CDCl3) δ 0.98-1.02 (t, 0.5H), 1.31-1.34 (t, 
2.5H), 3.94-4.01 (m, 0.4H), 4.32-4.43 (m, 1.6H), 4.77-4.96 (m, 3H), 7.25-7.51 (m, 
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7H), 7.56-7.59 (d, 0.8H), 7.65 (s, 0.8H), 7.95-8.05 (d, 0.2H), 8.12 (s, 0.2H); 13C 
NMR (125 MHz, CDCl3) δ 13.59, 13.85, 46.98 (d, J = 18.21 Hz ), 47.89 (d, J = 
19.12 Hz), 63.32, 63.92, 75.57 (d, J = 4.56 Hz), 100.96 (d, J = 206.79 Hz), 127.13, 
127.21, 127.27, 128.76, 128.86, 128.93, 129.09, 129.12, 129.18, 129.29, 129.70, 
130.16, 133.03, 133.68, 134.65,134.69, 135.57, 165.16 (d, J = 25.51 Hz), 191.13 (d, 
J = 26.42 Hz); HRMS (IT-TOF) m/z calcd for C19H17FClNO5 [M+2Na]+ = 439.0557, 
found = 439.0437; HPLC [Chiralcel OD-H, λ = 254 nm, 5% iPrOH/hexane, flow 
rate = 0.50 mL/min, tR (major) = 36.9 min, 54.1 min, tR (minor) = 35.1 min, 42.5 
min]. 
 
 (2S, 3R)-Ethyl 2-(3-chlorobenzoyl)-2-fluoro-3-(4-fluorophenyl)-4-nitrobutanoate 2-
7c 
 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.01-1.04 (t, 0.5H), 1.31-1.35 (t, 
2.5H), 3.97-4.04 (m, 0.4H), 4.32-4.43 (m, 1.6H), 4.75-4.93 (m, 3H), 6.96-6.98 (m, 
1.6H), 7.06-7.09 (m, 0.4H), 7.31-7.35 (m, 2.5H), 7.39-7.45 (m, 0.5H), 7.51-7.55 (d, 
0.8H), 7.61-7.71 (m, 1H), 7.75 (s, 0.8H), 8.02-8.05 (d, 0.2H), 8.13 (s, 0.2H); 13C 
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NMR (125 MHz, CDCl3) δ 13.85, 46.26 (d, J = 18.21 Hz ), 47.15 (d, J = 19.12 Hz), 
63.43, 64.03, , 75.59 (d, J = 5.46 Hz), 101.00 (d, J = 206.77 Hz), 115.80, 115.98, 
127.28, 128.34, 129.21, 129.25, 129.84, 131.52, 131.54, 131.58, 131.60, 133.92, 
134.82, 135.33, 135.36, 161.78, 164.93, 165.03 (d, J = 25.51 Hz), 190.72 (d, J = 
26.42 Hz); HRMS (IT-TOF) m/z calcd for C19H16F2ClNO5 [M-O]+ = 395.0736, 
found = 395.2298; HPLC [Chiralcel OD-H, λ = 254 nm, 5% iPrOH/hexane, flow 
rate = 0.50 mL/min, tR (major) = 27.7 min, 69.7 min, tR (minor) = 29.1 min, 41.5 
min]. 
         
 (2S, 3R)-Ethyl 2-fluoro-4-nitro-2-(4-nitrobenzoyl)-3-phenylbutanoate 2-7d 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ 0.95-0.98 (t, 0.7H), 1.31-1.35 (t, 2.3H), 
3.93-3.98 (m, 0.5H), 4.34-4.42 (m, 1.5H), 4.76-4.95 (m, 3H), 7.25-7.29 (m, 4H), 
7.35-7.38 (m, 1H), 7.67-7.68 (d, 1.5H), 8.10-8.15 (d, 1.5H), 8.20-8.23 (d, 0.5H), 
8.31-8.35 (d, 0.5H); 13C NMR (125 MHz, CDCl3) δ 13.60, 13.90, 46.98 (d, J = 17.31 
Hz ), 47.91 (d, J = 18.22 Hz), 63.61, 64.22, 75.31 (d, J = 5.46 Hz), 75.51 (d, J = 7.29 
Hz), 101.25 (d, J = 206.78 Hz), 123.43, 123.90, 129.02, 129.25, 129.36, 129.38, 
129.73, 129.74, 129.99, 130.05, 131.21, 131.26, 132.69, 132.71, 137.50, 137.53, 
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139.01, 139.04, 150.27, 150.97, 164.29 (d, J = 25.51 Hz), 164.67 (d, J = 25.50 Hz), 
192.22 (d, J = 27.34 Hz); HRMS (IT-TOF) m/z calcd for C19H17FN2O7 [M+Na]+ = 
427.0917, found = 427.2564; HPLC [Chiralcel AD-H, λ = 254 nm, 10% 
iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) = 29.3 min, 31.1 min, tR (minor) 
= 33.1 min, 39.3 min]. 
 
 (2S, 3R)-Ethyl 2-fluoro-4-nitro-2-(4-nitrobenzoyl)-3-p-tolylbutanoate 2-7e 
 
A yellow solid; 1H NMR (500 MHz, CDCl3) δ 0.98-1.01 (t, 0.6H), 1.31-1.34 (t, 
2.4H), 2.26 (s, 2.3H), 2.33 (s, 0.7), 3.95-3.99 (m, 0.4H), 4.32-4.42 (m, 1.6H), 4.72-
4.92 (m, 3H), 7.04-7.05 (d, 1.5H), 7.14-7.16 (m, 2H), 7.25-7.27 (m,  0.8H), 7.71-
7.77 (m, 1.5H), 8.14-8.19 (d, 1.5H), 8.21-8.25 (d, 0.4H), 8.31-8.35 (d, 0.4H); 13C 
NMR (125 MHz, CDCl3) δ 13.90, 21.05, 47.59 (d, J = 18.22 Hz ), 64.14, 75.43 (d, J 
= 5.46 Hz), 101.28 (d, J = 206.78 Hz), 123.40, 123.87, 129.19, 129.56, 129.70, 
130.07, 131.21, 138.85, 150.27, 164.75 (d, J = 25.51 Hz), 192.12 (d, J = 27.33 Hz); 
HRMS (IT-TOF) m/z calcd for C20H19FN2O7 [M]+ = 418.1176, found = 418.1648; 
HPLC [Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, flow rate = 0.50 mL/min, tR 
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(major) = 50.0 min, 63.9 min, tR (minor) 60.1 min, 114.5 min]. 
     
 (2S, 3R)-Ethyl 3-(3-bromophenyl)-2-fluoro-4-nitro-2-(4-nitrobenzoyl)butanoate 2-
7f 
 
A yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.01-1.04 (t, 0.6H), 1.31-1.34 (t, 2.6H), 
3.97-4.06 (m, 0.4H), 4.32-4.42 (m, 1.6H), 4.73-4.92 (m, 3H), 7.12-7.15 (m, 0.7H), 
7.23-7.26 (m, 1.3H), 7.34-7.54 (m,  2H), 7.80-7.85 (d, 1.6H), 8.18-8.22 (d, 1.6H), 
8.25-8.29 (d, 0.4H), 8.32-8.35 (d, 0.4H); 13C NMR (125 MHz, CDCl3) δ 13.89, 
47.37 (d, J = 18.21 Hz ), 64.38, 75.10 (d, J = 4.56 Hz), 100.92 (d, J = 207.70 Hz), 
122.97, 123.59, 123.94, 127.86, 128.37, 130.25, 130.54, 131.27, 132.16, 132.45, 
132.71, 135.17, 138.60, 150.49, 164.49 (d, J = 25.50 Hz), 192.32 (d, J = 27.33 Hz); 
HRMS (IT-TOF) m/z calcd for C19H16BrFN2O7 [M+Na]+ = 505.0023, found = 
505.2551; HPLC [Chiralcel IC, λ = 254 nm, 15% iPrOH/hexane, flow rate = 0.50 
mL/min, tR (major) = 22.1 min, 25.6 min, tR (minor) = 28.5 min, 29.5 min]. 
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 (2S, 3R)-Ethyl 2-fluoro-4-nitro-3-phenyl-2-(4-(trifluoromethyl)benzoyl)butanoate 2-
7g 
 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 0.98-1.01 (t, 0.5H), 1.32-1.35 (t, 
2.5H), 3.95-4.00 (m, 0.3H), 4.33-4.44 (m, 1.7H), 4.79-4.99 (m, 3H), 7.26-7.42 (m, 
5H), 7.60-7.65 (d, 1.6H), 7.75-7.78 (d,  1.6H), 7.79-7.81 (d, 0.4H), 8.22-8.25 (d, 
0.4H); 13C NMR (125 MHz, CDCl3) δ 13.86, 47.91 (d, J = 18.21 Hz ), 64.02, 75.49 
(d, J = 5.46 Hz), 101.11 (d, J = 206.77 Hz), 122.25, 124.38, 125.34, 125.37, 128.81, 
128.91, 128.97, 129.14, 129.36, 129.43, 129.72, 129.73, 130.45, 130.49, 132.96, 
135.75, 137.10, 164.94 (d, J = 25.51 Hz), 192.04 (d, J = 27.33 Hz); HRMS (IT-TOF) 
m/z calcd for C20H17F4NO5 [M]+ = 427.1043, found = 430.8768; HPLC [Chiralcel 
AD-H, λ = 254 nm, 2% iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) = 30.6 
min, 47.7 min, tR (minor) = 38.9 min, 42.3 min]. 
       





A colorless oil; 1H NMR (500 MHz, CDCl3) δ 0.96-0.99 (t, 0.6H), 1.29-1.32 (t, 
2.4H), 3.92-4.02 (m, 0.4H), 4.31-4.42 (m, 1.6H), 4.74-4.78 (m, 1H), 4.82-4.86 (m, 
0.2H), 5.00-5.04 (m, 1H), 5.44-5.53 (m, 0.8H), 7.11-7.14 (m, 1H), 7.18-7.21 (m, 1H), 
7.32-7.45 (m,  2H), 7.60-7.63 (d, 1.6H), 7.75-7.79 (d, 0.4H), 7.81-7.85 (d, 1.6H), 
8.15-8.19 (d, 0.4H); 13C NMR (125 MHz, CDCl3) δ 13.81, 43.08,  64.14, 75.09 (d, J 
= 6.37 Hz), 100.63 (d, J = 207.69 Hz), 122.21, 124.38, 125.50, 125.86, 127.37, 
127.65, 129.55, 129.61, 129.69, 129.89, 130.26, 130.44, 130.48, 130.53, 132.17, 
134.89, 135.16, 135.72, 136.70, 164.94 (d, J = 25.51 Hz), 190.87 (d, J = 25.50 Hz); 
HRMS (IT-TOF) m/z calcd for C20H16ClF4NO5 [M-Cl+H]+ = 427.1043, found = 
427.0031; HPLC [Chiralcel IA, λ = 254 nm, 5% iPrOH/hexane, flow rate = 0.50 
mL/min, tR (major) = 18.7 min, 21.5 min; tR (minor) = 25.6 min, 32.6 min]. 




A white solid; 1H NMR (500 MHz, CDCl3) δ 0.89-0.90 (s, 9H), 1.32-1.35 (t, 3H), 
4.29-4.36 (m, 2H), 4.60-4.64 (m, 0.5H), 4.67-4.78 (m, 1.5H), 4.80-4.83 (m, 1H), 
7.16-7.18 (m, 2H), 7.43-7.44 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 13.94, 25.46 
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(d, J = 4.55 Hz), 45.58 (d, J = 3.64 Hz), 47.71 (d, J = 18.21 Hz), 63.65, 74.91 (d, J = 
4.56 Hz), 102.32 (d, J = 211.10 Hz), 123.07, 131.70, 131.72, 131.88, 132.24, 164.81 
(d, J = 25.51 Hz), 204.79 (d, J = 24.60 Hz); HRMS (IT-TOF) m/z calcd for 
C17H21BrFNO5 [M+H]+ = 417.0587, found = 418.1651; HPLC [Chiralcel OD-H, λ = 





A yellow oil; 1H NMR (300 MHz, CDCl3) δ 0.87-0.88 (d, 9H), 1.31-1.36 (t, 3H), 
3.76 (s, 3H), 4.28-4.36 (m, 2H), 4.50-4.87 (m, 3H), 6.79-6.84 (m, 2H), 7.18-7.21 (m, 
2H); 13C NMR (125 MHz, CDCl3) δ 13.95, 25.46 (d, J = 4.55 Hz), 45.64 (d, J = 3.67 
Hz), 47.71 (d, J = 19.12 Hz),  55.22, 63.44, 75.29 (d, J = 4.56 Hz), 102.52 (d, J = 
211.10 Hz), 114.03, 124.85, 131.23, 159.79, 165.13 (d, J = 25.51 Hz), 205.06 (d, J = 
24.58 Hz); HRMS (IT-TOF) m/z calcd for C18H24FNO6 [M+H]+ = 392.1485, found = 
392.1051; HPLC [Chiralcel OD-H, λ = 210 nm, 5% iPrOH/hexane, flow rate = 0.50 
mL/min, tR (major) = 22.4 min, 38.1 min; tR (minor) = 15.1 min, 20.3 min]. 
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(2S, 3R)-tert-butyl 2-benzoyl-3-(2-chlorophenyl)-2-fluoro-4-nitrobutanoate 2-7k 
 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.10 (s, 2.5H), 1.42 (s, 6.5H), 4.67-
4.72 (m, 0.3H), 4.79-4.87 (m, 1 H), 4.99-5.03 (m, 0.8H), 5.39-5.47 (m, 0.7H), 5.63-
5.70 (m, 0.3H), 7.12-7.20 (m, 1.5H), 7.27-7.41 (m, 5.5H), 7.75-7.79 (d, 1.5H), 8.10-
8.15 (d, 0.5H); 13C NMR (125 MHz, CDCl3) δ 27.08, 27.55, 43.02, 43.18, 75.80, 
76.01,  85.59, 86.10, 100.24 (d, J = 206.77 Hz), 127,21, 127.53, 128.47, 128.76, 
128.90, 128.92, 128.94, 129.26, 129.31, 129.54, 129.93, 130.01, 130.11, 130.28, 
131.93,  132.73, 133.15, 133.18,133.99, 134.01, 134.47, 135.49, 135.94, 164.30 (d, J 
= 24.6 Hz), 191.06 (d, J = 24.6 Hz); HRMS (ESI) m/z calcd for C21H21FClNO5 
[M+Na]+ = 421.1092, found =421.1; The ee value was 98%, tR (major) = 25.0 min, 
tR (minor) = 23.7 min (Chiralcel OD-H, λ = 254 nm, 2.5% iPrOH/hexanes, flow rate 










Chapter 3 Asymmetric Mannich Reaction of Fluorinated Ketoesters                       
with a Tryptophan-Derived Bifunctional Thiourea 
Catalyst             
3.1 Introduction 
Hydrogen bonding is very important in molecular recognition and interaction, 
the utilization of hydrogen bonding activations with substrates have drawn much 
attention in asymmetric organocatalysis.60-63,134,139 Thiourea-based organic molecules 
can act as hydrogen-bond donor catalysts have been investigated by many research 
groups. In this context, Takemoto et al. developed the first example of novel 
bifunctional140 catalyst bearing a tertiary amine moiety and a thiourea moiety which 
gives good catalytic activity in Michael addition of malonate esters to 
nitroolefins.91Since then impressive progress has been made in this field in the past 
few years.141 In spite of  these remarkable achievements, these bifunctional thiourea 
catalysts are derived from a very limited range of chiral structural scaffolds, 
including cyclohexane-1,2-diamine, 1,1’-binaphthyl-2,2’-diamine, and cinchona 
alkaloids. The development of readily accessible novel bifunctional thiourea 
catalysts of this nature would be highly desirable. As part of our previous research 
towards the development of practical organocatalysts based on primary amino 
acids,142 we were intrigued by the possibility of designing novel tertiary amine–
thiourea catalysts on the basis of simple amino acids. To verify the feasibility of this 
idea, we selected L-tryptophan as the chiral precursor. We reasoned that the indole 
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moiety would be capable of engaging in substrate interactions which may affect the 
stereochemical control (Scheme 3.11). 
 
Scheme 3.11 Thiourea catalyst based on primary amino acid (tryptophan) 
Fluorinated molecules are useful in many areas such as pharmaceuticals, 
agrochemicals, fine chemicals, and there is a strong demand for asymmetric 
synthesis of various organofluorinated comounds.143 Organocatalytic approach to 
access fluorinated quaternary carbon stereocenters is a formidable challenge in 
organic synthesis.132 Up to present, only a few examples for the creation of 
fluorinated quaternary centers have been reported.129,130,144 Recently, we reported the 
first example that racemic α-fluorinated β-ketoesters were used as  nucleophiles. A 
C-C bond is formed rather than a C-F bond during the reaction, and in this way we 
and others145 have used fluorinated substrates in organocatalytic Michael and 
alkylation reactions for the construction of chiral fluorinated molecules. 
Highly functionalized chiral amines are valuable building blocks in biological 
natural products, and the asymmetric Mannich reaction is a very useful approach to 
access these building blocks. In particular, the direct asymmetric Mannich reactions 
73 
 
of β-ketoesters and imines yield structurally demanding and biologically important 
β-amino acids, and such reactions were reported recently by research groups of 
Schaus, Deng, and Dixon, all of whom employed organic catalysts derived from 
cinchona alkaloids.146 Herein, we report that tryptophan-based bifunctional thiourea 
derivatives promote the asymmetric Mannich reaction of fluorinated substrates to 
afford highly optically enriched fluorine-containing molecules containing adjacent 
quaternary and tertiary stereocenters. 
 
3.2 Synthesis of Catalysts 
Synthetic route for the preparation of the Tryptophan-derived thiourea catalysts 
Trp-1~3 was outlined in Scheme 3.12. Firstly L-tryptophan was reduced to alcohol 
and the free amino group was protected with benzyloxycarbonyl (Cbz). The 
generated hydroxy group was then converted to amine (d) through tosylation, azide 
substitution and Staudinger reduction. After reductive amination, tertiary amine (e) 
was obtained.  In the end, benzyloxycarbonyl (Cbz) protecting groups were removed 
by hydrogenolysis using palladium on activated charcoal (Pd/C) in methanol. After 




Scheme 3.12 Catalyst preparation 
 
3.3 Results and Discussion 
3.3.1 Catalyst Screening 
In our preliminary studies, the Mannich reaction of α-fluoro-β-ketoester 3-1a 
with N-Boc imine 3-2a was selected as a model reaction to test the catalytic 
activities of different bifunctional catalysts (Table 3.11). Quinidine-derived thioureas 
led to moderate diastereoselectivity but low enantioselectivity (entry 1-2). 
Quinidine-derived sulfonamide showed very low catalytic activity, almost no desired 
product was obtained (entries 3). However, when the tryptophan-based thiourea 
catalysts Trp-1–Trp-3 were used, we obtained adduct 3-3a in quantitative yield and 





Table 3.11 Catalyst screening for the asymmetric Mannich reaction of 3-1a and 3-
2aa 
 
Entry Cat. Temp (oC) Solvent Conv. (%) drb eec(%) 
1 QD-1 RT toluene >99 4:1 -43 
2 QD-2 RT toluene >99 3:1 -4 
3 QD-3 RT toluene <20 - - 
4 Trp-1 RT toluene >99 5:1 88 
5 Trp-2 RT toluene >99 4:1 59 
6 Trp-3 RT toluene >99 4:1 67 
a The reactions were performed with ketoester (0.05 mmol), imine (0.075 mmol) and 
catalyst (0.005 mmol) in solvent (1 ml) at room temperature， unless otherwise specified. b 
Determined by 1H NMR analysis of the crude product. c The ee value of both diastereomers 
or the major diastereomers, determined by chiral HPLC analysis. 
 
3.3.2 Solvent Screening 
Encouraged by the initial results, we next performed a solvent screening and the 
results are summarized in Table 3.12. Under optimized reaction conditions, toluene 
was found to be the best solvent, the fluorinated product containing adjacent 
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quaternary and tertiary stereo- centers was obtained with 9:1 dr and 97% ee (Table 
3.12, entry 5). 
Table 3.12 Solvent screening for the asymmetric Mannich reaction of 3-1a and 3-
2aa 
 
Entry Cat. Temp (oC) Solvent Conv.(%) drb eec(%) 
1 Trp-1 RT CH2Cl2 >99 4:1 80 
2 Trp-1 RT THF >99 3:1 15 
3 Trp-1 RT CH3CN >99 5:1 53 
4 Trp-1 -20 toluene >99 8:1 93 
5 Trp-1 -50 toluene >99 9:1 97 
a The reactions were performed with ketoester (0.05 mmol), imine (0.075 mmol) and 
catalyst (0.005 mmol) in solvent (1 ml) at room temperature， unless otherwise specified. b 
Determined by 1H NMR analysis of the crude product. c The ee value of both diastereomers 
or the major diastereomers, determined by chiral HPLC analysis. 
 
3.3.3 Reaction Scope 
3.3.3.1 α-Fluorinated β-Ketoesters Screening 
Next, we investigated the effects of various ketone components in the 
asymmetric induction (Table 3.13). Different aryl ketonesters could be employed, 
generating the desired adducts with good diastereoselectivity and excellent 
enantioselectivity (entries 1–7). Aliphatic ketoester substrates led to the formation of 
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products with excellent enantioselectivity but no diastereoselectivity (entries 8 and 
9). However, the use of the tert-butyl ketoester resulted in high diastereoselectivity 
and good enantioselectivity (entry 10). 
Table 3.13 Asymmetric Mannich reaction of different α-fluorinated β-ketoestersa 
 
Entry Donor Time Yieldb (%) drc eed(%) 
1 p-MeC6H4 72 h 92 12:1 97 
2 p-FC6H4 48 h 96 9:1 96 
3 p-ClC6H4 24 h 95 8:1 95 
4 p-BrC6H4 20 h 92 7:1 95 
5 p-NO2C6H4 20 h 93 8:1 92 
6 thiophenyl 24 h 95 4:1 95 
7 2-naphthyl 24 h 93 5:1 96 
8e Methyl 24 h 93 1:1 90/93 
9e Isobutyl 36 h 93 1:1 96/97 
10e tert-butyl 48 h 93 19:1 84 
a The reactions were performed with ketoester (0.05 mmol), imine (0.075 mmol) and catalyst 
(0.005 mmol) in solvent (1 ml). b Isolated yield. c Determined by 1H NMR analysis of the 
crude product. d The ee value of both diastereomers or the major diastereomers, determined 





3.3.3.2 Mannich Acceptors 
In order to expand the reaction scope, a variety of substituted N-Boc imines 
were synthesized and the results are summarized in Table 3.14.  
Table 3.14 Asymmetric Mannich reaction of different Boc-imines  
 
Entry R/R’ Time Yieldb(%) drc eed% 
1 Ph/p-BrC6H4 20 h 92 8:1 96 
2 p-ClC6H4/ p-BrC6H4 20 h 96 7:1 95 
3 Ph/p-FC6H4 20 h 95 10:1 97 
4 p-BrC6H4/p-BrC6H4 20 h 92 8:1 95 
5 Ph/o-MeC6H4 36 h 95 11:1 92 
6 Ph/p-CF3C6H4 20 h 92 6:1 97 
7 Ph/m-NO2C6H4 20 h 92 8:1 99 
8e Ph/c-C6H11 24 h 70 4:1 85 
9f Ph/c-C6H11 20 h 92 3:1 96 
10f Ph/nBu 20 h 93 3:1 81 
a The reactions were performed with ketoester (0.05 mmol), imine (0.075 mmol) and catalyst 
(0.005 mmol) in solvent (1 ml). b Isolated yield. c Determined by 1H NMR analysis of the 
crude product. d The ee value of both diastereomers or the major diastereomers, determined 
by chiral HPLC analysis. e The reaction was carried out at room temperature with 100mol% 
of Trp-1. f The N-tosylimine was used. 
From the table we can see that aryl imines worked well, almost quantitative 
yields and perfect enantioselectivities were achieved (entry 1-7). But alkyl imines 
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have low activities, the Mannich reaction of alkyl imines is a daunting synthetic 
challenge. The best result for this type of reaction was reported by Deng et al.146b By 
increasing the catalyst loading (100 mol%), the Mannich product was obtained in 
moderate yield and good enantioselectivity. In our case, high catalyst loading (100 
mol%) was also required for good yield and high enantioselectivity (entry 8). 
Gratifyingly, when N-tosylcyclohexylmethanimine was used, the Mannich reaction 
proceeded very efficiently in the presence of Trp-1 (10 mol%) to afford the desired 
fluorinated Mannich product with 96% ee (entry 9). When N-tosylbutylmethanimine 
was used, the enantioselectivity was slightly decreased (entry 10). 
 
3.3.3.3 None-fluorinated 1,3-Dicarbonyl Substrates 
Tryptophan-based Trp-1 is a versatile catalyst for the Mannich reaction of a 
variety of 1,3-dicarbonyl substrates. The reactions are not limited to fluorinated 
substrates; nonfluorinated and chlorinated ketoesters also proved to be suitable 
substrates. Excellent enantioselectivity was also observed when malonates were used 




Scheme 3.13 Mannich reaction of other ketoesters and malonates 
 
3.3.4 Chiral β-Amino Acid and β-Lactam Synthesis 
Given the importance of β-amino acids and β-lactams147 in biological sciences 
and medicinal chemistry, the synthesis of α-fluorinated analogues of these 
compounds is of great interest. As an illustration of the synthetic applicability of our 
methodology, the Mannich product 3-3a was converted into α-fluoro-β-amino acid 




Scheme 3.14 Preparation of the α-fluorinated β-amino acid 3-6 and β-lactam 3-8 
 
3.4 Kinetic Studies 
 
In our reaction, the rate is given by k = k [A]a[B]b[C]c according to the rate 
equation, where [A], [B] and [C] express the concentration of the species A, B and C 
(usually in moles per liter (molarity)); a, b and c are not the respective stoichiometric 
coefficients of the balanced equation, they must be determined experimentally. k is 
the rate constant of the reaction. 
When the concentration of one of the reactants remains constant (because it is a 
catalyst or it is in great excess with respect to the other reactants) its concentration 
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can be included in the rate constant, obtaining a pseudo constant. In our reaction, C 
is the catalyst whose concentration is constant so k = k[A]a[B]b[C]c = k'[A]a[B]b. 
Moreover, if B is in great excess with respect to A, then k = k'[A]a[B]b = k' '[A]a; if A 
is in great excess with respect to B, then k = k'[A]a[B]b = k' '[B]b. 
Firstly, the reaction was carried out with imine A (0.05 mmol), ketoester B (0.5 
mmol), catalyst C (0.005 mmol) in benzene-D6 at 285K in a NMR tube, 1,4-
dimethoxybenzene (0.025 mmol) was added as internal standard, the volume of the 
mixture was fixed to 0.5 ml. The reaction was monitored by 1H NMR spectroscopy. 
 
Table 3.15 Mannich reaction of imine and a large excess of fluorinated 
ketoester carried out in the presence of 10 mol% catalysta 
Entry Time (s) IAb [A]c -Ln([A]/[A]0) 
1 99 0.6456 0.06456 0.4376 
2 151 0.5426 0.05426 0.6114 
3 203 0.4639 0.04639 0.7681 
4 255 0.3891 0.03891 0.9439 
5 307 0.3229 0.03229 1.1304 
6 359 0.2665 0.02665 1.3224 
7 411 0.2225 0.02225 1.5028 
8 463 0.1894 0.01894 1.6639 
9 515 0.1515 0.01515 1.8885 
a Reaction was carried out with imine (0.05 mmol) and ketoester (0.5 mmol) 





Figure 3.11 –Ln([A]/[A]0) vs. time for the Mannich reaction monitored by 1H NMR 
spectroscopy in the presence of 10 mol% catalyst 
 
From the above data, we can see that when the reaction was carried out with a 
large excess of ketoester B, plotting in -Ln([A]/[A]0) versus time gave a straight line 
(R2 = 0.999), which indicates the reaction is first-order with respect to imine A . 
By the same procedure, it was determined that the reaction was first order with 
respect to ketoester B (Table 3.16 and Figure 3.12). 
 
  Table 3.16 Mannich reaction of fluorinated ketoester and a large excess 
of imine carried out in the presence of 10 mol% catalysta 
Entry Time (s) IBb [B]c -Ln([B]/[B]0) 
1 153 1.6336 0.05445 0.6078 
2 204 1.3487 0.04496 0.7995 
3 255 1.1229 0.03743 0.9827 
4 306 0.9377 0.03126 1.1629 
5 357 0.791 0.02637 1.3331 
6 408 0.691 0.02303 1.4682 
7 459 0.5594 0.01865 1.6795 
8 510 0.4716 0.01572 1.8502 
























9 561 0.3818 0.01273 2.0615 
10 612 0.3167 0.01056 2.2484 
11 663 0.262 0.008733 2.4380 
   a Reaction was carried out with imine (0.5 mmol) and ketoester (0.05 mmol) in 
benzene-D6 at 285K. b Integration value of ketoester. c Concentration of 
ketoester. 
 
Figure 3.12 –Ln([B]/[B]0) vs. time for the Mannich reaction monitored by 1H NMR 
spectroscopy in the presence of 10 mol% catalyst  
 
Based on the data above, the rate equation for the Mannich reaction is k= k [A] 
[B] [C]c (a=b=1), that means this reaction is a second order reaction with respect to 
A and B. For a second order reaction, if [A]0 = [B]0, [A]t = [B]t the integrated second 
order rate low is 1/[A] = kt + 1/[A]0 or 1/[B] = kt + 1/[B]0. 
Secondly, the reaction was carried out with imine A (0.05 mmol), ketoester B 
(0.05 mmol), catalyst C in benzene-D6 at room temperature in a NMR tube, 1,4-
dimethoxybenzene (0.025 mmol) was added as internal standard, the volume of the 
mixture was fixed to 0.5 ml. This time different catalyst loading was selected (10 
mol%, 15 mol%, 20 mol%, 25 mol%). The reactions were monitored by 1H NMR 
spectroscopy. 




















Table 3.17 Mannich reaction of imine and fluorinated ketoester carried out in the 
presence of 10 mol% catalysta 
  a Reaction was carried out with imine (0.05 mmol) and ketoester (0.05 mmol) in benzene-
D6 at rt. b Integration value of imine. c Integration value of ketoester. d Concentration of 
imine. e Concentration of ketoester. 
 
 
Figure 3.13 1/[A] vs. time for the Mannich reaction monitored by 1H NMR 
spectroscopy in the presence of 10 mol% catalyst. 
y = 0.0047 x + 10 















K = 0.0047 M-1s-1
Entry Time     (s) IA
b
          IBc         
[A]d      
(M) 
[B]e     
(M) 
1/[A]      
(M-1) 
1/[B]     
(M-1) 
1 179 0.8940 2.7539 0.0894 0.0918 11.1857 10.8936
2 509 0.7785 2.4326 0.0779 0.0811 12.8452 12.3325
3 839 0.6936 2.1585 0.0694 0.0720 14.4175 13.8985
4 1169 0.6217 1.9367 0.0622 0.0646 16.0849 15.4903
5 1499 0.5656 1.7619 0.0566 0.0587 17.6803 17.0271
6 1829 0.5183 1.6229 0.0518 0.0541 19.2938 18.4854
7 2159 0.4733 1.5012 0.0473 0.0500 21.1282 19.9840
8 2489 0.4404 1.3866 0.0440 0.0462 22.7066 21.6357
9 2819 0.4130 1.2934 0.0413 0.0431 24.2131 23.1947
10 3149 0.3837 1.2218 0.0384 0.0407 26.0620 24.5539
11 3479 0.3640 1.1492 0.0364 0.0383 27.4725 26.1051
12 3809 0.3473 1.0866 0.0347 0.0362 28.7936 27.6091
13 4139 0.3276 1.0341 0.0328 0.0345 30.5250 29.0107
14 4469 0.3114 0.9832 0.0311 0.0328 32.1130 30.5126
15 4799 0.2962 0.9368 0.0296 0.0312 33.7610 32.0239
16 5129 0.2880 0.8886 0.0288 0.0296 34.7222 33.7610
17 5459 0.2734 0.8568 0.0273 0.0286 36.5764 35.0140
18 5789 0.2614 0.8239 0.0261 0.0275 38.2555 36.4122
19 6119 0.2524 0.7885 0.0252 0.0263 39.6197 38.0469
20 6449 0.2422 0.7600 0.0242 0.0253 41.2882 39.4737
21 8099 0.2048 0.6413 0.0205 0.0214 48.8281 46.7800
22 9749 0.1789 0.5536 0.0179 0.0185 55.8971 54.1908
23 11399 0.1588 0.4848 0.0159 0.0162 62.9723 61.8812
24 13049 0.1445 0.4310 0.0145 0.0144 69.2042 69.6056




Figure 3.14 1/[B] vs. time for the Mannich reaction monitored by 1H NMR 
spectroscopy in the presence of 10 mol% catalyst 
 
Table 3.18 Mannich reaction of imine and fluorinated ketoester carried out in the 
presence of 15 mol% catalysta 
Entry time      (s) IA
b IBc 
[A]d      
(M) 
[B]e      
(M) 
1/[A]     
(M-1) 
1/[B]      
(M-1) 
1 218 0.8457 2.5603 0.0846 0.0853 11.8245 11.7174 
2 398 0.7686 2.3475 0.0769 0.0783 13.0107 12.7796 
3 578 0.7073 2.1350 0.0707 0.0712 14.1383 14.0515 
4 758 0.6548 1.9826 0.0655 0.0661 15.2718 15.1316 
5 938 0.6086 1.8399 0.0609 0.0613 16.4312 16.3052 
6 1118 0.5721 1.7224 0.0572 0.0574 17.4795 17.4176 
7 1298 0.5342 1.6232 0.0534 0.0541 18.7196 18.4820 
8 1478 0.5052 1.5218 0.0505 0.0507 19.7941 19.7135 
9 1658 0.4783 1.4426 0.0478 0.0481 20.9074 20.7958 
10 1838 0.4534 1.3678 0.0453 0.0456 22.0556 21.9330 
a Reaction was carried out with imine (0.05 mmol) and ketoester (0.05 mmol) in benzene-D6 
at rt. b Integration value of imine. c Integration value of ketoester. d Concentration of imine. e 
Concentration of ketoester. 
 
Figure 3.15 1/[A] vs. time for the Mannich reaction monitored by 1H NMR 
spectroscopy in the presence of 15 mol% catalyst  
y = 0.0046 x + 10 















K = 0.0046 M-1s-1




















Figure 3.16 1/[B] vs. time for the Mannich reaction monitored by 1H NMR 
spectroscopy in the presence of 15 mol% catalyst  
 
Table 3.19 Mannich reaction of imine and fluorinated ketoester carried out in the 
presence of 20 mol% catalysta 
Entry Time     (s) IA
b IBc 
[A]d      
(M) 
[B]e     
(M) 
1/[A]       
(M-1) 
1/[B]     
(M-1) 
1 173 0.8704 2.5700 0.0870 0.0857 11.4890 11.6732 
2 323 0.7674 2.2803 0.0767 0.0760 13.0310 13.1562 
3 473 0.6929 2.0598 0.0693 0.0687 14.4321 14.5645 
4 623 0.6325 1.8927 0.0633 0.0631 15.8103 15.8504 
5 773 0.5847 1.7467 0.0585 0.0582 17.1028 17.1752 
6 923 0.5427 1.6288 0.0543 0.0543 18.4264 18.4185 
7 1073 0.5075 1.5233 0.0508 0.0508 19.7044 19.6941 
8 1223 0.4780 1.4273 0.0478 0.0476 20.9205 21.0187 
9 1373 0.4519 1.3456 0.0452 0.0449 22.1288 22.2949 
10 1523 0.4281 1.2582 0.0428 0.0419 23.3590 23.8436 
11 1673 0.4067 1.1957 0.0407 0.0399 24.5881 25.0899 
12 1823 0.3885 1.1287 0.0389 0.0376 25.7400 26.5793 
13 1973 0.3737 1.0771 0.0374 0.0359 26.7594 27.8526 
14 2123 0.3572 1.0323 0.0357 0.0344 27.9955 29.0613 
15 2273 0.3431 0.9895 0.0343 0.0330 29.1460 30.3183 
16 2423 0.3302 0.9495 0.0330 0.0317 30.2847 31.5956 
17 2573 0.3183 0.9078 0.0318 0.0303 31.4169 33.0469 
18 2723 0.3091 0.8684 0.0309 0.0289 32.3520 34.5463 
19 2873 0.2983 0.8394 0.0298 0.0280 33.5233 35.7398 
20 3023 0.2891 0.8035 0.0289 0.0268 34.5901 37.3367 
a Reaction was carried out with imine (0.05 mmol) and ketoester (0.05 mmol) in benzene-D6 
at rt. b Integration value of imine. c Integration value of ketoester. d Concentration of imine. e 
Concentration of ketoester. 
 
y = 0.0066 x + 10 



















Figure 3.17 1/[A] vs. time for the Mannich reaction monitored by 1H NMR 
spectroscopy in the presence of 20 mol% catalyst. 
 
Figure 3.18 1/[B] vs. time for the  Mannich reaction monitored by 1H NMR 
spectroscopy in the presence of 20 mol% catalyst 
 
Table 3.20 Mannich reaction of imine and fluorinated ketoester carried out in the 
presence of 25 mol% catalysta 
Entry Time     (s) IA
b
          IBc         
[A]d    
(M) 
[B]e     
(M) 
1/[A]       
(M-1) 
1/[B]      
(M-1) 
1 113 0.9072 2.6899 0.0907 0.0897 11.0229 11.1528 
2 263 0.7581 2.2991 0.0758 0.0766 13.1909 13.0486 
3 413 0.6612 2.0198 0.0661 0.0673 15.1240 14.8530 
4 563 0.5867 1.8119 0.0587 0.0604 17.0445 16.5572 
5 713 0.5374 1.6403 0.0537 0.0547 18.6081 18.2893 
6 863 0.4943 1.4859 0.0494 0.0495 20.2306 20.1898 
7 1013 0.4536 1.3834 0.0454 0.0461 22.0459 21.6857 
8 1163 0.4202 1.2819 0.0420 0.0427 23.7982 23.4028 
9 1313 0.3949 1.1970 0.0395 0.0399 25.3229 25.0627 
10 1463 0.3691 1.1186 0.0369 0.0373 27.0929 26.8192 
















K = 0.009 M-1s-1
y = 0.009 x + 10














K = 0.009 M-1s-1
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11 1613 0.3497 1.0536 0.0350 0.0351 28.5959 28.4738 
12 1763 0.3337 1.0218 0.0334 0.0341 29.9670 29.3600 
13 1913 0.3159 0.9591 0.0316 0.0320 31.6556 31.2793 
14 2063 0.3000 0.9247 0.0300 0.0308 33.3333 32.4430 
15 2213 0.2890 0.8670 0.0289 0.0289 34.6021 34.6021 
a Reaction was carried out with imine (0.05 mmol) and ketoester (0.05 mmol) in benzene-D6 
at rt. b Integration value of imine. c Integration value of ketoester. d Concentration of imine. e 
Concentration of ketoester. 
 
Figure 3.19 1/[A] vs. time for the Mannich reaction monitored by 1H NMR 
spectroscopy in the presence of 25 mol% catalyst   
 
Figure 3.20 1/[B] vs. time for the Mannich reaction monitored by 1H NMR 




y = 0.0115 x + 10 













K = 0.0115 M-1s-1
y = 0.0112 x + 10














K = 0.0112 M-1s-1
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[A]0        
(M) 
[B]0        
(M) 
[Cat.]    
(M) 
K 
    (M-1s-1) 
10 0.0980 0.1000 0.0100 0.0047 
15 0.1000 0.1000 0.0150 0.0067 
20 0.1020 0.1000 0.0200 0.0090 
25 0.1000 0.1000 0.0250 0.0115 
 
 
Figure 3.21 Kobs based on imine vs. concentration of catalyst for the reaction 
 
Table 3.22 Observed reaction rate constant based on ketoester B 
Cat. 
Loading     
(mol%) 
[A]0        
(M) 
[B]0        
(M) 
[Cat.]    
(M) 
K      
(M-1s-1) 
10 0.0980 0.1000 0.0100 0.0046 
15 0.1000 0.1000 0.0150 0.0066 
20 0.1020 0.1000 0.0200 0.0090 
25 0.1000 0.1000 0.0250 0.0113 
 
 
Figure 3.22 Kobs based on ketoester vs. concentration of catalyst for the Mannich 
reaction 
y = 0.4556 x





















Conc. of Cat. (M)
kobs = 0.4556 M-2s-1
y = 0.4500 x
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Figure 3.23 Intermediate IMa formed from 3-1a, 3-2a, and Trp-1. Hydrogen-bond 




In summary, we have introduced a novel tryptophan-based bifunctional thiourea 
catalyst that was remarkably effective in promoting the asymmetric Mannich 
reaction of α-fluoro-β-ketoesters. The resulting compounds with fluorinated 
quaternary and tertiary stereocenters can be converted readily into α-fluoro-β-amino 
acids and α-fluoro-β-lactams. Preliminary computational studies suggest that the 
indole moiety of the catalyst plays a crucial role in substrate binding. We have 
shown that tertiary amine–thiourea bifunctional catalysts can be derived readily from 
natural amino acids; this strategy may lead to the discovery of various novel 
multifunctional organic catalysts. Further investigations into the reaction mechanism, 
the preparation of diverse bifunctional catalysts based on primary amines, and 








3.6 Experimental Section 
3.6.1 General Information 
Chemicals and solvents were purchased from commercial suppliers and used as 
received. 1H and 13C NMR spectra were recorded on a Bruker ACF300 or AMX500 
(500 MHz) spectrometer. Chemical shifts were reported in parts per million (ppm), 
and the residual solvent peak was used as an internal reference: proton (chloroform δ 
7.26), carbon (chloroform δ 77.0). Multiplicity was indicated as follows: s (singlet), 
d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), br s (broad 
singlet). Coupling constants were reported in Hertz (Hz). Low resolution mass 
spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI mode, and a 
Finnigan/MAT 95XL-T mass spectrometer in FAB mode. All high resolution mass 
spectra were obtained on a Finnigan/MAT 95XL-T spectrometer. For thin-layer 
chromatography (TLC), Merck pre-coated TLC plates (Merck 60 F254) were used, 
and compounds were visualized with a UV light at 254 nm. Further visualization 
was achieved by staining with iodine, or ceric ammonium molybdate followed by 
heating on a hot plate. Flash chromatography separations were performed on Merck 
60 (0.040 - 0.063 mm) mesh silica gel. The enantiomeric excesses of products were 




3.6.2 Preparation of Catalysts 
 
(S)-Benzyl 1-hydroxy-3-(1H-indol-3-yl) propan-2-ylcarbamate (a) 
L-Tryptophan (5 mmol, 1.02g) was added to a stirred mixture of NaBH4 (20 
mmol, 760 mg) in dry THF (25 ml) at room temperature. Then the reaction mixture 
was placed in an ice bath, and a solution of iodine (7.5 mmol, 1.91g) in THF (12 ml) 
was added dropwise over 15-20 minutes. The mixture was then allowed to warm to 
room temperature, followed by refluxing for 18h. After that, the flask was placed in 
an ice bath and MeOH was added dropwise until the solution turned clear, followed 
by addition of 20% aqueous solution of NaOH (10 ml). The ice bath was then 
removed and the reaction mixture was stirred overnight. THF was removed in vacuo 
and concentrated HCl was added until pH=11 (approx. 3 ml). The reaction mixture 
was then diluted by addition of MeOH (15 ml), followed by addition of solid 
NaHCO3 (5mmol, 420 mg), and benzyl carbamate chloride (6 mmol, 1.02 g). The 
reaction was stirred overnight. Water was added (10ml) and the solids were removed 
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by filtration. The aqueous phase was extracted with ethyl acetate (3x20ml). The 
organic phase was washed with brine, dried over Na2SO4. The solvent was removed 
in vacuo, and the residue was purified by column chromatography on silica gel 
(hexane: ethyl acetate = 5:1 to 3: 1) to afford a as a colorless oil (1.33 g, 82%). 
1H NMR (300 MHz, CDCl3) δ 3.01-3.04 (d, 2H), 3.61-3.67 (m, 2H), 4.08 (bs, 1H), 
5.12 (s, 2H), 5.25-5.27 (d, J = 7.89 Hz, 1H), 6.97 (bs, 1H), 7.15-7.37 (m, 8H), 7.68-





To a stirred solution of a (4.1 mmol, 1.33 g) in CH2Cl2 (10 ml), TEA (12.3 
mmol, 1.24 g) and DMAP (0.41 mmol, 50 mg) were added at 0oC, followed by TsCl 
(4.5 mmol, 794 mg) in one portion. The reaction mixture was stirred at room 
temperature for 4h. Then the solvent was removed under reduced pressure and the 
residue was dissolved in ethyl acetate (10 ml). The organic phase was washed with 
brine, dried over Na2SO4. The solvent was removed in vacuo, and the residue was 
purified by column chromatography on silica gel (hexane: ethyl acetate = 10:1 to 5: 
1) to afford b as a white solid (1.72 g, 88%). 
1H NMR (300 MHz, CDCl3) δ 2.46 (s, 2H), 3.03-3.06 (m, 2H), 4.06-4.07 (d, 1H), 
4.17-4.19 (m, 1H), 5.11 (s, 2H), 6.97-7.39 (m, 8H), 7.60-7.80 (m, 2H), 8.05-8.20 (m, 
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1H); 13C NMR (75 MHz, CDCl3) δ 21.56, 26.71, 50.29, 66.74, 69.92, 110.31, 111.20, 
118.59, 119.62, 122.14, 123.11, 127.85, 127.94, 128.11, 128.48, 129.79, 129.87, 
136.19, 144.98, 155.65; HRMS m/z calcd for C26H26N2O5S [M+Na] + = 501.1455, 
found =501.1467. 
 
(S)-benzyl 1-azido-3-(1H-indol-3-yl)propan-2-ylcarbamate (c) 
To a stirred solution of b (3.6 mmol, 1.78 g) in DMF (10 ml) was added 
sodium azide (18 mmol, 1.17 g). The temperature was heated to 90oC and the 
reaction mixture was stirred overnight at this temperature. Then the solvent was 
removed under reduced pressure and the residue was dissolved in ethyl acetate (10 
ml). The organic phase was washed with brine, dried over Na2SO4. The solvent was 
removed in vacuo, and the residue was purified by column chromatography on silica 
gel (hexane: ethyl acetate = 10:1 to 5: 1) to afford c as a colorless oil (0.82 g, 65%). 
1H NMR (300 MHz, CDCl3) δ 3.01-3.09 (m, 2H), 3.39-3.46 (m, 2H), 4.18-4.23 (m, 
1H), 5.06-5.09 (d, J = 7.56, 1H), 5.18 (s, 2H), 7.03 (s, 1H), 7.19-7.30 (m, 2H), 7.40 
(s, 5H), 7.65-7.70 (d, 1H), 8.21 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 27.65, 51.03, 
53.19, 66.82, 110.83, 111.23, 118.70, 119.72, 122.25, 122.89, 127.40, 128.05, 
128.15, 128.52, 136.24, 155.79; HRMS m/z calcd for C19H19N5O2 [M+Na] + = 




(S)-benzyl 1-amino-3-(1H-indol-3-yl)propan-2-ylcarbamate (d) 
To a stirred solution of c (2.3 mmol, 0.82 g) in THF (5 ml) and H2O (5 ml) was 
added triphenylphosphine (2.8 mmol, 0.74 g). The reaction mixture was stirred for 
1h at room temperature. Then the solvent was removed under reduced pressure and 
the residue was dissolved in ethyl acetate (10 ml). The organic phase was washed 
with brine, dried over Na2SO4. The solvent was removed in vacuo, and the residue 
was purified by column chromatography on silica gel (dichloromethane: methanol = 
20:1 to 5: 1) to afford d as a white solid (0.67 g, 90%). 
1H NMR (300 MHz, CDCl3) δ 2.57-2.93 (m, 4H), 3.90 (bs, 1H), 5.04 (s, 3H), 6.90 (s, 
1H), 7.02-7.15 (m, 2H), 7.27 (bs, 6H), 7.56-7.59 (d, 1H), 8.12 (s, 1H); 13C NMR (75 
MHz, CDCl3) δ 28.09, 44.78, 53.80, 66.58, 111.12, 111.77, 118.86, 119.52, 122.08, 
122.54, 127.70, 128.04, 128.49, 136.20, 141.35, 156.41; HRMS m/z calcd for 
C19H21N3O2 [M+H] + = 324.1707, found =324.1717. 
 
(S)-benzyl 1-(diethylamino)-3-(1H-indol-3-yl)propan-2-ylcarbamate (e) 
To a stirred solution of d (2.0 mmol, 0.67 g) in methanol (15 ml) was added 
acetaldehyde (8 mmol, 0.35 g). The reaction mixture was stirred for 0.5h and then 
NaBH3CN (4 mmol, 0.32 g) was added. The reaction mixture was stirred for another 
4h (during this time acetic acid was added to control the PH=5). Then ammonia 
solution was added until white solid precipitated, the solvent was removed under 
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reduced pressure and the residue was dissolved in dichlomethane (20 ml). The 
organic phase was washed with brine, dried over Na2SO4. The solvent was removed 
in vacuo, and the residue was purified by column chromatography on silica gel 
(dichloromethane: methanol = 50:1 to 10: 1) to afford e as a colorless oil (0.6 g, 82%). 
1H NMR (300 MHz, CDCl3) δ 1.02-1.07 (t, 6H), 2.54-2.67 (m, 6H), 3.07-3.15 (m, 
2H), 4.11-4.15 (m, 1H), 6.99 (s, 1H), 7.16-7.24 (m, 2H), 7.26-7.42 (m, 6H), 7.75 (bs, 
1H), 8.65 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 11.57, 28.08, 47.04, 49.89, 56.34, 
66.49, 111.24, 111.65, 119.00, 119.24, 121.76, 122.91, 127.96, 127.98, 128.48, 
136.28, 136.77, 156.58; HRMS m/z calcd for C23H29N3O2 [M+H] + = 380.2333, 




e (200 mg, 0.5 mmol) was hydrogenated with 10% palladium on carbon (60 
mg) in methanol (4.0 mL) and acetic acid (2.0 ml) at room temperature under an 
atmosphere of hydrogen for 24 h. The mixture was filtered with celite, and the 
filtrate was concentrated. This residue was dissolved in THF and 3, 5-Bis 
(trifluoromethyl) phenyl isothiocyanate (0.5 mmol, 0.135 g) was added. The mixture 
was stirred overnight and then the solvent was removed in vacuo, and the residue 
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was purified by column chromatography on silica gel (dichloromethane: methanol = 
50:1 to 20: 1) to afford Trp-1 as a white solid (0.26 g, 85%). 
1H NMR (300 MHz, CDCl3) δ 1.00-1.06 (t, 6H), 2.55-2.83 (m, 6H), 3.03-3.06 (d, 
2H), 4.17 (bs, 1H), 6.53 (bs, 1H), 7.13-7.30 (m, 3H), 7.41-7.44 (d, J = 7.89 Hz), 7.62 
(s, 2H), 8.00 (s, 2H), 8.40 (s, 1H), 13.38 (bs, 1H); 13C NMR (75 MHz, CDCl3) δ 10.6, 
29.55, 47.47, 59.64, 60.76, 110.30, 111.51, 117.61, 117.67, 118.21, 119.87, 121.29, 
122.54, 122.81, 123.22, 124.91, 126.95, 128.52, 130.93, 131.38, 131.83, 132.27, 
136.37, 141.68, 182.99; HRMS m/z calcd for C24H26F6N4S [M+H] + = 517.1855, 




Procedure was the same as above. 
1H NMR (300 MHz, MeOD) δ 0.92-0.97 (m, 6H), 2.61-2.71 (m, 6H), 3.08-3.10 (m, 
2H), 6.97-7.17 (m, 7H), 7.35-7.37 (d, J = 8.07, 2H), 7.73 (bs, 1H); 13C NMR (75 
MHz, MeOD) δ 9.89, 28.05, 46.95, 52.5, 55.1, 110.36, 110.79, 114.92, 115.22, 
118.33, 120.97, 12.97, 126.49, 127.61, 134.13, 136.61, 161.96, 180.85; HRMS m/z 




Procedure was the same as above. 
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1H NMR (300 MHz, MeOD) δ 0.94-0.99 (m, 6H), 2.57-2.79 (m, 6H), 3.10 (bs, 1H), 
6.99-7.14 (m, 3H), 7.34-7.37 (d, J = 8.07 Hz, 1H), 7.65-7.68 (m, 3H), 8.08-8.10 (d, 
2H); 13C NMR (75 MHz, MeOD) δ 9.75, 27.99, 46.98,  52.04, 54.99, 110.36, 110.85, 
118.35, 121.02, 123.00, 123.87, 124.12, 127.55, 136.64, 142.87, 145.81, 180.25; 
HRMS m/z calcd for C22H27N5O2S [M+H] + = 426.1958, found = 426.1974. 
 
3.6.3 Representative Procedure  
 
Ethyl 2-fluoro-3-oxo-3-phenylpropanoate 3-1a (10.5 mg, 0.05 mmol) was added 
to a mixture of catalyst Try-1 (2.5 mg, 0.005 mmol) and imine 3-2a (16.43 mg, 
0.075 mmol) in toluene (1.0 mL) in a sample vial. The vial was then capped and the 
reaction mixture was stirred at -50 oC for 48 h. Then the solvent was evaporated and 
the residue was purified by column chromatography on silica gel (hexane: ethyl 
acetate = 30:1 to 10: 1) to afford 3-3a as a white solid (20.4 mg, 95%). The 
enantiomeric excess of product was determined by chiral HPLC analysis. 
 






(2S, 3S)-Ethyl 3-(tert-butoxycarbonylamino)-2-fluoro-2-((S) hydroxy (phenyl) 
methyl)-3-p-tolylpropanoate 3-5 
To a solution of Mannich product 3-3a (100 mg, 0.23 mmol) in absolute EtOH 
(8 mL) at 0oC was added sodium borohydride (0.56 mmol, 34 mg). The reaction 
mixture was allowed to warm to room temperature, and stirring was continued for 
additional 1.5 h. The reaction was then placed in an ice bath and quenched by adding 
saturated aqueous solution of ammonium chloride (25 mL). The mixture was 
extracted with ethyl acetate (3 x 15 L), and the combined organic layers were dried 
over Na2SO4. After filtration and concentration, the residue was purified by column 
chromatography (hexane:ethyl acetate= 9:1 to 4:1) to yield 3-5 as a white solid (83 
mg, 83%). 
A white solid; 1H NMR (300 MHz, CDCl3) δ 0.63‐0.68 (t, 3H), 1.38 (s, 9H), 2.19 (s, 
3H), 3.62‐3.73 (m, 2H), 4.66 (bs, 1H), 4.99‐5.07 (d,1H), 5.24‐5.30 (t, J = 9.5 Hz, 
1H), 5.86‐5.89 (d, J = 10.5 Hz, 1H), 6.99‐7.07 (m, 4H), 7.15‐7.17 (m, 3H), 7.26‐7.28 
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(m, 2H); 13C NMR (75 MHz, CDCl3) δ 13.36, 20.91, 28.18, 54.72 (d, J = 31.29 Hz), 
61.28, 73.68 (d, J = 18.67 Hz), 81.23, 97.34, 100.10, 127.33, 127.35, 127.70, 127.71, 
127.86, 128.18, 128.99, 132.56, 136.87, 137.93, 156.52, 169.04 (d, J = 21.96 Hz). 
 
(3S, 4S)-3-fluoro-3-((S)-hydroxy (phenyl)methyl)-4-p-tolylazetidin-2-one 3-8 
To a solution of 3-5 (60 mg, 0.14 mmol) in dichloromethane (4 mL) at 0oC was 
added trifluoroacetic acid (0.4 mL). The ice bath was then removed and the reaction 
mixture was allowed to warm up to room temperature and stirred for 2 h. Saturated 
aqueous ammonium chloride (10 mL) was added to quench the reaction, and the 
resulting mixture was extracted with dichloromethane several times (3 x 10 mL). 
The combined organic extracts were dried over sodium sulfate, after filtration, the 
filtrate was concentrated to yield the crude free amine, which was used directly for 
the next step without further purification. Grignard reagent was prepared from 
isopropyl chloride (5 mmol, 392 mg) and magnesium (10 mmol, 240 mg) in dry 
THF (10 mL), initiated with a few crystals of iodine. To a solution of the crude 
amine in dry THF (2 mL) at 0oC, freshly prepared Grignard reagent was added (10 
eq., 2.5 ml of THF solution). The reaction mixture was then allowed to warm to 
room temperature and stirred overnight. The reaction was quenched with the 
addition of saturated aqueous ammonium chloride (10 mL). The mixture was 
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extracted with ethyl acetate several times (3 x 10 mL), and the organic extracts were 
combined, dried over Na2SO4 and concentrated. The residue was purified by column 
chromatography (hexane:ethyl acetate = 9:1 to 4:1) to afford β‐lactam 3-8 as a white 
solid (20 mg, 58%). 
A white solid; [α]D25 = 43.2 (c = 0.6, CHCl3); 1H NMR (300 MHz, CDCl3) δ 2.31 (s, 
3H), 3.37 (s, 1H), 5.04‐ 5.07 (d, J = 4.92 Hz, 1H), 5.27‐5.29 (d, J = 8.22 Hz, 1.0H), 
6.59‐6.61 (d, J = 6.06 Hz, 1H), 6.79‐6.82 (d, J = 8.07 Hz, 2H), 7.06‐7.09 (d, J = 7.89 
Hz, 2H), 7.37‐7.46 (m, 3H), 7.53‐7.56 (d, 2H); 13C NMR (75 MHz, CDCl3) δ 20.99, 
29.61, 58.35 (d, J = 23.46 Hz), 70.33 (d, J = 27.82 Hz), 104.2 (d, J = 226.4 Hz), 
126.66 (d, J = 1.64 Hz), 126.77, 128.35, 128.52, 129.02, 130.88 (d, J = 1.64 Hz), 
137.35, 138.14, 166.86 (d, J = 35.45 Hz); 
HRMS (IT‐TOF) m/z calcd for C17H16FNO2 [M+Na] + = 308.1063, found = 
308.0962. Crystal obtained for X-ray diffraction was recrystallized from a mixture of 
EtOAc/Hexane, see the appendix one for data. 
 
(2S, 3S)-3-(tert-butoxycarbonylamino)-2-fluoro-2-((S)-hydroxy (phenyl)methyl)-
3-p-tolylpropanoic acid 3-6 
To a solution of 3-5 (100 mg, 0.232 mmol) in THF (2 mL) and MeOH (1 mL), 
3M aqueous NaOH was added (2 mL). The reaction mixture was stirred at room 
temperature for 2.5 h. Upon completion, ethyl acetate (10 mL) was added to the 
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reaction mixture, followed by slow addition of 2M aqueous solution of HCl until pH 
1‐2 was reached. The phases were then separated and the aqueous layer was 
extracted with ethyl acetate (3 x 10 mL). The combined organic layers were dried 
over Na2SO4 and evaporated to yield crude product, which was purified by 
chromatography (ethyl acetate/hexane = 1:4 to 1:1) to afford acid 3-6 as a white 
solid (80 mg, 85%) 
A white solid; 1H NMR (300 MHz, CDCl3) δ 1.53 (s, 9H), 2.36 (s, 3.0 H), 5.15‐5.23 
(d, J = 24 Hz, 1H), 5.38‐ 5.44 (t, J = 9.0 Hz, 1H), 5.98‐6.01 (d, J = 9.0 Hz, 1H), 6.82 
(bs, 1H), 7.14‐7.22 (m, 4H), 7.30‐7.34 (m, 3H), 7.42‐7.43 (m, 2H); 13C NMR (75 
MHz, CDCl3) δ 21.01, 28.23, 54.88 (d, J = 30.9 Hz), 73.53 (d, J = 18.1 Hz), 81.73, 
99.1 (d, J = 203.8 Hz), 127.44, 127.74, 128.11, 128.42, 129.28, 132.15, 136.38, 
138.22, 156.69, 171.4 (d, J = 24.1Hz); HRMS m/z calcd for C22H26FNO5 [M+Na]+ = 




To a solution of acid 3-6 (77 mg, 0.19 mmol) in dry CH2Cl2 (3.5 mL), DMAP 
was added (0.02 mmol, 4.9 mg), followed by a solution of DCC (59 mg, 0.3 mmol) 
in dry CH2Cl2 (1.5 mL). The reaction mixture was stirred at room temperature for 6 
hours. Upon completion (judged by TLC), DCU was removed by filtration, and the 
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filtrate was washed with CH2Cl2 and the organic layers were combined and 
concentrated. The crude product was purified by chromatography using silica gel 
(ethyl acetate/hexane = 1:10) to afford lactone 3-9 as white solid (43 mg, 59%). 
A white solid; 1H NMR (300 MHz, CDCl3) δ 1.46 (s, 9H), 2.29 (s, 3.0 H), 5.07‐5.24 
(m, 2H), 5.57‐5.61 (d, J = 12.0 Hz, 1H), 6.54‐6.57 (d, J = 7.08 Hz, 2H), 6.90‐6.92 (d, 
J = 7.89 Hz, 2H), 7.20‐7.23 (d, J = 7.41 Hz, 2H), 7.32‐7.45 (m, 3H); 13C NMR (75 
MHz, CDCl3) δ 20.94, 28.16, 52.47 (d, J = 19.76 Hz), 80.48, 82.75 (d, J = 24.7 Hz), 
105.48 (d, J = 226.70 Hz), 126.65, 128.09, 128.13, 128.67, 128.86, 129.60, 130.90, 
131.52, 131.56, 138.03, 154.54, 164.29 (d, J = 25.24 Hz); HRMS m/z calcd for 
C22H24FNO4 [M+Na] + = 408.1587, found = 408.1408. 
 
3.6.5 Analytical Data of Substrates and Mannich Adducts  
Substrates: 3-1a~k were prepared according to the literature procedure.135 
Ethyl 2-fluoro-3-oxo-3-phenylpropanoate 3-1a 
 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.25-1.32 (t, 3H), 4.26-4.34 (m, 2H), 
5.78-5.94 (d, J = 48.81 Hz, 1H), 7.48-7.53 (m, 2H), 7.61-7.68 (m, 1H), 8.03-8.05 (d, 
2H). 
 




A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.24-1.28 (m, 3H), 2.43 (s, 3H), 4.22-
4.35 (m, 2H), 5.75-5.92 (d, J = 48.81Hz, 1H), 7.26-7.31 (m, 2H), 7.93-7.96 (d, 2H). 
 
Ethyl 2-fluoro-3-(4-fluorophenyl)-3-oxopropanoate 3-1c 
 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.25-1.28 (t, 3H), 4.27-4.34 (m, 2H), 
5.75-5.85 (d, J = 49.2Hz, 1H), 7.16-7.19 (m, 2H), 8.00-8.11 (d, 2H). 
 
Ethyl 3-(4-chlorophenyl)-2-fluoro-3-oxopropanoate 3-1d 
 
1H NMR (300 MHz, CDCl3) δ 1.18-1.23 (t, 3H), 4.20-4.28 (m, 2H), 5.65-5.81 (d, J = 
49.10Hz, 1H), 7.40-7.43 (m, 2H), 7.91-7.94 (d, 2H). 
 




1H NMR (300 MHz, CDCl3) δ 1.25-1.29 (t, 3H), 4.27-4.35 (m, 2H), 5.71-5.88 (d, J = 
48.83, 1H), 7.64-7.67 (m, 2H), 7.90-7.93 (m, 2H). 
 
Ethyl 2-fluoro-3-(4-nitrophenyl)-3-oxopropanoate 3-1f 
 
1H NMR (300 MHz, CDCl3) δ 1.30-1.35 (m, 3H), 4.33-4.41 (m, 2H), 5.79-5.96 (d, J 
= 48.86Hz, 1H), 8.24-8.25 (m, 2H), 8.27-8.40 (m, 2H). 
 
Ethyl 2-fluoro-3-oxo-3-(thiophen-3-yl)propanoate 3-1g 
 
1H NMR (300 MHz, CDCl3) δ 1.25-1.30 (m, 3H), 4.20-4.35 (m, 2H), 5.56-5.73 (d, J 
= 49.16Hz, 1H), 7.34-3.37 (m, 1H), 7.63-7.66 (m, 1H), 8.39-8.41 (m, 1H). 
 





1H NMR (300 MHz, CDCl3) δ 1.24-1.29 (t, 3H), 4.26-4.36 (m, 2H), 5.90-6.06 (d, J = 
48.83Hz, 1H), 7.56-7.63 (m, 2H), 7.65-8.06 (m, 4H), 8.07 (s, 1H).  
 




1H NMR (300 MHz, CDCl3) δ 2.31-2.32 (d, J = 4.11 Hz, 3H), 5.15-5.31 (d, J = 49.3 
Hz, 1H), 5.27 (s, 2H), 7.37 (s, 5H). 
 
Benzyl 2-fluoro-4-methyl-3-oxopentanoate 3-1j 
 
1H NMR (300 MHz, CDCl3) δ 1.07-1.11 (m, 6H), 3.03-3.13 (m, 1H), 5.27-5.41 (d, J 
= 45.20 Hz, 1H), 5.27 (s, 2H), 7.36 (s, 5H). 
 
Benzyl 2-fluoro-4,4-dimethyl-3-oxopentanoate 3-1k 
 
 
1H NMR (300 MHz, CDCl3) δ 1.20 (s, 9H), 5.26 (s, 2H), 5.43-5.59 (d, J = 48.65 Hz, 









A white solid; 1H NMR (300 MHz, CDCl3) δ 1.25-1.30 (t, 3.0H), 1.39 (s, 9H), 2.27 
(s, 3H), 4.20-4.39 (m, 2H), 5.38-5.43 (d, J = 10.2 Hz, 1H), 5.83-6.01 (dd, J = 10.3 
Hz, 1H), 7.05-7.08 (d, 2H), 7.26-7.29 (d, 2H), 7.34-7.39 (t, 2H), 7.49-7.54 (t, 2H), 
7.81-7.84 (d, 2H); 13C NMR (75 MHz, CDCl3) δ 13.76, 20.95, 28.12, 57.13 (d, J = 
18.54 Hz), 63.09, 79.97, 102.20 (d, J = 203.47 Hz), 128.33, 128.54, 128.56, 128.96, 
129.36, 129.43, 133.55, 133.63, 134.08, 134.16, 137.71, 154.28, 165.47 (d, J = 25.08 
Hz), 190.78 (d, J = 25.64 Hz); HRMS m/z calcd for C24H28FNO5 [M+Na]+ = 
452.1844, found = 452.1864; The ee value of the major diastereomer was 97% 
(Chiralcel AD-H, λ = 254 nm, 15% iPrOH/hexane, flow rate = 0.50 mL/min, tR 








A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.25-1.28 (t, 3.0H), 1.38-1.39 (d, 9H), 
2.27 (s, 3H), 2.36 (s, 3H),  4.07-4.34 (m, 2H), 5.38-5.41 (d, J = 10.7 Hz, 1H), 5.89-
5.97 (dd, J = 10.7 Hz, 1H), 7.05-7.07 (d, 2H), 7.16-7.17 (d, 2H), 7.26-7.28 (m, 2H), 
7.75-7.77 (d, 2H); 13C NMR (125 MHz, CDCl3) δ 13.86, 20.06, 21.71, 28.23, 57.17 
(d, J = 19.14Hz), 63.13, 80.02, 102.29 (d, J = 204.05Hz), 128.64, 128.65, 129.04, 
129.17, 129.68, 129.73, 131.58, 133.76, 137.73 144.89, 154.39, 165.76 (d, J = 27.33 
Hz), 190.22 (d, J = 24.59 Hz); HRMS m/z calcd for C25H30FNO5 [M+Na]+ = 
466.2000, found = 466.2020; The ee value of the major diastereomer was 97% 
(Chiralcel IC, λ = 254 nm, 7.5% iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) 





A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.26-1.29 (t, 3.0H), 1.38 (s, 9H), 2.27 
(s, 2.7H), 2.32 (s, 0.3H), 4.06-4.10 (m, 0.2H), 4.20-4.37 (m, 1.8H), 5.38-5.40 (d, J = 
10.05 Hz, 1H), 5.89-5.97 (dd, J = 10.1 Hz, 1H), 7.02-7.14 (m, 4H), 7.26-7.28 (m, 
2H), 7.87-8.05 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 13.87, 21.08, 28.22, 57.13 
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(d, J = 19.13 Hz), 63.04, 63.32, 80.15, 102.38 (d, J = 204.05Hz), 115.65,115.83, 
128.25, 128.61, 128.63, 129.11, 129.73, 130.40, 130.45, 132.41, 132.46, 132.48, 
132.54, 132.58, 132. 64, 133.50, 137.91, 154.36, 165.51 (d, J = 27.34 Hz), 189.25 (d, 
J = 24.58 Hz); HRMS m/z calcd for C24H27F2NO5 [M+Na] + = 470.1750, found = 
470.1733; The ee value of the major diastereomer was 96% (Chiralcel AD-H, λ = 
254 nm, 15% iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) = 21.8 min, 
30.6min). 
 







A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.29-1.34 (t, 3.0H), 1.43 (s, 9H), 2.31 
(s, 2.6H), 2.36 (s, 0.4H), 4.08-4.15 (m, 0.3H), 4.20-4.44 (m, 1.7H), 5.40-5.44 (d, J = 
10.5 Hz, 1H), 5.89-6.03 (dd, J = 10.35 Hz, 1H), 7.09-7.15 (d, 2H), 7.28-7.30 (m, 2H), 
7.35-7.46 (d, 2H), 7.79-7.80 (d, 2H); 13C NMR (75 MHz, CDCl3) δ 13.76, 20.96, 
28.11, 57.10 (d, J = 18.55 Hz), 62.95, 63.22, 80.07, 102.28 (d, J = 204.0 Hz), 128.15, 
128.48, 128.51, 128.73, 128.79, 129.01, 130.84, 131.08, 132.31, 133.35, 137.84, 
140.35, 154.25, 165.07,189.93; HRMS m/z calcd for C24H27ClFNO5 [M+Na]+ = 
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486.1454, found = 486.1463; The ee value of the major diastereomer was 82% 
(Chiralcel IA, λ = 254 nm, 15% iPrOH/hexane, flow rate = 0.50 mL/min, tR (major) 





A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.30-1.35 (t, 3.0H), 1.43 (s, 9H), 2.31 
(s, 2.7H), 2.36 (s, 0.3H), 4.08-4.15 (m, 0.3H), 4.21-4.44 (m, 1.7H), 5.40-5.44 (d, J = 
10.35 Hz, 1H), 5.89-6.03 (dd, J = 10.35 Hz, 1H), 7.09-7.17 (d, 2H), 7.53-7.63 (d, 
2H), 7.73-7.74 (d, 2H); 13C NMR (75 MHz, CDCl3) δ 13.77, 20.96, 28.12, 57.11 (d, 
J = 19.09 Hz), 62.95, 63.23, 80.08, 102.28 (d, J = 203.46 Hz),128.12, 128.14, 128.48, 
128.51, 129.02, 129.07, 129.13, 129.17, 130.82, 130.92, 131.02, 131.11, 131.17, 
131.80, 132.73, 132.78, 133.33, 137.86, 138.14, 154.25, 165.07, 190.01 (d, J = 25.09 
Hz); HRMS m/z calcd for C24H27BrFNO5 [M+Na]+ = 530.0949, found = 530.0938; 
The ee value of the major diastereomer was 95% (Chiralcel IA, λ = 254 nm, 15% 







A yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.32-1.35 (t, 3.0H), 1.40-1.42 (d, 9H), 
2.31 (s, 2.3H), 2.37 (s, 0.7H), 4.11-4.31 (m, 0.4H), 4.36-4.43 (m, 2.6H), 5.41-5.44 (d, 
J = 9.5 Hz, 1H), 5.91-5.99 (dd, J = 10.1Hz, 1H), 7.09-7.11 (d, 1.5H), 7.15-7.17 (d, 
0.5H), 7.25-7.31 (m, 2H), 7.90-7.92 (d, 1.5H), 8.10-8.11 (d, 0.5H), 8.12-8.13 (d, 
1.5H), 8.20-8.21 (d, 0.5H); 13C NMR (125 MHz, CDCl3) δ 13.72, 13.89, 21.07, 
21.14, 28.20, 57.29 (d, J = 18.21Hz), 63.62, 80.36, 102.47 (d, J = 204.05 Hz), 
123.50, 123.58, 128.15,128.54, 128.56, 129.26, 129.31, 130.35, 130.40, 130.61, 
132.95, 138.27, 138.51, 138.89, 138.92, 150.37, 154.31, 164.76 (d, J = 27.35Hz), 
190.55 (d, J = 27.34Hz); HRMS m/z calcd for C24H27FN2O7 [M+Na]+ = 497.1695, 
found = 497.1700; The ee value of the major diastereomer was 92% (Chiralcel IA, λ 
= 254 nm, 15% iPrOH/hexane, flow rate = 1.0 mL/min, tR (major) = 13.9 min, 







A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.29-1.32 (t, 3.0H), 1.39-1.41 (d, 9H), 
2.29 (s, 2.4H), 2.34(s, 0.6H), 4.04-4.43 (m, 2H), 5.43-5.45 (d, J = 10.1 Hz, 1H), 
5.89-5.98 (dd, J = 10.05 Hz, 1H), 7.09-7.11 (d, 1.6H), 7.15-7.17 (d, 0.4H), 7.23-7.24 
(d, 0.8H), 7.24-7.31 (m, 2H), 7.51-7.52 (d, 2H), 8.30 (s, 1H); 13C NMR (125 MHz, 
CDCl3) δ 13.71, 13.88, 21.07, 21.13, 28.22, 56.86 (d, J = 19.21 Hz), 62.89, 63.19, 
80.08, 102.36 (d, J = 203.12 Hz), 125.63, 128.14, 128.23, 128.37, 128.58, 128.59, 
129.08, 129.72, 129.86, 133.53, 135.74, 135.85, 137.39, 137.42, 137.86, 138.12, 
154.36, 165.43 (d, J = 27.33Hz), 184.11 (d, J = 25.5Hz); HRMS m/z calcd for 
C22H26FNO5S [M+Na]+ = 458.1408, found = 458.1408; The ee value of the major 
diastereomer was 95% (Chiralcel AD-H, λ = 254 nm, 15% iPrOH/hexane, flow rate 







A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.27-1.30 (t, 3.0H), 1.39-1.41 (d, 9H), 
2.27 (s, 2.5H), 2.33(s, 0.5H), 4.10-4.12 (m, 0.3H), 4.22-4.38 (m, 1.7H), 5.41-5.43 (d, 
J = 10.1Hz, 1H), 5.96-6.04 (dd, J = 10.1Hz, 1H), 7.06-7.08 (d, 1.7H), 7.14-7.16 (d, 
0.3H), 7.30-7.32 (d, 2H), 7.50-7.59 (m, 2H), 7.78-7.90 (m, 4H), 8.45 (s, 0.8H), 8.60 
(s, 0.15H); 13C NMR (125 MHz, CDCl3) δ 13.88, 21.06, 28.24, 57.31 (d, J = 19.12 
Hz), 63.25, 80.09, 102.52 (d, J = 204.05 Hz), 124.58, 124.62, 126.82, 127.66, 127.71, 
128.25, 128.29, 128.67, 128.68, 129.06, 129.11, 129.15, 130.06, 131.36, 131.39, 
131.95, 132.02, 132.31, 133.73, 135.72, 137.84, 154.41, 154.47, 165.76 (d, J = 26.4 
Hz), 190.60 (d, J = 25.5 Hz); HRMS m/z calcd for C28H30FNO5 [M+Na]+ = 
502.2000, found = 502.1994; The ee value of the major diastereomer was 96% 
(Chiralcel IC, λ = 254 nm, 7.5% iPrOH/hexane, flow rate = 0.5 mL/min, tR (major) = 





A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.37 (s, 9H), 1.99 (s, 1.3H), 2.30-2.34 
(m, 4.7H), 4.99-5.07 (q, J = 40.35 Hz, 1H), 5.16-5.29 (m, 1.5H), 5.47 (s, 0.5H), 
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5.60-5.66 (m, 1H), 7.03-7.04 (d, J = 7.6 Hz, 1H), 7.09-7.19 (m, 4H), 7.26-7.32 (m, 
4H); 13C NMR (75 MHz, CDCl3) 20.99, 21.03, 26.20, 26.34, 28.08, 56.89, 68.08, 
66.26, 80.37, 80.42, 102.00, 127.81, 127.84, 127.93, 127.96, 128.07, 128.28, 128.34, 
128.46, 128.54, 129.05, 129.17, 132.48, 132.74, 132.75, 134.07, 134.47, 138.14, 
138.17, 154.29, 164.16, 199.50 ; HRMS m/z calcd for C24H28FNO5 [M+Na]+ = 
452.1844, found = 452.1856; The ee value of the both diastereomers were 90/93% 
(Chiralcel IA, λ = 210 nm, 10% iPrOH/hexane, flow rate = 0.5 mL/min, tR = 12.8 
min, 16.6 min, 22.1min, 25.1 min). 




A colorless oil; 1H NMR (300 MHz, CDCl3) δ 0.60-0.62 (d, 1.5H), 0.90-0.95 (d, 
1.5H), 0.96-0.98 (1.5H), 1.01-1.04 (d, 1.5H), 1.36 (s, 9H), 2.71 (s, 0.5H), 3.03-3.13 
(m, 0.5H), 5.05 (s, 1H), 5.16-5.63 (m, 3H), 6.86-7.00 (m, 2H), 7.17-7.50 (m, 7H); 
13C NMR (75 MHz, CDCl3) δ 17.95, 17.98, 28.08, 29.60, 36.48, 36.75, 56.58, 68.15, 
80.36, 102.14 (d, J = 204.01Hz), 115.14 (d, J = 2.18 Hz), 115.42 (d, J = 2.18 Hz), 
128.09, 128.41, 128.51, 128.53, 128.62, 129.75, 129.79, 129.87, 129.90, 130.19, 
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130.22, 130.30, 130.33, 131.67, 131.92, 134.03, 134.43,154.07, 154.20, 160.89, 
164.16, 205.08; HRMS m/z calcd for C25H29F2NO5 [M+Na]+ = 484.1906, found = 
484.1923; The ee value of the both diastereomers were 96/ 97% (Chiralcel IA, λ = 
210 nm, 10% iPrOH/hexane, flow rate = 0.5 mL/min, tR = 17.5 min, 18.0 min, 29.5 
min, 31.6 min). 
     
(S)-Benzyl 2-((S)-(tert-butoxycarbonylamino) (p-tolyl) methyl)-2-fluoro-4, 4-
dimethyl-3-oxopentanoate 3-3k 
 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 0.82 (s, 9H), 1.37 (s, 9H), 2.29(d, 3H), 
5.12-5.15 (d, 12.6H), 5.29-5.39 (m, 2H), 5.71-5.79 (dd, J = 10.1Hz, 1H), 7.06-7.09 
(d, 2H), 7.17-7.19 (d, 2H), 7.31-7.36 (m, 5H); 13C NMR (125 MHz, CDCl3) δ 21.09, 
25.21 (d, J = 3.64 Hz), 28.23, 45.36 (d, J = 4.55 Hz), 57.99 (d, J =18.21 Hz), 68.24, 
80.08, 103.96 (d, J = 207.71Hz), 128.19, 128.49, 128.58, 128.75, 128.95, 133.06, 
134.71, 138.00, 154.44, 164.78 (d, J = 27.3 Hz), 204.56 (d, J = 24.6 Hz); HRMS m/z 
calcd for C24H34FNO5 [M+Na]+ = 494.2313, found = 494.2329; The ee value of the 
mqjor diastereomers was 84% (Chiralcel IC, λ = 210 nm, 10% iPrOH/hexane, flow 
rate = 0.5 mL/min, tR = 12.5 min, 15.7 min). 






A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.25-1.29 (t, 3.0H), 1.39 (s, 9H), 
4.08-4.20 (m, 0.2H), 4.23-4.41 (m, 1.8H), 5.40-5.44 (d, J = 10.35 Hz, 1H), 5.87-5.99 
(dd, J = 10.35 Hz, 1H), 7.26-7.27 (d, 2H), 7.29-7.47 (m, 4H), 7.51-7.54 (t, 1H), 7.80-
7.90 (d, 2H); 13C NMR (75 MHz, CDCl3) δ 13.76, 28.10, 56.81 (d, J = 19.09Hz), 
63.05, 63.26, 80.33, 101.91 (d, J = 204.55 Hz), 122.22, 128.47, 129.40, 129.48, 
129.54, 129.62, 130.06, 130.09, 130.47, 130.51, 130.87, 131.42, 131.49, 132.36, 
133.75, 133.79, 133.94, 135.63, 154.20, 165.20 (d, J = 26.73 Hz), 190.39 (d, J = 
25.64 Hz); HRMS m/z calcd for C23H25BrFNO5 [M+Na]+ = 516.0792, found = 
516.0785; The ee value of the major diastereomer was 96% (Chiralcel AD-H, λ = 
254 nm, 15% iPrOH/hexane, flow rate = 0.5 mL/min, tR (major) = 27.5 min, 30.5 
min). 






A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.29-1.34 (t, 3.0H), 1.43 (s, 9H), 
4.11-4.45 (m, 2H), 5.42-5.46 (d, J = 10.35 Hz, 1H), 5.89-6.02 (dd, J = 10.53 Hz, 1H), 
7.29-7.31 (d, 2H), 7.38-7.51 (m, 4H), 7.71-7.74 (d, 2H); 13C NMR (75 MHz, CDCl3) 
δ 13.65, 13.76, 28.08, 56.75 (d, J = 18.54 Hz), 63.18, 63.40, 80.42, 101.97 (d, J = 
204.01 Hz), 122.33, 122.58, 128.88, 130.01, 130.04, 130.43, 130.46, 130.85, 130.94, 
131.00, 131.09, 131.48, 131.55, 131.95, 131.99, 132.36, 135.43, 140.72, 154.17, 
164.98 (d, J = 27.27 Hz), 189.32 (d, J = 25.08Hz); HRMS m/z calcd for 
C23H24BrClFNO5 [M+Na]+ = 550.0403, found = 550.0423; The ee value of the 
major diastereomer was 95% (Chiralcel AD-H, λ = 254 nm, 15% iPrOH/hexane, 







A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.29-1.34 (t, 3.0H), 1.43 (s, 9H), 
4.13-4.27 (m, 0.2H), 4.30-4.45 (m, 1.8H), 5.45-5.49 (d, J = 10.02Hz, 1H), 5.93-6.06 
(dd, J = 10.35Hz, 1H), 6.95-7.01 (m, 2H), 7.39-7.45 (m, 4H), 7.54-7.59 (t, 1H), 
7.85-7.90 (d, 2H); 13C NMR (75 MHz, CDCl3) δ 13.77, 28.10, 56.73 (d, J = 18.00 
Hz), 62.98, 63.23, 80.24, 102.06 (d, J = 203.46 Hz), 115.22, 128.43, 129.47, 130.15, 
130.54, 132.32, 133.89, 154.24, 160.71, 163.99, 165.27 (d, J = 27.27 Hz), 190.64 (d, 
J = 25.64 Hz); HRMS m/z calcd for C23H25F2NO5 [M+Na]+ = 456.1593, found = 
456.1604; The ee value of the major diastereomer was 97% (Chiralcel IA, λ = 254 
nm, 15% iPrOH/hexane, flow rate = 0.5 mL/min, tR (major) = 19.2 min, 24.3 min). 









A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.29-1.34 (t, 3.0H), 1.43 (s, 9H), 
4.09-4.17 (m, 0.2H), 4.21-4.44 (m, 1.8H), 5.43-5.46 (d, J = 10.2 Hz, 1H), 5.90-6.04 
(dd, J = 10.17 Hz, 1H), 6.96-7.05 (m, 2H), 7.37-7.42 (m, 2H) 7.54-7.55 (d, 2H), 755-
7.58 (d, 2H); 13C NMR (75 MHz, CDCl3) δ 13.77, 28.09, 56.67 (d, J = 19.09 Hz), 
63.11, 63.37, 80.34, 102.12 (d, J = 204.01 Hz), 115.25, 129.45, 130.04, 130.07, 
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130.15, 130.18, 130.43, 130.46, 130.54, 130.56, 130.80, 130.89, 131.01, 131.10, 
131.84, 132.19, 132.24, 132.50, 132.56, 154.20, 160.75, 164.02, 165.02 (d, J = 27.28 
Hz), 189.81 (d, J = 25.64 Hz); HRMS m/z calcd for C23H24BrF2NO5 [M+Na]+ = 
534.0698, found = 534.0721; The ee value of the major diastereomer was 95% 
(Chiralcel IA, λ = 254 nm, 15% iPrOH/hexane, flow rate = 0.5 mL/min, tR (major) = 
29.2 min, 31.3 min). 







A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.29-1.34 (t, 3.0H), 1.43 (s, 9H), 3.78 
(s, 2.7H), 3.82 (s, 0.3H), 4.09-4.22 (m, 0.18H), 4.24-4.44 (m, 1.82H), 5.43-5.46 (d, J 
= 10.2 Hz, 1H), 5.89-6.03 (dd, J = 10.68 Hz, 1H), 6.80-6.90 (m, 2H), 7.34-7.47 (m, 
4H) 7.50-7.58 (t, 1H), 7.84-7.90 (d, 2H); 13C NMR (75 MHz, CDCl3) δ 13.78, 28.12, 
55.09 (d, J = 3.8 Hz), 56.88 (d, J = 16.99 Hz), 63.09, 79.99, 102.26 (d, J = 203.47 
Hz), 113.64, 113.67, 128.35, 128.42, 128.67, 129.33, 129.41, 129.52, 129.60, 129.87, 
129.91, 133.64, 133.71, 134.09, 134.15, 154.29, 159.19, 165.45 (d, J = 27.27 Hz), 
190.86 (d, J = 25.64 Hz); HRMS m/z calcd for C24H28FNO5 [M+Na]+ = 452.1844, 
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found = 452.1864; The ee value of the major diastereomer was 92% (Chiralcel IA, λ 
= 254 nm, 15% iPrOH/hexane, flow rate = 1.0 mL/min, tR (major) = 12.1 min, 16.9 
min). 




A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.29-1.34 (t, 3.0H), 1.41-1.43 (d, 9H), 
4.12-4.47 (m, 2H), 5.49-5.53 (d, J = 10.14 Hz, 1H), 6.01-6.11 (dd, J = 10.68 Hz, 1H), 
7.41-7.51 (m, 2H), 7.56-7.67 (m, 6H), 7.87-7.90 (d, 2H); 13C NMR (75 MHz, CDCl3) 
δ 13.60, 13.76, 28.04, 28.08, 28.19, 29.6, 56.89 (d, J = 19.08 Hz), 63.13, 63.36, 
80.49, 101.85 (d, J = 204.56 Hz), 122.04, 125.20, 125.25, 125.30, 125.38, 125.57, 
125.64, 126.55, 128.51, 128.80, 129.21, 129.24, 129.43, 129.51, 129.63, 130.00, 
130.43, 133.59, 134.06, 140.52, 154.20, 165.13 (d, J = 26.18 Hz), 190.20 (d, J = 
25.09 Hz); HRMS m/z calcd for C24H25F4NO5 [M+Na]+ = 506.1561, found = 
506.1578; The ee value of the major diastereomer was 97% (Chiralcel IA, λ = 254 







A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.29-1.34 (t, 3.0H), 1.42 (d, 9H), 
4.17-4.47 (m, 2H), 5.61-5.65 (d, J = 10.05 Hz, 1H), 6.05-6.18 (dd, J = 10.2 Hz, 1H), 
7.41-7.63 (m, 4H), 7.80-7.90 (m, 3H), 8.13-8.17 (d, 2H), 8.34 (s, 1H); 13C NMR (75 
MHz, CDCl3) δ 13.78,  28.07, 56.62 (d, J = 18.54 Hz), 63.34, 63.48, 80.72, 101.61 
(d, J = 204.56 Hz), 123.09, 123.31, 123.45, 123.72, 128.59, 129.15, 129.32, 129.50, 
129.58, 129.66, 133.34, 133.39, 134.27, 135.42, 138.67, 148.11, 154.17, 164.80 (d, J 
= 26.72 Hz), 189.89 (d, J = 25.10 Hz); HRMS m/z calcd for C23H25FN2O7 [M+Na]+ 
= 483.1538, found = 483.1534; The ee value of the major diastereomer was 99% 
(Chiralcel IA, λ = 254 nm, 15% iPrOH/hexane, flow rate = 0.5 mL/min, tR (major) = 
16.8 min, 26.9 min). 






A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.09-1.33 (m, 9H), 1.46-1.49 (d, 9H), 
1.66-1.71 (m, 7H), 4.18-4.37 (m, 2H), 4.58-5.01 (m, 2H), 7.45-7.52 (m, 2H), 7.60-
7.64 (m, 1H), 7.96-7.99 (d, 2H); 13C NMR (75 MHz, CDCl3) δ 13.68, 13.80, 25.87, 
26.01, 26,34, 28.15, 30.78, 30.82, 31.65, 40.07. 40.12, 57.70 (d, J = 13.64 Hz), 57.97 
(d, J = 12.55 Hz), 62.86, 79.48, 103.47 (d, J = 202.37 Hz), 128.39, 128.50, 129.36, 
129.45, 129.57, 129.65, 133.54, 133.74, 134.08, 134.13, 155.01, 165.96 (d, J =26.73 
Hz), 191.14 (d, J = 25.10 Hz); HRMS m/z calcd for C23H32FNO5 [M+Na]+ = 
444.2162, found = 444.2243; The ee value of the major diastereomer was 85% 
(Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, flow rate = 0.5 mL/min, tR (major) = 






A colorless oil; 1H NMR (300 MHz, CDCl3) δ 0.87-1.59 (m, 9H), 1.63-1.84 (m, 7H), 
2.44 (s, 3H), 3.86-4.32 (m, 2H), 4.51-4.63 (m, 1H), 4.94-5.01 (m, 1H), 7.20-7.34 (m, 
3H), 7.41-7.58 (m, 3H), 7.61-7.72 (m, 2H), 7.91-7.99 (m, 2H); 13C NMR (75 MHz, 
CDCl3) δ 13.57, 13.74, 21.37, 25.68, 25.98, 26.10, 26.34, 26.42, 27.63, 27.67, 28.18, 
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31.48, 31.87, 40.23, 61.19 (d, J = 20.73 Hz), 61.63 (d, J = 20.73Hz), 63.04, 102.20 
(d, J = 204.01 Hz), 103.677 (d, J = 204.01 Hz), 126.94, 127.00, 128.13, 128.54, 
129.16, 129.32, 129.37, 129.47, 129.55, 129.64, 133.65, 133.73, 133.98, 138.73, 
138.86, 142.75, 165.29 (d, J =26.18 Hz), 191.06 (d, J = 25.10 Hz); HRMS m/z calcd 
for C25H30FNO5S [M+Na]+ = 498.1726, found = 498.1228; The ee value of the 
major diastereomer was 96% (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, flow 
rate = 1.0 mL/min, tR (major) = 19.5 min, 25.1min). 
 
(2S, 3S)-Ethyl 2-benzoyl-2-fluoro-3-(4-methylphenylsulfonamido)heptanoate 3-3u 
 
 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 0.72-0.76 (m, 3H), 1.09-1.29 (m, 7H), 
1.48-1.55 (m, 2H), 2.43-2.45 (d, 3H), 3.96-4.32 (m, 2H), 4.32-4.68 (m, 1H), 4.90-
4.94 (d, J = 10.35Hz),  5.04-5.08 (d, J = 10.2Hz), 7.26-7.39 (m, 2H), 7.40-7.50 (m, 
2H), 7.62-7.65 (m, 1H), 7.71-7.76 (m, 2.5H), 7.91-7.99 (d, 1.5H); 13C NMR (75 
MHz, CDCl3) δ 13.56, 13.58, 13.68, 21.34, 22.17, 27.73, 30.83, 30.85, 31.23, 31.28, 
57.64 (d, J = 21.82 Hz), 57.75 (d, J = 24 Hz), 63.07, 63.13, 100.17 (d, J = 202.37 
Hz), , 103.677 (d, J = 205.75Hz), 126.93, 127.00, 128.30, 128.53, 129.24, 129.38, 
129.47, 129.51, 129.56, 129.64, 133.67, 133.71, 133.84, 133.93, 133.98, 134.03, 
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138.55, 138.70, 142.95, 143.24, 165.24 (d, J =26.18 Hz), 165.36 (d, J =25.10 Hz), 
191.09 (d, J = 25.63 Hz), 192.07 (d, J = 26.18 Hz); HRMS m/z calcd for 
C23H28FNO5S [M+Na]+ = 472.1570, found = 472.1368; The ee value of the major 
diastereomer was 95% (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, flow rate = 








A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.09-1.14 (t, 3.0H), 1.40 (s, 9H), 2.34 
(s, 3H), 4.08-4.21 (m, 2H), 5.86-6.03 (m, 2H), 7.13-7.15 (d, 2H), 7.38-7.46 (m, 4H), 
7.53-7.56 (m, 1H), 7.93-7.97 (d, 2H); 13C NMR (75 MHz, CDCl3) δ 13.43, 20.98, 
28.15, 28.24, 29.61, 59.33, 63.44, 79.85, 128.20, 128.55, 128.72, 129.08, 129.32, 
129.45, 133.17, 133.96, 134.06, 137.81, 154.33, 166.70, 189.71; HRMS m/z calcd 
for C24H28ClNO5 [M+Na]+ = 468.1554, found = 468.1358; The ee value of the major 
diastereomer was 82% (Chiralcel AD-H, λ = 254 nm, 15% iPrOH/hexane, flow rate 




(3R)-Ethyl 2-benzoyl-3-(tert-butoxycarbonylamino)-3-p-tolylpropanoate 3-4b 
 
 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.16-1.24 (m, 3H), 1.39 (s, 4.5H), 
1.43 (s, 4.5H), 2.29 (s, 1.5H), 2.32 (s, 1.5H), 4.09-4.26 (m, 2H), 4.93-4.98 (m, 1H), 
5.05-5.63 (m, 1H), 6.05 (s, 0.5H), 6.36 (s, 0.5H), 7.08-7.16 (m, 2H), 7.25-7.30 (m, 
2H), 7.41-7.56 (m, 3H), 7.85- 7.87 (m, 1H), 7.97-8.00 (m, 1H); 13C NMR (75 MHz, 
CDCl3) 13.80, 20.86, 20.92, 28.12, 18.15, 28.23, 53.43, 54.20, 57.33, 59.23, 61.52, 
61.79, 79.43, 79.49, 126.33, 128.21, 128.35, 128.60, 128.79, 129.04, 129.18, 133.60, 
135.70, 136.78, 136.86, 137.00, 137.10, 137.25, 154.88, 155.14, 167.66, 168.36, 
193.02, 194.89; HRMS m/z calcd for C24H29NO5 [M+Na]+ = 434.1938, found = 
434.1919; The ee value of the both diastereomers were 97/92% (Chiralcel AD-H, λ = 
254 nm, 10% iPrOH/hexane, flow rate = 1.0 mL/min, tR = 27.2 min, 31.9min, 35.9 








A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.36-1.47 (m, 12H), 4.06-4.20 (m, 
2H), 4.96-5.03 (m, 1H), 5.59-5.73 (m, 1H), 6.11 (s, 0.5H), 6.44 (s, 0.5H), 7.43-7.57 
(m, 4H), 7,74-7.95 (m,2H), 8.19-8.24 (m, 2H), 8.34-8.40 (s, 1H); 13C NMR (75 MHz, 
CDCl3) δ 13.78, 13.81, 28.01, 28.08, 53.17, 53.83, 56.88, 58.64, 61.98, 62.22, 80.97, 
121.36, 121.54, 121.67, 122.44, 122.63, 123.36, 123.60, 128.24, 128.35, 128.80, 
128.98, 129.44, 129.70, 132.36, 133.17, 134.40, 135.31, 136.19, 141.32, 148.30, 
154.53, 167.14, 192.37, 194.25; HRMS m/z calcd for C23H26N2O7 [M+Na]+ = 
465.1632, found = 465.1646; The ee value of the both diastereomers were 98/96% 
(Chiralcel AD-H, λ = 254 nm, 10%iPrOH/hexane, flow rate = 1.0 mL/min, tR = 22.0 
min, 23.8 min, 34.8 min, 41.6 min).       
 
(R)-dimethyl 2-((tert-butoxycarbonylamino)(p-tolyl)methyl)malonate 3-4d 
 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.45 (m, 9H), 2.34 (s, 3H), 3.68 (s, 
3H), 3.77 (s, 3H), 3.93-3.95 (d, J = 4.77, 1H), 5,48 (s, 1H), 6.11 (s, 1H), 7.14-7.23 
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(m, 4H); The ee value of the diastereomer was 92% (Chiralcel AD-H, λ = 220 nm, 
10% iPrOH/hexane, flow rate = 1.0 mL/min, tR = 21.9min, 25.3 min). 
     
(R)-dibenzyl 2-((tert-butoxycarbonylamino)(p-tolyl)methyl)malonate 3-4e 
 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.40 (m, 9H), 2.31 (s, 3H), 5.06-5.20 
(m, 4H), 5.51 (s, 1H), 6.12 (s, 1H), 7.06-7.16 (m, 6H), 7.24-7.35 (m, 8H); The ee 
value of the diastereomer was 92% (Chiralcel IC, λ = 220 nm, 10% iPrOH/hexane, 
flow rate = 0.5 mL/min, tR = 39.0 min, 50.3 min). 
 
3.6.6 DFT Calculations 
DFT calculations were performed at the B3LYP/6-31G** level of theory using 
Gaussian 03 program (Revision D.02).1-3 Geometry optimizations were performed in 
gas phase using the default convergence criteria without any constraints. 
 Structure of intermediate IMa: 
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 H                 -3.88221100    1.94292400   -7.25411900 
 H                 -3.57506200    0.29269300  -11.21546400 
 C                 -2.39872400   -2.05424600  -10.52467000 
 C                 -4.28975000    2.53355000   -9.85286800 
 C                 -3.35965200    0.09492800   -2.42068100 
 H                 -4.16912900    0.81305200   -2.55414500 
 C                 -2.33374300    0.63522400   -1.42062700 
 H                 -1.54186900   -0.10022700   -1.26921900 
 H                 -2.83146400    0.84098400   -0.47212100 
 C                 -3.98622600   -1.22366300   -1.89071900 
 H                 -3.19170900   -1.96741600   -1.78239700 
 H                 -4.66160200   -1.57801800   -2.67849900 
 C                 -4.73712200   -1.06482100   -0.59933200 
 C                 -5.94619400   -0.30173200   -0.37856400 
 C                 -6.28755100   -0.44007600    0.99524600 
 F                 -1.12687100   -1.84517200  -10.95449300 
 F                 -3.16959900   -2.13550800  -11.63242000 
 F                 -2.41624800   -3.26166100   -9.92570500 
 F                 -4.86881900    2.36161900  -11.06216200 
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 F                 -3.28675900    3.43194200  -10.02372400 
 F                 -5.19925000    3.11627500   -9.04519300 
 N                 -1.65835700    1.90973300   -1.87259500 
 C                 -2.64228200    3.03450900   -2.11724600 
 H                 -3.32464800    2.67642800   -2.89165600 
 H                 -3.21419800    3.16806000   -1.19514900 
 C                 -0.50892400    2.27106400   -0.95754500 
 H                  0.03754700    3.07051200   -1.45812500 
 H                  0.14500500    1.39705100   -0.95407100 
 C                 -1.98594900    4.33123600   -2.57500600 
 H                 -1.35136900    4.16152700   -3.44818000 
 H                 -1.39217300    4.81163400   -1.79254200 
 H                 -2.77716600    5.02832000   -2.86419700 
 C                 -0.91775200    2.67428600    0.45259300 
 H                 -1.42173000    1.86682500    0.98906900 
 H                 -1.56497100    3.55549800    0.46375400 
 H                 -0.01303200    2.92560500    1.01351800 
 H                 -1.97731300   -0.87440000   -5.80218300 
 O                 -0.63993200   -1.62087300   -4.97000000 
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 C                 -0.16241400   -2.80933900   -4.89558200 
 C                  0.12448200   -3.43266800   -3.67835400 
 C                 -0.16516300   -2.93124100   -2.37109400 
 O                 -0.74100100   -1.86865600   -2.09659800 
 H                 -1.96122700   -0.73917300   -3.79972400 
 F                  0.81011200   -4.63237500   -3.69567600 
 O                  0.28035900   -3.77037400   -1.38695600 
 C                  0.06102900   -3.33181500   -0.04130500 
 H                  0.52061900   -2.34776900    0.10367800 
 H                 -1.01528400   -3.21878700    0.13777200 
 C                  0.67164500   -4.37374900    0.87868000 
 H                  1.74523000   -4.46686400    0.69303000 
 H                  0.21016300   -5.35235800    0.71926200 
 H                  0.52454200   -4.08700400    1.92518600 
 C                  0.14095300   -3.51597900   -6.18934700 
 C                  0.59941000   -4.68878500   -8.70546300 
 C                  0.47168900   -2.72746600   -7.30273400 
 C                  0.04406000   -4.90681400   -6.35811100 
 C                  0.26686400   -5.48396900   -7.60766400 
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 C                  0.70567200   -3.30550900   -8.54858800 
 H                  0.54128400   -1.65324000   -7.16884500 
 H                 -0.21185600   -5.53304400   -5.51296100 
 H                  0.17414300   -6.56009400   -7.72466700 
 H                  0.94619500   -2.67784800   -9.40080400 
 H                  0.76828700   -5.14204700   -9.67795000 
 H                 -1.18703000    1.72639100   -2.78776000 
 N                  1.74461300    0.85364100   -3.22572700 
 C                  1.05828100    1.44721100   -4.27526500 
 C                  2.06913100   -0.39000700   -3.24078000 
 H                  1.72018400   -1.05676800   -4.03273000 
 C                  2.92057900   -0.97936000   -2.20639000 
 C                  4.62775300   -2.13346400   -0.27378800 
 C                  3.19552100   -2.35554600   -2.22843000 
 C                  3.50795200   -0.18516500   -1.20309500 
 C                  4.34364400   -0.75536700   -0.25520800 
 C                  4.03778000   -2.91857200   -1.27082300 
 H                  2.73513400   -2.99258200   -2.97690700 
 H                  3.30264400    0.88041600   -1.19368600 
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 H                  4.79364200   -0.12969200    0.51174900 
 H                  4.23715300   -3.98602400   -1.30018300 
 C                  5.56215800   -2.73625400    0.74596200 
 H                  5.50662300   -3.82782400    0.74577400 
 H                  5.33236500   -2.38291500    1.75667100 
 H                  6.60239700   -2.45751200    0.53771900 
 O                 -0.02244300    2.02026900   -4.12448100 
 O                  1.77177600    1.43597600   -5.39942500 
 C                  1.40510600    2.23279400   -6.60130000 
 C                  1.44269200    3.71970500   -6.24208600 
 H                  1.28773600    4.31575600   -7.14656200 
 H                  2.41538700    3.98872500   -5.81912400 
 H                  0.65976900    3.97314200   -5.52610000 
 C                  2.52791100    1.87447100   -7.57591100 
 H                  2.38718000    2.41084200   -8.51863000 
 H                  2.52838900    0.80138300   -7.78533300 
 H                  3.50292400    2.14669100   -7.16230800 
 C                  0.04605800    1.79252600   -7.14103000 
 H                 -0.14389000    2.29221400   -8.09604700 
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 H                 -0.75821500    2.04109000   -6.45022100 
 H                  0.03399700    0.71369500   -7.31438200 
 H                 -5.33763300   -1.56988200    2.52818000 
 C                 -6.77686900    0.47184400   -1.21070100 
 H                 -6.54963800    0.58839600   -2.26704100 
 C                 -7.41635800    0.17090400    1.55150000 
 H                 -7.66319200    0.05272800    2.60296800 
 C                 -8.21443700    0.93185700    0.70536500 
 H                 -9.10004200    1.41808000    1.10385700 
 C                 -4.40751600   -1.61977100    0.61284400 
 H                 -3.58254500   -2.27158100    0.86532800 
 N                 -5.32686300   -1.24352100    1.57617600 
 C                 -7.89872500    1.07945800   -0.66079700 
 H                 -8.54832700    1.67628500   -1.29395000 
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Chapter 4  Highly Enantioselective Amination Reactions of     
Fluorinated Ketoesters Mediated by Novel Chiral 
Guanidines Derived from Cinchona Alkaloids 
 
4.1 Introduction 
Hydrogen bonding is very important in molecular recognition and interaction, 
the utilization of hydrogen bonding activations with substrates have drawn much 
attention in asymmetric organocatalysis.60-63,134,139 Guanidine-based organic 
molecules are very important hydrogen-bond donor catalysts in a wide range of 
organic reactions.109-114 Despite their tremendous utility, these catalysts are derived 
from a very limited range of chiral structural scaffolds. The development of readily 
accessible novel chiral guanidine catalysts would be highly desirable. Recently 
cinchona alkaloids derived bifunctional thiourea catalysts have been synthesized and 
employed in many reactions.101-108,134 We were intrigued by the possibility of 
designing novel bifunctional guanidine catalysts on the basis of cinchona alkaloids 
(Scheme 4.11). 
 
Scheme 4.11 Guanidine catalyst based on cinchona alkaloid (quinidine) 
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To assess the utility of cinchona alkaloids-derived bifunctional guanidine 
catalysts, we chose to focus on the direct asymmetric Amination reaction of α-
fluorinated β-ketoesters, as such reactions yield structurally demanding and 
biologically important α-fluoro α-amino acids possessing quaternary carbon centers. 
Asymmetric Amination reactions of β-ketoesters were reported recently by the 
research groups of Jørgensen, Togni, Deng, Terada, and Kim112,113,148 Herein, we 
reported the highly efficient and enantioselective asymmetric Amination reaction of 
fluorinated substrates catalyzed by novel chiral guanidines derived from cinchona 
alkaloids  to afford highly optically enriched fluorine-containing molecules. 
 
4.2 Synthesis of Catalysts 
Synthetic route for the preparation of the cinchona alkaloids-derived guanidine 
catalysts QDG-1 was outlined in Scheme 4.12. Using quinidine as a starting material, 
quinidine-based thiourea (c) was prepared according to the literature procedure. 
Then (c) was treated with mercury (II) oxide to form the key intermediate 
carbodiimide (d). After ammonia carbonate added, the catalyst QDG-1 was obtained 




Scheme 4.12 Preparation of catalysts 
 
4.3 Results and Discussion 
4.3.1 Catalyst Screening 
We selected the Amination reaction of α-fluoro-β-ketoester 3-1a with di-tert-
butyl azodicarboxylate 4-2a as a model reaction and examined the catalytic effects 
of various bifunctional catalysts (Table 4.11). Tryptophan and quinidine-derived 
thioureas and a quinidine-derived sulfonamide gave disappointing results (entries 1–
3). On the other hand, the cinchona alkaloids-based guanidine derivatives were 
found to be good catalysts. They afforded the Amination product 4-3a in quantitative 





Table 4.11 Catalyst screening for the Amination reaction of 3-1a and 4-2a 
 
 
Entry Cat. Time Conv.b(%) eec(%) 
1 QD-1 24 h 30 47 
2 QD-3 24 h <30 0 
3 Trp-1 24 h 50 60 
4 CDG-1 3 h >99 70 
5 CDG-2 5 h >99 71 
6 QDG-1 3 h >99 73 
7  QDG-1 5 h >99 73 
a The reactions were performed with ketoester (0.05 mmol), DBAD (0.05 
mmol) and catalyst (0.005 mmol) in solvent (0.5 ml) at room temperature， 
unless otherwise specified. b Determined by 1H NMR analysis of the crude 
product. c The ee values were determined by chiral HPLC analysis. 
 
4.3.2 Solvent Screening 
Encouraged by the initial results, we next performed a solvent screening and the 
results are summarized in Table 4.12. Under optimized reaction conditions, toluene 
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was found to be the best solvent, the fluorinated product was obtained with 90%ee 
when the temperature was lowed to -50oC (Table 4.12, entry8). 
Table 4.12 Solvent screening for the Amination reaction of 3-1a and 4-2a 
 
Entry Cat. Temp (oC) Solvent time Conv.b(%) eec(%) 
1 QDG-1 RT CH2Cl2 20h >99 50 
2 QDG-1 RT THF 24h 50 60 
3 QDG-1 RT CH3CN 20h >99 21 
4 QDG-1 RT ether 12h >99 69 
5 QDG-1 RT benzene 12h >99 66 
6 QDG-1 RT xylene 12h >99 71 
7 QDG-1 -50 oC toluene 12h >99 87 
8 QDG-1 -50 oC Toluene(0.033M) 20h >99 90 
a The reactions were performed with ketoester (0.05 mmol), DBAD (0.05 mmol) and catalyst 
(0.005 mmol) in solvent (0.5 ml) at room temperature，unless otherwise specified. b 
Determined by 1H NMR analysis of the crude product. c The ee values were determined by 
chiral HPLC analysis.  
 
4.3.3 Reaction Scope 
We next explored the effects of various ketone components in the asymmetric 
induction (Table 4.13). Different aryl ketonesters could be employed, generating the 
desired adducts with good yields and excellent enantioselectivities (entries 1–11). 
When methyl ketone was utilized (entry 12), the enantioselectivity was very low. 
However, tert-butyl ketone turned out to be less effective, much longer reaction time 
was required to achieve moderate chemical yield and there was no improvement in 
enantioselectivity (entry 13). 
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Table 4.13 Asymmetric Amination reaction of different α-fluorinated β-ketoestersa 
 
Entry  R1/R2 Time  Yieldb(%) eec(%) 
1 Ph/Me  20 h 96 91 
2 Ph/Bn 20 h 91 88 
3 p-NO2C6H4/Et  20 h 93 88 
4 p-BrC6H4/Et  20 h 92 90 
5  m-BrC6H4/Et 20 h 93 88 
6  p-ClC6H4/Et 20 h 93 91 
7 p-MeC6H4/Et 72 h 96 91 
8 p-MeOC6H4/Et 48 h 90 91 
9 2-naphthyl/Et 72 h 96 93 
10 thiophenyl/Et 72h 78 88 
11 Me/Bn 96 h 86 57 
12 iPr/Bn 96 h 82 47 
13d t-Bu/Bn 96 h 80 70 
a The reactions were performed with ketoester (0.05 mmol), DBAD (0.05 mmol) 
and catalyst (0.005 mmol) in solvent (1.5 ml) at -50 oC. b Isolated yields. c The ee 
values were determined by chiral HPLC analysis. d The reaction was carried out at 
room temperature. 
 
The absolute configuration of the amination product 4-3e was determined to 





4.4 Modification of Amination Product 
Organofluorine compounds are very important in medicinal chemistry, different 
class of fluorinated compounds have been investigated, but so far very little have 
been done toward the synthesis of α-fluoro α-amino acids. The reason for this might 
be the possible inherent instability of α-fluoro α-amino acids toward the elimination 
of HF.  
Herein, several conditions have been tried for the preparation of α-fluoro α-
amino acid based on our amination product (The key points focus on the reduction of 
ketone to alkane and cleavage of the N-N bond). 
 
Scheme 4.13 α-Fluoro α-amino acid based on the amination product 
 A mild method for converting ketones to alkanes is via a two-step process 
involving a tosylhydrazone.149 First, the ketone is converted to the corresponding 
tosylhydrazone, and then treated with the mild reducing agent sodium 
cyanoborohydride under slightly acidic condition to afford the alkane. But in our 
reaction, the first step didn’t proceed even if the reaction was heated for 3h, 
presumably due to the steric hindrance induced by the tosylhydrazine and the 
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amination product 4-3a. When we changed tosylhydrazine to hydrazine 
monohydrate, the reaction still cannot proceed (Scheme 4.14).  
 
Scheme 4.14 Reduction of ketone to alkane 
As Raney Nickel is an effective catalyst for the conversion of thioketals to 
alkanes, a ketone can be converted to the alkane with this mild method through a 
thioketal.150 But in my case, the reaction was very complicated in the first step 
(Scheme 4.15). 
 
Scheme 4.15 Conversion of ketone to alkane through a thioketal 
The Barton Deoxygenation is a two-step reaction for the reduction of an alcohol 
to an alkane.151Since the above methods are not possible, we decided to reduce 
ketone to alcohol first, followed by the Barton Deoxygenation. But after the 
reduction, many new spots generated, the alcohol is not stable presumably due to the 




Scheme 4.16 The Barton Deoxygenation via a methylxanthate 
Several methods have been reported with respect to the cleavage of N-N 
bond,152 but in our reaction, these methods could not provide the desired product 
(Scheme 4.17). The reason is still under investigation. 
 
Scheme 4.17 Cleavage of N-N bond 
 
4.5 Conclusion 
In summary, we have developed a highly efficient catalytic enantioselective 
amination of α-fluoro β-ketoesters using novel cinchona alkaloid-based bifunctional 
guanidine catalyst. The resulting compounds with fluorinated quaternary carbon 
centers were obtained in good yields with excellent enantioselectivities (up to 
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93%ee). We believe that this method could provide a practical entry for the 
preparation of α-fluoro α-amino acid derivatives. Further investigations into the 
reaction mechanism, the application of the amination products are in progress in our 
laboratory, and will be presented in due course. 
 
4.6 Experimental Section 
4.6.1 General Information 
Chemicals and solvents were purchased from commercial suppliers and used as 
received. 1H and 13C NMR spectra were recorded on a Bruker ACF300 or AMX500 
(500 MHz) spectrometer. Chemical shifts were reported in parts per million (ppm), 
and the residual solvent peak was used as an internal reference: proton (chloroform δ 
7.26), carbon (chloroform δ 77.0). Multiplicity was indicated as follows: s (singlet), 
d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), br s (broad 
singlet). Coupling constants were reported in Hertz (Hz). Low resolution mass 
spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI mode, and a 
Finnigan/MAT 95XL-T mass spectrometer in FAB mode. All high resolution mass 
spectra were obtained on a Finnigan/MAT 95XL-T spectrometer. For thin-layer 
chromatography (TLC), Merck pre-coated TLC plates (Merck 60 F254) were used, 
and compounds were visualized with a UV light at 254 nm. Further visualization 
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was achieved by staining with iodine, or ceric ammonium molybdate followed by 
heating on a hot plate. Flash chromatography separations were performed on Merck 
60 (0.040 - 0.063 mm) mesh silica gel. The enantiomeric excesses of products were 
determined by chiralphase HPLC analysis. 
 
4.6.2 Preparation of Catalyst 
 
 
N-((S)-((R)-(6-methoxyquinolin-4-yl) ((2R)-5-vinylquinuclidin-2-yl) methylimino) 
methylene)-3, 5-bis (trifluoromethyl) benzenamine (d) 
To a stirred solution of c (0.5 mmol, 0.29 g) in CH2Cl2 (5 ml) and H2O (5 ml) 
was added mercuric oxide (1.5 mmol, 0.33 g). The reaction mixture was stirred 
overnight at room temperature. Then the mixture was filtered with celite, and the 
filtrate was concentrated. The residue was dissolved in dichlomethane (20 ml). The 
organic phase was washed with brine, dried over Na2SO4. The solvent was removed 
in vacuo, and the residue was purified by column chromatography on silica gel 
(CH2Cl2: CH3OH = 50:1 to 10: 1) to afford d as a white solid (0.25 g, 90%). 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 1,87-1.93 (m, 2H), 2.08-2.17 (m, 2H), 
2.23 (s, 1H), 2.80-2.82 (d, J = 6.65 Hz, 1H), 3.28-3.43 (m, 3H), 3.77-3.95 (m, 5H), 
5.22-5.26 (d, J = 17.2 Hz, 1H), 5.31-5.33 (d, J = 10.55 Hz), 5.42-5.44 (d, J = 9.6 Hz, 
1H), 5.81-5.88 (m, 1H), 7.26 (s, 1H), 7.38-7.40 (m, 1H), 7.51-7.52 (d, J = 4.35 Hz, 
1H), 7.57 (s, 1H), 8.04-8.06 (d, J = 9.15Hz), 8.13 (s, 1H), 8.75-8.76 (d, J = 4.35 Hz, 
1H); 13C NMR (125 MHz, CDCl3) δ 23.68, 23.96, 28.11, 37.08, 52.55, 53.01, 55.20, 
66.29, 67.83, 101.86, 111.92, 117.78, 118.76, 121.66, 122.63, 125.86, 127.76, 
130.90 (q, J = 143 Hz),134.74, 143.94, 144.43, 147.73, 151.90, 156.43, 157.67; 




To a stirred solution of d (0.25 mmol, 0.14 g) in DMF (4 ml) was added 
ammonium carbonate (1.5 mmol, 0.14 g). The temperature was heated to 80oC and 
the reaction mixture was stirred overnight at this temperature. Then the solvent was 
removed under reduced pressure and the residue was dissolved in dichlomethane (10 
ml). The organic phase was washed with brine, dried over Na2SO4. The solvent was 
removed in vacuo, and the residue was purified by column chromatography on silica 




A white solid; 1H NMR (300 MHz, CDCl3) δ 1.04-1.10 (m, 1H), 1.25-1.34 (m, 2H), 
1.59-1.62 (m, 2H), 1.74 (s, 1H), 2.40-2.43 (m, 1H), 2.90-3.15 (m, 5H), 3.95 (s, 3H), 
5.18-5.24 (m, 2H), 5.89-6.01 (m, 1H), 7.25 (s, 2H), 7.41-7.46 (m, 2H), 7.52-7.74 (d, 
J = 4.59 Hz, 1H), 7.65-7.66 (d, J = 2.46Hz), 8.06-8.09 (d, J = 9.36 Hz, 1H), 8.79-
9.81 (d, J = 4.44Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 24.94, 26.16, 27.15, 38.74, 
45.95, 46.71, 48.88, 55.41, 61.50, 101.19, 114.85, 114.90, 114.96, 122.01, 123.10, 
131.92, 132.40, 139.89, 144.79, 147.66, 150.59, 151.98, 157.95; HRMS m/z calcd 




To a stirred solution of d (0.25 mmol, 0.14 g) in DMF (4 ml) was methylamine 
solution 33 wt. % in absolute ethanol (0.2 ml). The temperature was heated to 70oC 
and the reaction mixture was stirred overnight at this temperature. Then the solvent 
was removed under reduced pressure and the residue was dissolved in 
dichlomethane (10 ml). The organic phase was washed with brine, dried over 
Na2SO4. The solvent was removed in vacuo, and the residue was purified by column 
chromatography on silica gel (CH2Cl2: CH3OH = 50:1 to 10: 1) to afford QDG-2 as 
a white solid (0.13 g, 90%). 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 0.85-0.90 (m, 1H), 1.21-1.31 (m, 1H), 
1.36-1.43 (m, 1H), 1.49-1.52 (m, 1H), 1.63 (s, 1H), 2.28-2.30 (m, 1H), 2.65 (s, 3H), 
2.74-2.95 (m, 5H), 3.89 (s, 3H), 5.10-5.13 (m, 2H), 5.86-5.94 (m, 1H), 7.21 (s, 2H), 
7.34 (s, 1H), 7.37-7.38 (d, J = 2.5 Hz, 1H), 7.39-7.40 (d, J = 2.55 Hz, 1H), 7.43 (s, 
1H), 7.54 (s, 1H), 8.01-8.03 (d, J = 8.8 Hz, 1H), 8.72-8.73 (d, J = 4.45 Hz, 1H); 13C 
NMR (125 MHz, CDCl3) δ 25.08, 26.28, 27.25, 28.69, 38.95, 46.66, 48.74, 55.39, 
60.50, 100.97, 114.26, 114.86, 120.36,122.21, 122.53, 123.43, 124.70, 126.87, 
127.63, 132.01 (q, J = 97.46 Hz), 132.04, 140.25, 144.94, 147.7, 151.80, 152.63, 
158.00; HRMS m/z calcd for C30H31F6N5O [M+H] + = 591.2433, found = 592.2387. 
Catalysts CDG-1 and CDG-2 were prepared following the similar experimental 




A white solid; 1H NMR (500 MHz, CDCl3) δ 1,23-1.25 (m, 1H), 1.63-1.69 (m, 1H), 
1.81-1.94 (m, 2H), 2.13-2.15 (d, J = 3.65 Hz, 1H), 2.72 (s, 1H), 3.01-3.03 (m, 1H), 
3.26-3.29 (d, J = 13.5 Hz, 1H), 3.46-3.59 (m, 2H), 3.89-3.94 (q, J = 23.85 Hz, 1H), 
5.04-5.09 (m, 2H), 5.55-5.59 (m, 1H), 5.60-5.61 (d, J = 4.6Hz, 1H), 7.27-7.30 (m, 
1H), 7.53-7.56 (m, 1H), 7.62-7.63 (d, J = 4.35 Hz, 1H), 7.88-7.94 (m, 2H), 8.29 (s, 
2H), 8.72-8.74 (d, J = 4.6 Hz, 1H); 13C NMR (125 MHz, CDCl3) 23.78, 24.35, 27.38, 
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38.14, 48.92, 57.08, 64.13, 111.81, 117.33, 118.75, 122.22, 122.52, 126, 03, 126,18, 
128.95, 129.58, 131.35 (q, J = 160 Hz), 137.19, 146.09, 147.42, 150.08, 152.18, 




A white solid; 1H NMR (500 MHz, CDCl3) δ 0.89-0.93 (m, 1H), 1.25-1.32 (m, 1H), 
1.44-1.55 (m, 2H), 1.65 (s, 1H), 2.31-2.2.33 (m, 1H), 2.85-3.02 (m, 5H), 5.12-5.18 
(m, 2H), 5.30 (br, 1H), 5.88-5.95 (m, 1H), 7.14 (s, 2H), 7.35 (s, 1H), 7.51-7.53 (d, J 
= 4.45 Hz, 1H), 7.58-7.62 (d, J = 15.8Hz, 1H), 7.72-7.75 (t, J = 15.57Hz, 1H), 8.14-
8.16 (d, J = 8.2Hz, 1H), 8.39-8.41 (d, J = 8.85Hz, 1H), 8.88-8.89 (d, J = 3.75 Hz, 
1H); 13C NMR (125 MHz, CDCl3) δ 25.05, 26.32, 27.36, 29.67, 39.14, 46.96, 48.94, 
61.17, 114.66, 115.07, 122.38, 123.16, 124.56, 126.79, 129.37, 130.49, 131.14 (q, J 
= 97.48 Hz),139.93, 148.63, 150.13, 151.13, 152.01; HRMS m/z calcd for 




A white solid; 1H NMR (500 MHz, CDCl3) δ 1.12 (br, 1H), 1.63 (br, 1H), 1.94-2.09 
(m, 3H), 2.65 (s, 1H), 2.79 (s, 3H), 3.21-3.33 (m, 2H), 3.59-3.64 (m, 1H), 4,12 (br, 
2H), 5.11-5.15 (m, 2H), 5.67-5.74 (m, 1H), 6.15 (br, 1H), 7.15 (s, 2H), 7.38 (s, 1H), 
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7.59-7.62 (t, J = 15.1 Hz, 1H), 7.73-7.76 (m, 2H), 8.12-8.14 (d, J = 8.2 Hz, 1H), 
8.48-8.50 (d, J = 7.5 Hz, 1H), 8.96 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 24.65, 
25.49, 26.93, 30.00, 37.60, 41.64, 54.26, 60.59, 115.60, 116.61, 119.89, 122.05, 
122.20, 123.41, 124.22, 127.44, 129.67, 130.36, 132.20 (q, J = 100.2 Hz),138.23, 
148.53, 150.39, 153.58; HRMS m/z calcd for C29H29F6N5 [M+H] + = 562.2327, 
found = 562.2358. 
 
4.6.3 Representative Procedure  
 
Ethyl 2-fluoro-3-oxo-3-phenylpropanoate 3-1 (10.5 mg, 0.05 mmol) was added 
to a mixture of catalyst QDG-1 (2.8 mg, 0.005 mmol) and di-tert-butyl 
azodicarboxylate 4-2 (11.5 mg, 0.05 mmol) in toluene (1.5 mL) in a sample vial. The 
vial was then capped and the reaction mixture was stirred at -50 oC for 20 h. Then 
the solvent was evaporated and the residue was purified by column chromatography 
on silica gel (hexane: ethyl acetate = 10:1 to 5: 1) to afford 4-3a as a white solid (21 










A white solid; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C21H29FN2O7Na [M+Na]+ = 463.1856, found = 
463.1843; The ee value was 90% (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, 





A white solid; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C20H27FN2O7Na [M+Na]+ = 449.1700, found = 
449.1675; The ee value was 91% (Chiralcel IC, λ = 254 nm, 7.5% iPrOH/hexane, 







A white solid; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C26H31FN2O7Na [M+Na]+ = 525.2013, found = 
525.1995.; The ee value was 88% (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, 





A yellow oil; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C21H28FN3O9Na [M+Na]+ = 508.1707, found = 
508.1714; The ee value was 82% (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, 







A white solid; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C21H28BrFN2O7Na [M+Na]+ = 541.0962, found = 
541.0977; The ee value was 89% (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, 





A colorless oil; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C21H28BrFN2O7Na [M+Na]+ = 541.0962, found = 
541.0974; The ee value was 88% (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, 





A white solid; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C21H28ClFN2O7Na [M+Na]+ = 497.1467, found = 
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497.1472; The ee value was 89% (Chiralcel AD-H, λ = 254 nm, 10% iPrOH/hexane, 





A white solid; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C22H31FN2O7Na [M+Na]+ = 477.2013, found = 
477.2018; The ee value was 91% (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, 





A colorless oil; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C22H31FN2O8Na [M+Na]+ = 493.1962, found = 
493.1939; The ee value was 89% (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, 






A colorless oil; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C25H31FN2O7Na [M+Na]+ = 513.2013, found = 
513.1991; The ee value was 92% (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, 





A colorless oil; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C19H27FN2O7SNa [M+Na]+ = 469.1421, found = 
469.1404; The ee value was 87% (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexane, 







A colorless oil; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C21H29FN2O7Na [M+Na]+ = 463.1856, found = 
463.1843; The ee value was 57% (Chiralcel AD-H, λ = 210 nm, 10% iPrOH/hexane, 





A colorless oil; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
see below; HRMS m/z calcd for C23H33FN2O7Na [M+Na]+ = 505.2326, found = 
505.2321; The ee value was 47% (Chiralcel IC, λ = 210 nm, 10% iPrOH/hexane, 





A colorless oil; 1H NMR (500 MHz, CDCl3) see below; 13C NMR (125 MHz, CDCl3) 
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see below; HRMS m/z calcd for C23H33FN2O7Na [M+Na]+ = 505.2326, found = 
505.2321; The ee value was 70% (Chiralcel IC, λ = 210 nm, 10% iPrOH/hexane, 














































































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              6
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          300.0 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :           1233
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          300.0 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz





























































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              6
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          300.0 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :           8141
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          300.0 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz





























































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              6
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          300.0 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :           1050
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          300.0 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz































































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              8
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          297.4 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :           1292
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          297.5 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz






















































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              6
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          300.0 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :           1000
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          300.0 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz




































































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              8
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          297.5 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :            401
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          297.8 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz











































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              6
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          300.0 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :            904
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          300.0 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz











































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              6
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          300.0 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :            902
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          300.0 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz


























































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              8
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          297.7 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :            509
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          297.7 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz




























































































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              6
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          300.0 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :            787
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          300.1 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz














































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              6
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          300.0 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :            513
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          300.0 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz












































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              8
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          296.6 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :           3000
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          296.7 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz



















































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              8
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          297.0 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz





















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :            541
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          297.9 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz






































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              8
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          297.4 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300130 MHz
*** 1D NMR Plot Parameters ***
NUCLEUS : off



















*** Acquisition  Parameters ***
LOCNUC : 2H
NS :           2701
NUCLEUS : off
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
TD :          65536
TE :          297.4 K
*** Processing Parameters ***
LB :           1.00 Hz
SF :    125.7577890 MHz
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Z, Calculated density                          2,  1.273 Mg/m3 
Absorption coefficient                        0.092 mm-1 
F(000)                                                 300 
Crystal size                                         0.70 x 0.10 x 0.08 mm 
Theta range for data collection           2.73 to 27.52o 
Limiting indices                                 -7<=h<=9, -9<=k<=8, -18<=l<=19 
Reflections collected / unique            5253 / 3028 [R(int) = 0.0196] 
Completeness to theta = 27.52           99.2 % 
Absorption correction                        Empirical 
Max.and min. transmission                0.9927 and 0.9385 
Refinement method                            Full-matrix least-squares on F2 
Data / restraints / parameters             3028 / 40 / 193 
Goodness-of-fit on F^2                     1.033 
Final R indices [I>2sigma(I)]            R1 = 0.0526, wR2 = 0.1346 
R indices (all data)                             R1 = 0.0566, wR2 = 0.1382 
Absolute structure parameter            0.0(11) 





Table 2.  Atomic coordinates (x 104) and equivalent isotropic 
displacement parameters (Å2 x 103) for jhl7. U(eq) is defined 
as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________ 
         x                 y                  z            U(eq) 
________________________________________________________ 
C(1)         1832(3)       8419(4)       4787(2)       51(1) 
O(1)         3018(2)       9041(3)       5398(1)       68(1) 
C(2)         1842(3)       7760(3)       3822(1)       46(1) 
F(1)         2175(2)       9296(2)       3306(1)       58(1) 
C(3)         -345(3)       7358(3)       3766(1)       44(1) 
N(1)           -51(2)       8086(3)       4694(1)       52(1) 
C(4)         3128(3)       6116(3)       3642(2)       47(1) 
O(2)         3058(2)      4725(3)       4315(1)        59(1) 
C(5)         2459(3)      5371(4)        2701(2)       50(1) 
C(6)         1428(4)      3699(4)        2542(2)       67(1) 
C(7)          650(5)       3154(6)        1672(3)       93(1) 
C(8)          896(5)       4275(8)         964(2)      100(1) 
C(9)         1955(5)       5901(7)       1114(2)       91(1) 
C(10)       2754(4)       6464(5)       1976(2)       67(1) 
C(11)       -1675(3)      8439(4)      3055(1)       47(1) 
IV 
 
C(12)       -1997(3)       7743(4)      2189(2)      61(1) 
C(13)       -3053(4)       8784(5)      1493(2)      74(1) 
C(14)       -3845(4)      10497(5)     1650(2)      74(1) 
C(15)       -3585(4)      11159(5)     2515(2)      76(1) 
C(16)       -2491(4)      10150(4)     3214(2)      62(1) 
C(17)       -4961(6)      11645(9)       872(3)     130(2) 
________________________________________________________ 
 
Table 3.  Bond lengths [Å] and angles [o] for jhl7. 
__________________________________ 
C(1)-O(1)                     1.211(3) 
C(1)-N(1)                     1.342(3) 
C(1)-C(2)                     1.538(3) 
C(2)-F(1)                     1.379(3) 
C(2)-C(4)                     1.528(3) 
C(2)-C(3)                     1.569(3) 
C(3)-N(1)                     1.477(3) 
C(3)-C(11)                   1.500(3) 
C(4)-O(2)                     1.420(3) 
V 
 
C(4)-C(5)                     1.512(3) 
C(5)-C(6)                     1.379(4) 
C(5)-C(10)                   1.389(3) 
C(6)-C(7)                     1.387(4) 
C(7)-C(8)                     1.370(6) 
C(8)-C(9)                     1.361(6) 
C(9)-C(10)                   1.382(4) 
C(11)-C(16)                 1.373(3) 
C(11)-C(12)                 1.381(3) 
C(12)-C(13)                 1.384(4) 
C(13)-C(14)                 1.366(5) 
C(14)-C(15)                 1.373(4) 
C(14)-C(17)                 1.523(4) 
C(15)-C(16)                 1.386(4) 
O(1)-C(1)-N(1)            132.9(2) 
O(1)-C(1)-C(2)            135.2(2) 
N(1)-C(1)-C(2)          91.89(16) 
F(1)-C(2)-C(4)         108.26(16) 
F(1)-C(2)-C(1)         109.87(19) 
VI 
 
C(4)-C(2)-C(1)        120.53(18) 
F(1)-C(2)-C(3)         112.66(16) 
C(4)-C(2)-C(3)         118.52(18) 
C(1)-C(2)-C(3)           85.51(15) 
N(1)-C(3)-C(11)       118.00(19) 
N(1)-C(3)-C(2)           85.82(14) 
C(11)-C(3)-C(2)       115.68(17) 
C(1)-N(1)-C(3)           96.75(17) 
O(2)-C(4)-C(5)             113.4(2) 
O(2)-C(4)-C(2)         106.51(16) 
C(5)-C(4)-C(2)         109.70(17) 
C(6)-C(5)-C(10)           119.0(3) 
C(6)-C(5)-C(4)             121.3(2) 
C(10)-C(5)-C(4)           119.4(2) 
C(5)-C(6)-C(7)              120.2(3) 
C(8)-C(7)-C(6)              120.2(4) 
C(9)-C(8)-C(7)              119.8(3) 
C(8)-C(9)-C(10)            120.9(4) 
C(9)-C(10)-C(5)            119.8(3) 
VII 
 
C(16)-C(11)-C(12)        118.5(2) 
C(16)-C(11)-C(3)          123.0(2) 
C(12)-C(11)-C(3)          118.4(2) 
C(11)-C(12)-C(13)        120.7(3) 
C(14)-C(13)-C(12)        120.8(3) 
C(13)-C(14)-C(15)        118.6(3) 
C(13)-C(14)-C(17)        120.0(3) 
C(15)-C(14)-C(17)        121.3(3) 
C(14)-C(15)-C(16)        121.0(3) 
C(11)-C(16)-C(15)        120.4(3) 
___________________________________ 
Symmetry transformations used to generate equivalent atoms: 
 
Table 4.  Anisotropic displacement parameters (Å2 x 103) for 
jhl7. The anisotropic displacement factor exponent takes the 
form: -2 π2 [h2 a*2 U11 + ... + 2 h k a* b* U12 ] 
________________________________________________ 
  U11         U22          U33        U23         U13        U12 
________________________________________________ 
C(1)     41(1)      52(1)      57(1)       -1(1)       3(1)      -1(1) 
O(1)     46(1)      84(2)      70(1)     -17(1)      -3(1)      -6(1) 
VIII 
 
C(2)     35(1)       47(1)      53(1)       2(1)       5(1)      -3(1) 
F(1)     52(1)       46(1)      77(1)      11(1)      16(1)     -3(1) 
C(3)     36(1)       45(1)      50(1)      -1(1)       6(1)      -1(1) 
N(1)     40(1)       66(1)      48(1)      -3(1)       6(1)       0(1) 
C(4)     34(1)       50(1)      59(1)       8(1)      11(1)       2(1) 
O(2)     47(1)       65(1)      67(1)      23(1)     14(1)      14(1) 
C(5)     40(1)       49(1)      64(1)       4(1)      17(1)      10(1) 
C(6)     64(1)       55(2)      86(2)      -9(1)      25(1)       2(1) 
C(7)     82(2)       92(3)     108(3)     -43(2)    29(2)     -16(2) 
C(8)     81(2)     139(4)      80(2)     -39(3)     11(2)      11(2) 
C(9)     97(2)     121(3)      61(2)       8(2)       30(2)      22(2) 
C(10)    69(2)      72(2)      66(2)       7(1)       26(1)       4(1) 
C(11)    32(1)      54(1)      53(1)      -1(1)        3(1)       0(1) 
C(12)    49(1)      72(2)      59(1)     -11(1)       0(1)      13(1) 
C(13)    53(1)    114(3)      52(1)      -3(2)        0(1)      14(2) 
C(14)    51(1)    101(2)      70(2)      24(2)      12(1)      23(2) 
C(15)    68(2)      75(2)      86(2)      13(2)      19(1)      30(2) 
C(16)    58(1)      67(2)      59(1)      -4(1)      10(1)      15(1) 
C(17)   110(3)   186(6)      92(2)      56(3)      17(2)      75(4) 
IX 
 
Table 5.  Hydrogen coordinates (x 104) and isotropic 
displacement parameters (Å2 x 103) for jhl7 
________________________________________________ 
           x               y                z           U(eq) 
________________________________________________ 
H(3)         -624          5987          3739          53 
H(1)         -831          8244          5057          62 
H(4)         4443          6583          3701          57 
H(2)         4140          4323          4507          89 
H(6)         1255          2934          3021          81 
H(7)          -41           2024          1569         111 
H(8)          341          3927            382         121 
H(9)         2144         6643            631         110 
H(10)       3486         7571          2070          81 
H(12)      -1498         6563          2072          74 
H(13)      -3227         8311            911          89 
H(15)      -4151        12303         2634          91 
H(16)      -2308        10634         3794          74 
H(17A)    -4333        11560           368         194 
H(17B)    -5020        12956         1048         194 
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Volume 1198.90(10) Å3 
Z 2 
Density (calculated) 1.439 Mg/m3 
Absorption coefficient 1.764 mm-1 
F(000) 536 
Crystal size 0.40 x 0.30 x 0.20 mm3 
Theta range for data collection 1.63 to 27.50°. 
Index ranges -11<=h<=11, -13<=k<=13, -16<=l<=16 
Reflections collected 15406 
Independent reflections 5453 [R(int) = 0.0265] 
Completeness to theta = 27.50° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7192 and 0.5388 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5453 / 1 / 299 
Goodness-of-fit on F2 1.014 
Final R indices [I>2sigma(I)] R1 = 0.0282, wR2 = 0.0644 
R indices (all data) R1 = 0.0309, wR2 = 0.0653 
Absolute structure parameter 0.016(5) 
XIII 
 
Largest diff. peak and hole 0.521 and -0.188 e.Å-3 
Table 2.  Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for 9366A.  U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
____________________________________________________________________ 
 x y z U(eq) 
____________________________________________________________________ 
Br(1) 6037(1) -1825(1) 10326(1) 45(1) 
F(1) -110(1) -112(1) 5061(1) 40(1) 
O(1) -527(2) -272(2) 7781(1) 49(1) 
O(2) -2149(2) -104(2) 6341(2) 64(1) 
O(3) 1317(2) -2041(1) 5779(1) 41(1) 
O(5) 1026(2) 2716(1) 8115(1) 38(1) 
O(6) -708(1) 3926(1) 7147(1) 35(1) 
O(7) 2785(1) 2656(1) 6059(1) 32(1) 
O(8) 3151(2) 578(1) 5659(1) 35(1) 
N(1) 1065(2) 1223(1) 6323(1) 26(1) 
N(2) 85(2) 2223(2) 6401(1) 26(1) 
C(1) -2048(3) 955(3) 8889(2) 57(1) 
C(2) -1711(3) -333(3) 8494(2) 56(1) 
C(3) -931(2) -122(2) 6755(2) 35(1) 
XIV 
 
C(4) 424(2) -2(2) 6131(1) 29(1) 
C(5) 1484(2) -1149(2) 6384(2) 29(1) 
C(6) 2573(2) -1217(2) 7364(2) 27(1) 
C(7) 3429(2) -2308(2) 7455(2) 31(1) 
C(8) 4464(2) -2501(2) 8336(2) 35(1) 
C(9) 4626(2) -1573(2) 9117(2) 32(1) 
C(10) 3811(2) -469(2) 9039(2) 34(1) 
C(11) 2771(2) -289(2) 8161(2) 31(1) 
C(12) 230(2) 2950(2) 7315(1) 27(1) 
C(13) -700(2) 5006(2) 7899(2) 39(1) 
C(14) -1229(4) 4562(3) 8941(2) 71(1) 
C(15) -1753(4) 5930(3) 7293(3) 73(1) 
C(16) 807(3) 5587(2) 8050(2) 51(1) 
C(17) 2446(2) 1447(2) 5964(2) 28(1) 
C(18) 4297(2) 3110(2) 5914(1) 31(1) 
C(19) 5383(3) 2449(2) 6722(2) 48(1) 
C(20) 4625(3) 2892(2) 4775(2) 45(1) 




Table 3.   Bond lengths [Å] and angles [°] for 9366A. 
__________________________________ 
Br(1)-C(9)  1.9042(18) 
F(1)-C(4)  1.384(2) 
O(1)-C(3)  1.310(3) 
O(1)-C(2)  1.477(3) 
O(2)-C(3)  1.180(3) 
O(3)-C(5)  1.205(2) 
O(5)-C(12)  1.202(2) 
O(6)-C(12)  1.340(2) 
O(6)-C(13)  1.474(2) 
O(7)-C(17)  1.309(2) 
O(7)-C(18)  1.493(2) 
O(8)-C(17)  1.203(2) 
N(1)-N(2)  1.391(2) 
N(1)-C(17)  1.407(2) 
N(1)-C(4)  1.423(2) 
N(2)-C(12)  1.371(2) 
C(1)-C(2)  1.483(4) 
XVI 
 
C(3)-C(4)  1.540(3) 
C(4)-C(5)  1.558(3) 
C(5)-C(6)  1.500(3) 
C(6)-C(7)  1.386(3) 
C(6)-C(11)  1.395(3) 
C(7)-C(8)  1.393(3) 
C(8)-C(9)  1.378(3) 
C(9)-C(10)  1.376(3) 
C(10)-C(11)  1.391(3) 
C(13)-C(16)  1.503(3) 
C(13)-C(14)  1.514(4) 
C(13)-C(15)  1.515(4) 
C(18)-C(20)  1.507(3) 
C(18)-C(21)  1.507(3) 





























































Table 4. Anisotropic displacement parameters (Å2x 103) for 9366A.  The 
anisotropic displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h 

















Br(1) 45(1)  48(1) 39(1)  12(1) -9(1)  -4(1) 
F(1) 45(1)  42(1) 29(1)  -4(1) -8(1)  1(1) 
O(1) 35(1)  72(1) 41(1)  10(1) 11(1)  -3(1) 
O(2) 30(1)  101(2) 61(1)  -7(1) -1(1)  -13(1) 
O(3) 53(1)  29(1) 37(1)  -8(1) -6(1)  -1(1) 
O(5) 41(1)  41(1) 29(1)  -2(1) -6(1)  1(1) 
O(6) 32(1)  37(1) 36(1)  -10(1) -1(1)  7(1) 
O(7) 27(1)  23(1) 47(1)  0(1) 12(1)  -1(1) 
O(8) 35(1)  26(1) 45(1)  -2(1) 15(1)  1(1) 
N(1) 26(1)  22(1) 31(1)  0(1) 5(1)  0(1) 
N(2) 26(1)  28(1) 24(1)  1(1) 1(1)  4(1) 
C(1) 53(2)  69(2) 53(2)  15(1) 17(1)  5(1) 
C(2) 49(1)  70(2) 52(2)  10(1) 24(1)  -9(1) 
C(3) 31(1)  31(1) 44(1)  -5(1) 4(1)  -8(1) 
C(4) 29(1)  30(1) 25(1)  -2(1) -1(1)  -5(1) 
XXI 
 
C(5) 32(1)  26(1) 30(1)  1(1) 4(1)  -7(1) 
C(6) 29(1)  24(1) 28(1)  2(1) 6(1)  -4(1) 
C(7) 34(1)  27(1) 33(1)  -3(1) 6(1)  -3(1) 
C(8) 34(1)  32(1) 39(1)  4(1) 4(1)  3(1) 
C(9) 29(1)  36(1) 30(1)  6(1) -1(1)  -7(1) 
C(10) 41(1)  33(1) 28(1)  -2(1) 1(1)  -2(1) 
C(11) 34(1)  26(1) 32(1)  -2(1) 1(1)  0(1) 
C(12) 25(1)  29(1) 28(1)  1(1) 5(1)  -2(1) 
C(13) 36(1)  40(1) 42(1)  -15(1) 9(1)  1(1) 
C(14) 85(2)  73(2) 61(2)  -27(2) 45(2)  -24(2) 
C(15) 63(2)  59(2) 93(2)  -35(2) -14(2)  26(1) 
C(16) 44(1)  43(1) 68(2)  -12(1) 7(1)  -9(1) 
C(17) 28(1)  27(1) 30(1)  2(1) 5(1)  0(1) 
C(18) 24(1)  30(1) 39(1)  -1(1) 7(1)  -6(1) 
C(19) 38(1)  48(1) 56(1)  4(1) -3(1)  3(1) 
C(20) 50(1)  40(1) 47(1)  0(1) 21(1)  -5(1) 




Table 5.   Hydrogen coordinates (x 104) and isotropic displacement parameters 
(Å2x 10 3) for 9366A. 
____________________________________________________________________ 
 x  y  z  U(eq) 
____________________________________________________________________ 
H(2N) -240(30) 2550(20) 5850(20) 39 
H(1A) -1174 1315 9278 86 
H(1B) -2818 893 9361 86 
H(1C) -2373 1498 8284 86 
H(2A) -1408 -888 9106 67 
H(2B) -2594 -698 8102 67 
H(7) 3310 -2929 6912 37 
H(8) 5037 -3245 8397 42 
H(10) 3956 158 9575 41 
H(11) 2203 458 8106 37 
H(14A) -2162 4127 8791 106 
H(14B) -1350 5291 9398 106 
H(14C) -514 3982 9301 106 
H(15A) -1360 6195 6639 110 
H(15B) -1880 6670 7738 110 
XXIII 
 
H(15C) -2695 5517 7116 110 
H(16A) 1482 4996 8438 77 
H(16B) 775 6372 8455 77 
H(16C) 1136 5767 7355 77 
H(19A) 5066 2536 7433 72 
H(19B) 6343 2835 6710 72 
H(19C) 5435 1554 6540 72 
H(20A) 4740 1987 4653 67 
H(20B) 5524 3332 4653 67 
H(20C) 3821 3217 4284 67 
H(21A) 3353 4873 5712 63 
H(21B) 5073 4939 6017 63 









Table 6.  Hydrogen bonds for 9366A  [Å and °]. 
____________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________
N(2)-H(2N)...O(3)#1 0.81(3) 2.21(3) 2.997(2) 165(2) 
____________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x, y+1/2,-z+1       
 
 
 
 
 
 
 
 
